Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.7812648089745446,-2.006223512341455,0.0,0.016190865393971236,0.015,13/19,13.75%,GRM7;GRIA2;GRM5;GRIA1;GRM1;GRM3;GRIK4;GRIA4;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,platelet-derived growth factor binding (GO:0048407),-0.8043452436703431,-1.8344867091470556,0.0,0.17303987389806758,0.267,7/11,2.27%,COL1A2;COL3A1;COL1A1;PDGFRB;PDGFRA;COL5A1;COL6A1
prerank,metalloendopeptidase activity (GO:0004222),-0.5257950397918871,-1.8212008123280332,0.0,0.13863428493587873,0.305,22/76,12.48%,TRABD2B;ADAMTS12;ADAMTS2;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;ADAMTS10;ADAMTS5;ADAMTSL1;MMP14;ADAMTS17;ADAMTSL4;MMP16;ADAM19;ADAMTS15;ADAMTS1;ADAM33;MMP2;ADAMTS14;ADAM9;MMP11
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.7450772719831229,-1.8198755474643629,0.002369668246445498,0.10574658960437464,0.309,6/15,8.99%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH2;ALDH7A1;ALDH1L1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.7643510726900085,-1.8146278073924849,0.00234192037470726,0.0920855469282114,0.33,6/13,8.99%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH2;ALDH7A1;ALDH1L1
prerank,retinoid binding (GO:0005501),-0.6780971038702964,-1.8065595749096346,0.005154639175257732,0.08837514027542633,0.371,7/22,8.27%,ALDH1A2;PTGDS;RBP1;ABCA4;RBP4;CYP26B1;CRABP2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7720782284859554,-1.7987379099692509,0.0,0.08543572721283037,0.406,7/14,15.95%,SLC7A11;SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.7590645283683042,-1.790005956203383,0.004405286343612335,0.08247222060054099,0.43,5/13,9.04%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,BMP receptor binding (GO:0070700),-0.759070183563673,-1.769987819744451,0.00646551724137931,0.09264772975439096,0.508,5/12,9.04%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,adenylate cyclase binding (GO:0008179),-0.82366219027173,-1.7568967409681173,0.0,0.09916905053807383,0.576,5/10,5.97%,ADCY5;ADCY2;AKAP12;AKAP6;CAP2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.7288964758071483,-1.7537515650149098,0.0024691358024691358,0.09328146312208428,0.588,7/15,15.95%,SLC1A3;SLC1A5;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18
prerank,pre-mRNA binding (GO:0036002),-0.6211576204607101,-1.751672685743729,0.0,0.0872788837643762,0.592,9/28,15.58%,CELF2;DDX5;CELF4;U2AF2;RBM4;CELF1;HNRNPU;HNRNPA1;RNPC3
prerank,amino acid:sodium symporter activity (GO:0005283),-0.7549080902299004,-1.717320715714347,0.015659955257270694,0.12158717185280322,0.736,6/11,7.50%,SLC6A13;SLC1A3;SLC6A1;SLC6A12;SLC6A15;SLC1A2
prerank,death receptor activity (GO:0005035),0.8397631085813276,1.7089046296360348,0.009398496240601503,1.0,0.897,6/11,7.31%,TNFRSF19;FAS;TNFRSF11A;TNFRSF1B;TNFRSF25;TNFRSF1A
prerank,phospholipid transfer activity (GO:0120014),0.733359505037858,1.7036427441686108,0.01011804384485666,1.0,0.91,10/21,13.86%,CERT1;PLTP;PRELID2;PITPNM2;GLTP;ABCA3;PLEKHA8;PITPNC1;C2CD2L;PITPNB
prerank,anion transmembrane transporter activity (GO:0008509),0.8146499757453639,1.6962576309350963,0.01217391304347826,1.0,0.927,3/12,0.92%,SLCO2B1;ABCG2;SLC39A8
prerank,sialyltransferase activity (GO:0008373),0.739907070923832,1.6886651103388464,0.014109347442680775,0.9276531164687317,0.945,6/20,7.31%,ST3GAL6;ST6GALNAC3;ST6GAL1;ST3GAL1;ST8SIA4;ST6GALNAC2
prerank,cadherin binding (GO:0045296),0.5121676242015208,1.6840626522988345,0.0,0.7800527570755532,0.956,86/315,14.47%,PTPRB;MRTFB;TJP1;DOCK9;FNBP1L;CLINT1;PKP4;BMPR2;KDR;ITGA6;EHD4;SPTBN1;EPN2;F11R;PPFIBP1;FLNB;PTPRM;CD2AP;LRRFIP1;TJP2;WASF2;IQGAP1;MYH9;DAB2IP;FASN;PTPRJ;SLC3A2;BSG;ESYT2;NCK1;COBLL1;STK24;PROM1;SWAP70;NUMB;TMOD3;PKN2;PAK2;TES;CDH2;PDLIM1;LASP1;CTNNA1;RPL34;TAGLN2;CHMP2B;ACVR1;UBAP2;SH3GLB1;FMNL2;UNC45A;HNRNPK;TBC1D2;TRIM25;CDH15;RPL15;PSEN1;SLK;RPL14;CHMP4B;PTPN1;CDH23;GAPVD1;SERBP1;TWF2;SPTAN1;FSCN1;SFN;CBL;STK38;PICALM;RAB11B;RPL6;RACK1;DBNL;HSP90AB1;LIMA1;CAPZA1;CAST;CDH5;TMPO;RARS1;APC;ERC1;RPL29;CNN3
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7690555995364455,1.6760392930885541,0.019642857142857142,0.605834544200918,0.966,4/16,5.16%,PTPRB;PTPRG;PTPRM;PTPRK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7690555995364455,1.6760392930885541,0.019642857142857142,0.605834544200918,0.966,4/16,5.16%,PTPRB;PTPRG;PTPRM;PTPRK
prerank,phosphatidylinositol binding (GO:0035091),0.5792437515228103,1.67032654841042,0.004037685060565276,0.5636169122136085,0.973,34/91,14.15%,EPB41;MCF2L;PARD3;HIP1;HIP1R;SCARB1;PITPNM2;DENND1B;MTM1;ESYT2;FCHO2;WDFY3;CCDC88A;EEA1;GRB7;ITPR3;PIGU;PLEKHF2;MYO1E;SNX24;MREG;PITPNC1;SH3YL1;PIGK;AIDA;ANKFY1;PICALM;PARD3B;SNX11;C2CD2L;ESYT1;EXOC8;PITPNB;SNX13
prerank,phosphatidylcholine transporter activity (GO:0008525),0.7366622183238292,1.6682906985579478,0.015817223198594025,0.5137906893104848,0.973,8/17,13.86%,ATP8B1;PLTP;ATP10A;PITPNM2;ABCA3;PITPNC1;ABCG1;PITPNB
prerank,leak channel activity (GO:0022840),-0.6658014780075546,-1.6678037597654574,0.011990407673860911,0.19009810708100155,0.9,3/18,2.75%,KCNK2;NALCN;KCNK5
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.5120316465949304,1.6618535654475572,0.0,0.4973630677433104,0.978,39/254,8.59%,MECOM;ERG;LEF1;ELK3;FOXO1;ESR1;MEF2C;ZBTB16;SMAD1;ZIC3;NFATC1;IRF2;HHEX;STAT3;NR3C1;HIF1A;KLF7;RREB1;SOX17;SOX18;TCF12;FOSL2;GTF2I;MAFF;SOX9;FOXF1;ELK4;FOXF2;HOXA10;TCF4;ATMIN;KLF10;NR1I3;HOXD8;TCF3;NFKB1;NEUROD1;NRL;CREB1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.7246585962098974,-1.661502986086032,0.017582417582417582,0.18882596765718956,0.912,5/12,8.73%,SULF1;SULF2;ARSI;ARSB;ARSG
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.8046411186602684,1.655843299509605,0.027985074626865673,0.48383201929329817,0.984,1/10,0.03%,MECOM
prerank,poly(U) RNA binding (GO:0008266),-0.6297481641584135,-1.6501961725898282,0.007537688442211055,0.19745266312491483,0.924,5/20,6.19%,RBMS3;HNRNPH1;ATXN1;DAZAP1;RBMS1
prerank,pyridoxal phosphate binding (GO:0030170),-0.6282820773940401,-1.6460086166181604,0.009523809523809525,0.19369513232346472,0.929,9/20,22.96%,PYGB;ABAT;PYGM;ACCS;OAT;CBS;PDXK;CTH;PNPO
prerank,glycerophospholipid flippase activity (GO:0140333),0.7986204472005016,1.6434529629485037,0.027124773960216998,0.5011031373949371,0.99,6/11,8.15%,ATP8B1;ATP8A1;ATP10A;ATP11C;ABCA3;ATP11A
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5882461227913608,-1.6271407217798186,0.00963855421686747,0.21570955040509596,0.962,13/29,13.75%,GRIA2;GABRG2;GABRA2;GRIK4;GRIA4;GABRB1;GRIK2;GRIK5;GABRB3;GRID2;GRIK1;GABRG3;GRIN2D
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.6764708239025284,-1.6256063217959686,0.022675736961451247,0.2077117599884468,0.964,5/14,5.64%,TIMP3;COL4A3;TIMP2;RECK;NGF
prerank,ligand-gated ion channel activity (GO:0015276),-0.5551098890900044,-1.61678858296269,0.015345268542199489,0.21280868702200945,0.974,14/30,13.75%,GRIN3A;GRIA2;GRIA3;GRIA1;ANXA6;GRIK4;GRIA4;GRIN2A;GABRB1;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,estrogen receptor binding (GO:0030331),0.6467188151629637,1.6146317423797807,0.012779552715654952,0.6128724074469527,0.997,9/32,11.94%,LEF1;TACC1;ESR1;DDX54;NCOA1;NRIP1;CNOT1;MMS19;DCAF1
prerank,ligand-gated channel activity (GO:0022834),-0.5589158296270728,-1.6045901665889126,0.020253164556962026,0.22937059308125918,0.984,14/29,13.75%,GRIN3A;GRIA2;GRIA3;GRIA1;ANXA6;GRIK4;GRIA4;GRIN2A;GABRB1;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,actin monomer binding (GO:0003785),0.6627628049430341,1.5664427379646138,0.03735144312393888,0.8910916896909779,1.0,8/22,13.49%,NOS3;MTSS1;TMSB4X;MRTFA;TWF2;ABL2;PFN4;LIMA1
prerank,poly-pyrimidine tract binding (GO:0008187),-0.5775776493414194,-1.5646992839515568,0.031007751937984496,0.30914433611613834,0.996,6/23,10.01%,RBMS3;HNRNPH1;ATXN1;DAZAP1;RBMS1;U2AF2
prerank,metallopeptidase activity (GO:0008237),-0.4244570259059841,-1.558871041023033,0.0,0.31180614958444064,0.997,21/113,9.27%,TRABD2B;ADAMTS12;ADAMTS2;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;PAPPA;ADAMTS10;ADAMTS5;ADAMTSL1;MMP14;ADAMTS17;ADAMTSL4;MMP16;ADAM19;ADAMTS15;ADAMTS1;ADAM33;MMP2;ADAM12
prerank,growth factor receptor binding (GO:0070851),0.525656793010147,1.5540870309874089,0.018469656992084433,0.9174092973786567,1.0,20/95,8.58%,IL1R1;IL6ST;ERN1;PDGFB;VEGFC;HIP1;IL6R;PDGFD;PTPRJ;FYN;FGF23;SDCBP;VEGFD;IL27RA;CCDC88A;PDGFC;TGFA;ERAP1;ITGA5;PSEN1
prerank,calcium channel activity (GO:0005262),-0.4415884580935676,-1.5536735666764494,0.01098901098901099,0.31150550398609245,0.997,19/84,10.29%,SLC24A3;CACNA1C;CACNA2D3;CACNA2D1;CACNA1D;PKD1;P2RX4;MCU;CACNB2;ITGAV;TRPC3;ANXA2;TRPC6;ANXA6;TRPC1;CACNB1;RYR2;SLC24A2;TRPC4
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6191701332960989,1.5518554792434436,0.03225806451612903,0.8748411816202644,1.0,10/35,7.46%,PEAK1;LYN;PTK2B;YES1;FYN;SRMS;DYRK1A;BMX;LCK;PTK2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.47431425308623065,-1.5495597929789575,0.017543859649122806,0.30928600618833557,0.997,10/55,4.86%,SLC7A2;SLC6A13;SLC16A12;SLC13A3;PDPN;SLC6A12;SLC16A6;SLC22A4;SLC38A11;SLC16A11
prerank,voltage-gated calcium channel activity (GO:0005245),-0.5232431870600861,-1.5490819516235892,0.017595307917888565,0.2983633993033257,0.997,7/37,5.58%,CACNA1C;CACNA2D3;CACNA2D1;CACNA1D;CACNB2;CACNA1G;ITGAV
prerank,protein phosphatase 2A binding (GO:0051721),0.657012830023003,1.5489653811936526,0.040783034257748776,0.8426546308800322,1.0,4/23,2.51%,FOXO1;CTTNBP2NL;DAB2IP;MFHAS1
prerank,solute:anion antiporter activity (GO:0140323),-0.647543168040205,-1.5471590599995262,0.04319654427645788,0.29158549251179683,0.997,6/14,14.48%,SLC7A11;SLC26A7;SLC26A2;SLC4A3;SLC4A2;SLC26A6
prerank,SH3 domain binding (GO:0017124),0.5563121231564142,1.5439604709731767,0.02109704641350211,0.8289936095080486,1.0,13/62,6.17%,SHANK3;ABI3;CD2AP;ELMO1;WASF2;PTPN12;DAB2IP;AFAP1L1;AFAP1L2;ARHGAP27;EVL;SKAP1;ADAM15
prerank,alkali metal ion binding (GO:0031420),-0.6542595370533975,-1.5380659229221867,0.031042128603104215,0.3019524115326555,0.998,2/13,2.18%,ATP1A2;HDAC4
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.7180824376990668,1.5270311784618784,0.050788091068301226,0.901170392258739,1.0,8/13,7.99%,IL1R1;ERN1;PDGFB;PDGFD;PTPRJ;VEGFD;PDGFC;ITGA5
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.7237703620941265,1.519191529364879,0.05555555555555555,0.9110213908055246,1.0,9/12,22.17%,CNOT6;PAN3;CNOT6L;CNOT1;CNOT2;CNOT7;PAN2;TOE1;NOCT
prerank,phospholipase inhibitor activity (GO:0004859),-0.6920741565113699,-1.5163310579355118,0.04421052631578947,0.34328821927993325,1.0,6/10,18.11%,ANXA5;ANXA1;ANXA2;ANXA4;SNCA;ANGPTL3
prerank,ligand-gated anion channel activity (GO:0099095),-0.6073759160151484,-1.5101056973526752,0.05491990846681922,0.3490143421487925,1.0,10/17,22.93%,GLRB;GABRG2;GABRA2;GABRB1;GABRB3;GABRG3;CFTR;GABRA1;GABRA5;GABRA3
prerank,cytokine receptor activity (GO:0004896),0.5261208228586539,1.5074753492409603,0.022606382978723406,0.945183215373164,1.0,12/83,6.17%,IL1R1;IL6ST;LIFR;IL6R;FZD4;OSMR;GHR;CSF2RB;IL27RA;CX3CR1;IFNAR1;IFNAR2
prerank,ion channel activity (GO:0005216),-0.42790209338216967,-1.503541393674001,0.006872852233676976,0.3528368226682159,1.0,23/80,13.75%,TRPM3;NALCN;PIEZO2;GRIN3A;GRIA2;ABCC9;GRIA3;GRIA1;TRPC6;ANXA6;TRPC1;CALHM5;GRIK4;GRIA4;UNC80;GRIN2A;GABRB1;GRIK2;GRIK5;TMEM63A;GRID2;GRIK1;GRIN2D
prerank,cation channel activity (GO:0005261),-0.42261082046810716,-1.5034195156319226,0.0,0.34196878587969715,1.0,22/94,10.14%,SLC24A3;TRPM3;NALCN;PIEZO2;CACNA1D;KCNK5;PKD1;MCU;ANO1;ABCC9;CACNB2;TRPC3;ANXA2;TRPC6;ANXA6;KCNQ4;TRPC1;CALHM5;RYR2;SLC24A2;UNC80;TMEM38A
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5871818168998789,-1.4989499330106346,0.04398148148148148,0.34285997342801594,1.0,5/18,10.97%,ALDH1A1;ALDH1A2;AKR1B1;ALDH2;FAR1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.7536046295837775,1.4929655852198425,0.07532956685499058,1.0,1.0,4/10,8.27%,CASP4;CASP8;CASP7;CASP1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6794053200689634,-1.4909411903345515,0.06041666666666667,0.3516155951551033,1.0,3/10,2.76%,SLC6A13;SLC6A1;SLC6A12
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.5562764173353447,-1.4874754365287968,0.05025125628140704,0.35050332351984526,1.0,4/22,3.91%,RBMS3;CPEB1;CPEB2;CPEB3
prerank,fatty acid synthase activity (GO:0004312),0.7423654647354856,1.4858352334295466,0.06844106463878327,1.0,1.0,2/10,3.86%,ELOVL7;ELOVL5
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.6338630079414965,1.4846701837641094,0.05188679245283019,0.9750659463444415,1.0,6/25,4.08%,NOS3;FMO2;FMO4;FMO1;CH25H;CYP26A1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6471668914844275,-1.4825823234153264,0.042283298097251586,0.3522918680254193,1.0,8/12,22.93%,GABRG2;GABRA2;GABRB1;GABRB3;GABRG3;GABRA1;GABRA5;GABRA3
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.683848698158589,-1.4825186617448387,0.052521008403361345,0.3428798639260429,1.0,4/10,8.66%,CACNA1C;CACNA1D;CACNB2;CACNB1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.5225636385723172,-1.4815216708356216,0.04456824512534819,0.3362533837659125,1.0,10/29,15.95%,SLC13A3;SLC26A7;SLC1A5;SLC26A2;SLC25A12;SLC25A13;SLC19A1;SLC26A6;SLC1A1;SLC25A18
prerank,Hsp90 protein binding (GO:0051879),0.5910751493291279,1.478948705392081,0.06697819314641744,0.9722062824692155,1.0,7/33,6.74%,KDR;ERN1;AHR;NR3C1;HIF1A;UNC45B;UNC45A
prerank,gap junction channel activity (GO:0005243),-0.5581107095986516,-1.4788597484597,0.04896907216494845,0.333910651850987,1.0,3/22,3.58%,GJB6;GJA1;GJB2
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5836945113361562,-1.4784830539446425,0.07621247113163972,0.32619534123416427,1.0,11/17,13.75%,GRIN3A;GRIA2;GRIA3;GRIA1;GRIK4;GRIA4;GRIN2A;GRIK2;GRIK5;GRIK1;GRIN2D
prerank,protein kinase C activity (GO:0004697),0.6999023140084372,1.4771663525646275,0.07465277777777778,0.9464998595566598,1.0,4/14,4.32%,PRKCH;PRKD1;PRKD3;PKN1
prerank,wide pore channel activity (GO:0022829),-0.5510978926372998,-1.4765138607898136,0.05384615384615385,0.3224598420308449,1.0,3/23,3.58%,GJB6;GJA1;GJB2
prerank,FMN binding (GO:0010181),0.719528131080411,1.4737275444631204,0.07339449541284404,0.9336934944459163,1.0,1/11,0.31%,NOS3
prerank,GTPase activator activity (GO:0005096),0.44776422638209057,1.4723490755639406,0.0054466230936819175,0.9078652637606942,1.0,68/313,10.32%,CHN2;FGD5;TBC1D8;ARHGAP31;RGS3;DOCK9;GNAQ;PREX2;RAPGEF5;DENND5B;RALGAPA2;TBC1D30;ARAP3;ARHGEF15;RASGRF2;RIN3;CYTH1;DOCK1;ELMO1;TBC1D4;IQGAP1;FGD6;ARHGEF2;BCR;SRGAP2;DENND4C;DENND1B;SPATA13;DOCK4;RALGAPA1;ARHGAP27;SGSM1;RASGRP3;PLCB1;TBC1D22A;ADRB1;TBC1D15;KALRN;ARHGAP8;PREX1;SIPA1L3;DENND2D;ARHGAP17;HERC2;RAP1GDS1;MYCBP2;CCDC88A;OPHN1;RAPGEF2;PGAM5;TBC1D12;SMAP1;ARRB1;RASA1;RAP1A;TBC1D2;BNIP2;RASA4;EIF2B5;ARHGEF7;LLGL1;CYTH2;ARHGAP28;NPRL2;GAPVD1;OCRL;RGL2;LARS1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.7013244396826346,1.46591551755272,0.08178438661710037,0.9142570018712437,1.0,9/12,14.62%,VEGFC;DAB2IP;VEGFD;GREM1;CCDC88A;ITGA5;ITGB3;CDH5;PGF
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.5854604473863948,-1.4622794927938085,0.06234413965087282,0.3481036059703816,1.0,6/16,15.95%,SLC13A3;SLC1A5;SLC25A12;SLC25A13;SLC1A1;SLC25A18
prerank,C2H2 zinc finger domain binding (GO:0070742),0.7241169961183694,1.4593466996777091,0.07792207792207792,0.9226056773371116,1.0,2/11,2.03%,LEF1;GATA2
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.45823731454107186,-1.4558499809820051,0.0440251572327044,0.3549517772344014,1.0,9/47,3.68%,SLC7A11;SLC7A2;SLC6A13;SLC47A1;PDPN;SLC6A1;SLC1A5;SLC22A4;SLC38A11
prerank,1-phosphatidylinositol binding (GO:0005545),0.6806186854826971,1.450482962008948,0.07944732297063903,0.9472636586686326,1.0,5/15,11.71%,EPB41;SCARB1;WDFY3;EEA1;PICALM
prerank,actin binding (GO:0003779),0.46609206865571357,1.44945627977194,0.01182033096926714,0.9239916544757123,1.0,20/170,4.28%,MYRIP;FLII;NOS3;PARVB;ABLIM1;SLC6A2;UTRN;LCP1;EPS8;FLNB;MYH9;KLHL2;MTSS1;ACTN4;SHROOM2;SSH2;TMSB4X;SORBS1;PDLIM1;MRTFA
prerank,potassium ion leak channel activity (GO:0022841),-0.6042782314617647,-1.4450615028764682,0.0883054892601432,0.3711479910907782,1.0,2/15,2.75%,KCNK2;KCNK5
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5679271479743278,-1.4447225633084422,0.066815144766147,0.363574877346843,1.0,11/19,22.93%,GABRG2;GABRA2;GRIK4;GRIK2;GRIK5;GRID2;GRIK1;GABRG3;GABRA1;GABRA5;GABRA3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.7066171254952526,1.442872701408956,0.1111111111111111,0.9337536725577686,1.0,4/11,8.27%,CASP4;CASP8;CASP7;CASP1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.46808705558133384,1.4408222135978004,0.017135862913096694,0.9179427586407837,1.0,26/147,6.12%,FGD5;DOCK9;PREX2;RAPGEF5;DENND5B;ARHGEF15;RASGRF2;RIN3;CYTH1;DOCK1;ELMO1;FGD6;ARHGEF2;BCR;DENND4C;DENND1B;SPATA13;DOCK4;ADRB1;KALRN;PREX1;DENND2D;HERC2;MYCBP2;CCDC88A;RAPGEF2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.5995449662845389,1.4403884949894645,0.09313725490196079,0.8938435487772569,1.0,6/24,9.21%,CERT1;PLA2G4A;DAB2IP;PLEKHA5;SNX3;PLEKHA8
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5995466363438599,1.4372036007722702,0.07804878048780488,0.8865564809161967,1.0,10/29,15.49%,GCH1;NFATC1;PTPRJ;PPM1D;DUSP16;MAPKAPK3;TNIP1;DUSP7;DUSP2;ACE
prerank,calcium channel regulator activity (GO:0005246),0.552777400498433,1.4361698388627069,0.07120743034055728,0.8682310937986931,1.0,4/37,8.74%,PRKG1;FKBP1A;SGK3;MCUB
prerank,TBP-class protein binding (GO:0017025),0.6190893706217155,1.435542795164858,0.0867430441898527,0.8484923735045745,1.0,6/21,12.88%,ESR1;AHR;HHEX;TAF1B;YEATS2;GTF2A2
prerank,protein kinase C binding (GO:0005080),0.5467421645804648,1.4348769728398643,0.07163742690058479,0.8299186550992157,1.0,12/43,10.19%,NELL2;HDAC9;ADCY4;CAVIN2;PRKD2;HDAC7;TIRAP;PKN1;CCDC88A;TRPV4;HINT1;TWF2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.6762588674326794,1.4312028540707955,0.10873440285204991,0.8277138216626542,1.0,2/15,6.32%,PLA2G4A;PLA2G2D
prerank,GABA receptor activity (GO:0016917),-0.5410141110191633,-1.4255139062543019,0.07542579075425791,0.40232980596513584,1.0,11/21,23.01%,GPR156;GABRG2;GABRA2;GABBR1;GABRB1;GABRB3;GABRG3;GABRA1;GABRA5;GABRA3;GABBR2
prerank,hexose transmembrane transporter activity (GO:0015149),0.6943270249748783,1.4233858117798923,0.09386281588447654,0.8468799631841135,1.0,3/12,6.85%,SLC2A1;MFSD4A;PPBP
prerank,peptidase inhibitor activity (GO:0030414),-0.4801821826428751,-1.4193865979142086,0.06629834254143646,0.4088624120099918,1.0,7/33,6.42%,GPC3;TIMP2;TFPI;ITIH2;RENBP;RECK;SERPIND1
prerank,retinoic acid receptor binding (GO:0042974),0.6307417274431312,1.4167043670954969,0.10479573712255773,0.8611380345164455,1.0,6/17,14.92%,TACC1;ACTN4;NRIP1;CNOT1;ASXL1;SNW1
prerank,endopeptidase inhibitor activity (GO:0004866),-0.40801218198456896,-1.4163028617717615,0.020491803278688523,0.40865069634991985,1.0,18/82,12.41%,TIMP3;SERPING1;COL4A3;TIMP2;TFPI;SERPINH1;ITIH2;RENBP;RECK;SERPINE2;NGF;SERPIND1;ANXA2;SERPINF1;BIN1;SERPINE1;CST3;SPOCK3
prerank,FAD binding (GO:0071949),-0.518092563692446,-1.4160988606623854,0.09571788413098237,0.4008478281849257,1.0,6/24,10.64%,MICAL3;MICAL2;DDO;PRODH;CRY2;AIFM1
prerank,CARD domain binding (GO:0050700),0.6675622696584053,1.4156333684658442,0.12280701754385964,0.8463533620379973,1.0,10/14,20.06%,NOD1;CASP4;CARD10;CASP1;CARD16;RIPK2;IRGM;CARD9;BCL10;CARD19
prerank,glutamate receptor binding (GO:0035254),0.6412303957310598,1.4132528900529948,0.1183533447684391,0.8399359961798768,1.0,3/17,3.95%,SHANK3;HIP1;HOMER2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5001038367867855,-1.4100712376468516,0.08823529411764706,0.4064514371339054,1.0,12/28,22.93%,GABRG2;GABRA2;GRIK4;GRIK2;GRIK5;GRID2;GRIK1;GABRG3;CHRNA7;GABRA1;GABRA5;GABRA3
prerank,nucleoside-diphosphatase activity (GO:0017110),0.6848697221972555,1.409506962936933,0.1038961038961039,0.8403572429628435,1.0,1/12,0.26%,ENTPD1
prerank,potassium ion antiporter activity (GO:0022821),-0.5705328942362697,-1.4022568537131026,0.11358574610244988,0.4176687702734002,1.0,4/15,11.28%,SLC24A3;SLC9A9;SLC24A2;SLC9A1
prerank,protein kinase binding (GO:0019901),0.41422997961919655,1.39454234455966,0.004162330905306972,0.8953718111743433,1.0,113/479,14.30%,NELL2;FRMD5;HDAC9;BMPR2;CAV1;ESR1;UTRN;SLC12A7;ADCY4;ACVRL1;GCH1;CAVIN2;SMAD1;PLCG1;NEDD9;TJP2;IQGAP1;DAB2IP;PRKD2;KCNQ1;ADAM10;STAT3;NR3C1;HDAC7;TRIM14;HIF1A;MSN;PTPRJ;SIK1;CCNK;TAOK2;PRKAR2B;PLCG2;CAV2;PPP1R12A;PAK2;SOX9;TIRAP;PKN1;RPS19;IKBKB;CEACAM1;GHR;PTPRK;TRIM68;TCF7L2;LRBA;CCDC88A;AURKA;DUSP22;RPS7;SKAP1;IFNAR2;ACVR1;RAC1;SASH1;CDKN1B;TRIB3;GNAT1;HNRNPA0;PPM1D;LCK;PTK2;AP2A1;GRB7;TCF3;TRPV4;RHOBTB1;DUSP16;POLA1;RPTOR;NEK6;ARHGEF7;LLGL1;MAP3K11;CRK;HINT1;RELB;PTPN1;RICTOR;MAP2K3;BCL2L1;MAPKAPK3;SPAG9;MAD2L2;TWF2;TNIP1;PRKAB1;EPHA4;PICK1;MAP3K13;STK38;IRAK4;PEBP1;RHOB;RELA;ADIPOR1;GSTP1;CEP68;ZFP36;RACK1;MYH6;WARS1;DUSP7;TRIB1;CDC25C;GSKIP;RPS6;CDH5;NPM1;TRAF6;BCL2L14;APC
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.6289017511924763,1.3923143056179765,0.12110726643598616,0.887898591518919,1.0,8/18,16.68%,RPS6KA3;RPS6KA1;SERPINB9;XIAP;GAS6;TNFAIP8;BIRC3;BIRC2
prerank,alanine transmembrane transporter activity (GO:0022858),0.6837312904318668,1.3914442745411395,0.11327433628318584,0.8732897146740696,1.0,3/12,4.80%,SLC38A5;SLC3A2;SLC6A6
prerank,GTPase regulator activity (GO:0030695),0.4371993232818358,1.390896490598217,0.025522041763341066,0.8581018031485457,1.0,44/212,10.32%,CHN2;TBC1D8;ARHGAP31;RGS3;GNAQ;PREX2;RALGAPA2;TBC1D30;ARAP3;DOCK1;TBC1D4;SH3BP4;IQGAP1;BCR;SRGAP2;RALGAPA1;ARHGAP27;SGSM1;RASGRP3;PLCB1;TBC1D22A;TBC1D15;ARHGAP8;PREX1;SIPA1L3;ARHGAP17;RAP1GDS1;CCDC88A;OPHN1;RAPGEF2;PGAM5;TBC1D12;SMAP1;ARRB1;RASA1;TBC1D2;BNIP2;RASA4;LLGL1;ARHGAP28;NPRL2;OCRL;RGS12;LARS1
prerank,protein phosphatase binding (GO:0019903),0.4649133217485999,1.3906837875611873,0.03896103896103896,0.8418135532696717,1.0,27/117,10.16%,FOXO1;PPP1R16B;CTTNBP2NL;IQGAP1;DAB2IP;KCNQ1;STAT3;MFHAS1;PXN;FLT4;PPP1R9B;JAK3;CEACAM1;ATP2B4;PPP3CB;SKAP1;CDKN1B;LCK;JAK1;PTK2;SNX3;SHOC2;ANAPC7;FBXL2;ANK1;SMG7;AP3B1
prerank,antiporter activity (GO:0015297),0.6316421955161713,1.387736986819427,0.10696095076400679,0.8384687122173579,1.0,6/20,10.18%,SLC25A16;SLC35E4;CLCN3;ATP1A3;SLC25A30;SLC35D2
prerank,BMP binding (GO:0036122),0.6754282066479445,1.3868157486357808,0.13932980599647266,0.8262205943987475,1.0,4/11,6.59%,BMPR2;ENG;GREM1;SOST
prerank,GTPase activity (GO:0003924),0.4351302152737825,1.385126355305104,0.03575547866205306,0.8183876903924266,1.0,52/192,17.98%,DNM3;RAB27A;GNAQ;GCH1;RAB11A;GBP5;GBP4;RASD2;GNB1;RAP1B;GPN3;RHOJ;RALB;GBP7;GNAI2;KRAS;NRAS;RAC1;GNAT1;RAP1A;RHOBTB1;RAB2A;GNA12;RAB38;ARL8B;DRG2;RNF112;RAB43;RAB11B;RHOB;HBS1L;GNA13;RAB31;RAB5A;RAB7A;ATL1;GBP3;RAB5B;NKIRAS1;RAB18;RAB32;GNAI3;RAB6A;IRGM;RHEB;MFN1;RHOA;RAB8B;RHOT1;EEF2;RND1;RAB1A
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.6648611123765398,1.3812295460318937,0.13097345132743363,0.8211420375255285,1.0,4/12,2.87%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,semaphorin receptor activity (GO:0017154),0.67758593922039,1.3811714026225603,0.14408233276157806,0.8064107700669044,1.0,3/11,2.82%,NRP2;PLXNA4;PLXND1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.6446664363954718,1.3743545278249105,0.14122137404580154,0.82146185314576,1.0,7/14,19.59%,NOD1;MAL;CASP1;RACK1;APAF1;CASP8AP2;CTSH
prerank,protein tyrosine kinase binding (GO:1990782),0.4775728513580383,1.3712209609449906,0.07417974322396577,0.8205333060110448,1.0,16/71,10.90%,PTPN14;BMPR2;NEDD9;TJP2;PITPNM2;DOCK4;NCK1;GRB14;CEACAM1;DUSP22;ACVR1;CRK;PTPN1;GAS6;EPHA4;CBL
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.5803213305888422,-1.3705737266237243,0.10426540284360189,0.49150563372059075,1.0,11/14,38.90%,ALDH4A1;ALDH1L1;MTHFD1;NOXRED1;AASS;BLVRB;PYCR1;PYCR2;MTHFR;CRYM;ALDH1L2
prerank,NAD binding (GO:0051287),-0.4979026727658026,-1.3680653749278349,0.09207161125319693,0.48904814410516423,1.0,6/26,7.60%,ALDH1A1;ME1;CRYL1;SIRT2;ALDH2;BDH2
prerank,peptidoglycan binding (GO:0042834),0.6689418070521016,1.3676294143995542,0.1415929203539823,0.822273201574371,1.0,2/10,6.35%,NOD1;PGLYRP2
prerank,low-density lipoprotein particle binding (GO:0030169),0.6236394147612303,1.367061895577269,0.152753108348135,0.810608346363809,1.0,4/16,5.30%,PLTP;SCARB1;STAB1;SCARF1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.4353447203595219,-1.3642572327287192,0.046242774566473986,0.48941762904438285,1.0,11/48,9.98%,TRPM3;NALCN;PIEZO2;SLC41A1;SLC12A2;ABCC9;TRPC6;TRPC1;CALHM5;ATP6V1B2;UNC80
prerank,cytokine receptor binding (GO:0005126),0.4733340446702876,1.3613707662710341,0.07372654155495978,0.821607247762432,1.0,17/83,9.61%,IL6ST;LIFR;KITLG;VEGFC;IL6R;SOCS2;OSMR;PXDN;FKBP1A;SDCBP;VEGFD;IL27RA;USP15;JAK1;ERAP1;CSF1;IL23A
prerank,Toll-like receptor binding (GO:0035325),0.6544197447660739,1.3557105513631793,0.148014440433213,0.8334663558925317,1.0,2/11,4.28%,DAB2IP;TIRAP
prerank,N-acyltransferase activity (GO:0016410),0.5510396033971573,1.353923208447959,0.10747663551401869,0.8282391183422433,1.0,6/32,10.44%,TGM2;NMT2;CERS4;GLYAT;PLAAT3;SMARCE1
prerank,AMP binding (GO:0016208),-0.6036998539825809,-1.3530463253525846,0.125,0.5097546779606444,1.0,7/11,18.16%,MPPED2;PFKP;PRKAG2;PRKAG3;ACSS2;PRKAG1;PFKM
prerank,mRNA 3'-UTR binding (GO:0003730),-0.3845262619713662,-1.3484722639107463,0.04597701149425287,0.512234889869311,1.0,19/79,16.23%,CELF2;RBMS3;CPEB1;DDX5;CPEB2;CPEB3;HNRNPA2B1;FXR2;DAZAP1;RBMS1;CPEB4;CIRBP;RBM4;CELF1;IGF2BP2;CSDC2;HNRNPU;ELAVL4;PCBP4
prerank,semaphorin receptor binding (GO:0030215),0.568406056040381,1.3456149596679472,0.13945578231292516,0.8503969579568855,1.0,6/23,10.43%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;SEMA4D
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.6280732547919167,1.3436129627879485,0.14535901926444833,0.8454098536509509,1.0,6/15,14.80%,SOCS2;PIK3R6;CISH;SLA2;SOCS6;SOCS4
prerank,lipoprotein particle binding (GO:0071813),0.5972026047525207,1.3409557679753943,0.15282392026578073,0.8434939113160116,1.0,5/20,8.24%,PLTP;SCARB1;STAB1;SCARF1;LPL
prerank,tropomyosin binding (GO:0005523),-0.5451595138819015,-1.3402422727823333,0.12941176470588237,0.5258658156083575,1.0,3/16,5.39%,CALD1;S100A6;TMOD2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.6373690501814341,1.3387838323953078,0.1718146718146718,0.8398908625959873,1.0,6/12,19.59%,NOD1;CASP1;RACK1;APAF1;CASP8AP2;CTSH
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.596224309465401,-1.3362710474931538,0.1461864406779661,0.5281746423186328,1.0,6/10,22.93%,GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,calcium:sodium antiporter activity (GO:0005432),-0.610388806449134,-1.3349901242364401,0.13793103448275862,0.5226184951479848,1.0,3/10,3.39%,SLC24A3;SLC8A3;SLC8A1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.41084909887584126,-1.3332286999125942,0.04827586206896552,0.5186979845745681,1.0,16/53,15.95%,SLC7A11;SLC7A2;SLC1A3;SLC47A1;SLC1A5;SLC6A9;SLC1A2;SLC25A12;SLC66A1;SLC7A6;SLC43A1;SLC6A7;SLC25A13;SLC1A1;SLC22A2;SLC25A18
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.4862983489950537,-1.3311529120926773,0.10164835164835165,0.5155695753885575,1.0,11/27,18.76%,SLC41A1;SLC12A2;CNNM2;TUSC3;MAGT1;SLC9B2;CNNM4;MRS2;SLC8A2;SLC4A8;ATP2A3
prerank,sequence-specific DNA binding (GO:0043565),0.39477346151430914,1.3303839890094944,0.011224489795918367,0.8629675966750284,1.0,90/590,11.89%,ERG;LEF1;ELK3;FLI1;FOXO1;LHX6;EPAS1;PBX1;TBX1;ESR1;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;SOX13;ELF2;HHEX;NR3C1;HIF1A;TGIF1;PKNOX2;PITX1;SOX18;TCF12;HMBOX1;MAFF;SOX9;KLF2;FOXF1;FOXQ1;ELK4;MBNL2;FOXL2;XBP1;TET3;TCF7L1;FOXF2;HOXA10;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;ELF5;FOSL1;ETS2;JUNB;KLF13;SPDEF;FOXN2;HOXD8;HOXD1;GMEB2;HNRNPD;NEUROD1;BACH2;NRL;CREM;CREB1;FOXK1;MYBBP1A;SOX4;MAFB;NFIB;SMG7;CREB3L4;SP2;KLF12;SMAD5;USF2;EGR3;TFAP4;POU2F1;CSRNP1;ACD;ATF6;CBFB;SP3;CEBPD;LONP1;PRDM2
prerank,"DNA binding, bending (GO:0008301)",0.6308837435196109,1.3276701647397449,0.17206132879045996,0.8615350709876063,1.0,2/14,2.25%,LEF1;HHEX
prerank,general transcription initiation factor binding (GO:0140296),0.5496395815004275,1.325124549574297,0.15847860538827258,0.8596404031520691,1.0,7/25,12.88%,ESR1;AHR;HHEX;TAF1B;YEATS2;RELA;GTF2A2
prerank,transcription coregulator binding (GO:0001221),0.4969404689665887,1.3248724207745144,0.11988304093567251,0.8483385799690961,1.0,11/50,9.12%,ESR1;PPARD;ZBTB16;LMO2;AHR;VGLL4;MTF2;TEAD2;CTBP1;NEK6;RPL23
prerank,clathrin adaptor activity (GO:0035615),0.6202025318855459,1.3248011769180488,0.1628721541155867,0.8365160147527718,1.0,4/15,7.58%,HIP1;HIP1R;AP2B1;AP2A1
prerank,protein serine/threonine kinase activity (GO:0004674),0.40254938878687974,1.3223690512466584,0.022653721682847898,0.8342479108991614,1.0,87/335,15.78%,PRKCH;RPS6KA5;BMPR2;SNRK;ERN1;ACVRL1;PRKD1;CDK6;DAPK1;NEK7;PIM3;PRKD2;BCR;PTK2B;STK10;PRKD3;MAP4K3;SIK1;CCNK;TAOK2;STK24;STK3;PKN3;PKN2;PAK2;PKN1;RPS6KA3;KALRN;STK4;LMTK2;MARK3;MAP3K9;IKBKB;RPS6KA1;HIPK1;ACVR2A;CDC42BPB;MAPK8;SRPK3;PLK2;MAST2;ULK1;LIMK2;AURKA;SIK3;ACVR1;TSSK6;DYRK1A;TNIK;SGK3;AKT2;NEK6;MAP3K11;AURKC;SLK;BRD4;CDK2;MAPKAPK3;MAPK11;NUAK1;AKT3;MAP3K13;SIK2;STK38;IRAK4;PIM1;RIPK1;MKNK2;RIPK2;TRIO;EIF2AK4;TGFBR2;TOP1;UHMK1;MAPK6;RIOK1;ACVR2B;MAP3K20;MYLK;NRBP1;PRKCG;PAK4;IRAK3;RPS6KA4;MAP4K2;CSNK1G2;CDKL4
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.5420742201446661,1.318371744513461,0.14960629921259844,0.8383804332063769,1.0,5/27,6.07%,RNF125;DCUN1D3;RNF144B;FOXL2;RNF144A
prerank,protease binding (GO:0002020),-0.3639953073809027,-1.3161041504885038,0.049107142857142856,0.5477311005607669,1.0,24/99,8.13%,COL1A2;COL3A1;COL1A1;TIMP3;PRKN;BCL2;TIMP2;CCBE1;SLC2A13;F3;DPP4;FAP;ATP9A;ADAMTSL4;NTRK2;SELENOS;ITGAV;PSAP;LDLR;STIM1;ANXA2;AMFR;ECM1;BDKRB2
prerank,GTPase binding (GO:0051020),0.4178998314067868,1.3138695789876982,0.0539906103286385,0.8461449135311346,1.0,50/195,15.31%,FGD5;FNBP1L;UNC13B;CAV1;LCP1;SPTBN1;TBC1D30;EPS8;RASIP1;RIN3;SH3BP4;IQGAP1;FGD6;ARHGEF2;SRGAP2;GNB1;DOCK4;SGSM1;PAK2;EXPH5;PKN1;BICDL1;NCKAP1;ULK1;MYCBP2;IARS1;RUSC2;RASA1;GCC2;EXOC5;YBX3;EXOC4;OCRL;CYRIB;MYO1C;BNIP3;ANKFY1;CYFIP1;PICALM;RILP;CCDC186;EXOC8;EVI5;RABGAP1L;ERC1;TNPO3;STRN3;AIMP1;RAPGEF6;YBX1
prerank,ephrin receptor binding (GO:0046875),0.5746138103714317,1.3101301561792413,0.18394648829431437,0.8504057840799573,1.0,9/21,11.23%,ANKS1A;LYN;EFNA1;FYN;PIK3CG;CRK;PTPN1;CBL;ANKS1B
prerank,anion:anion antiporter activity (GO:0015301),-0.5179696045312752,-1.3075336701745628,0.13064133016627077,0.5634999402294633,1.0,7/17,19.25%,SLC26A7;SLC26A2;SLC4A3;SLC4A2;SLC19A1;SLC26A6;SLC25A4
prerank,GTP binding (GO:0005525),0.4195499259337767,1.3061112529851138,0.07322929171668667,0.8558479599526387,1.0,37/172,13.82%,RAB27A;TGM2;GCH1;INSR;GBP5;MFHAS1;GBP4;RAP1B;RHOJ;RALB;GBP7;KRAS;NRAS;RAC1;ARL4A;GNAT1;RAP1A;RHOBTB1;RAB2A;DYNC1LI1;RAB38;TUBE1;ARL5A;NUDT16;ARL8B;NMUR2;DRG2;RNF112;RAB26;RAB11B;RHOB;RAB31;RAB5A;RAB7A;EIF2B2;ATL1;GBP3
prerank,transcription cis-regulatory region binding (GO:0000976),0.39425316042581837,1.3058304051974892,0.025423728813559324,0.8457775714661204,1.0,57/406,11.89%,LEF1;ELK3;FLI1;LHX6;EPAS1;DACH1;PBX1;SMARCA2;MEF2C;SOX7;NR5A2;AHR;ETV6;IRF2;FOXP1;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;RREB1;SOX17;ACTN4;ZFP57;SOX18;TCF12;FOSL2;SOX9;ZBTB46;FOXF1;XBP1;FOXF2;TCF7L2;ATMIN;KLF10;NR1I3;FOXA3;ASCL4;FOXN2;HOXD8;TCF3;NFKB1;CREM;FOXK1;TCF15;SOX4;FOXN3;ZBTB10;TFAP4;GABPB1;RB1;ATF6;SP3;SNAPC3;LONP1;PRDM2
prerank,protein tyrosine kinase activity (GO:0004713),0.4338843760573721,1.3044131196642796,0.1034928848641656,0.840764602489229,1.0,22/108,7.46%,TEK;FLT1;KDR;TIE1;EPHB4;INSR;PEAK1;LYN;PTK2B;YES1;FYN;SRMS;FLT4;LMTK2;JAK3;HIPK1;RET;DYRK1A;BMX;LCK;JAK1;PTK2
prerank,carbohydrate kinase activity (GO:0019200),-0.5854234106981586,-1.303629643003573,0.14549653579676675,0.5652730749022126,1.0,4/11,16.10%,GALK2;NAGK;HK2;GALK1
prerank,glucose transmembrane transporter activity (GO:0005355),0.5964036529461203,1.3022558818088856,0.17064846416382254,0.8388447918098948,1.0,3/17,6.85%,SLC2A1;MFSD4A;PPBP
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.5168488889654457,1.3015550947309504,0.15269461077844312,0.8311394606798521,1.0,10/33,16.32%,RNF125;DCUN1D3;RNF144B;FOXL2;RNF144A;SIAH1;TRAF6;ARIH2;RNF5;UBE3D
prerank,double-stranded DNA binding (GO:0003690),0.3882532557404353,1.301541174107426,0.025693730729701953,0.821013323230733,1.0,69/531,10.34%,ERG;LEF1;ELK3;FLI1;LHX6;PBX1;TBX1;ESR1;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;ELF2;AIM2;NR3C1;TGIF1;PKNOX2;PITX1;SOX18;TCF12;HMBOX1;MAFF;SOX9;KLF2;FOXQ1;ELK4;MBNL2;FOXL2;XBP1;TCF7L1;HOXA10;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;ELF5;FOSL1;ETS2;JUNB;KLF13;SPDEF;FOXN2;HOXD8;HOXD1;GMEB2;NEUROD1;BACH2;NRL;CREM;CREB1;FOXK1;SOX4;CGAS;NFIB;CREB3L4;SP2;KLF12;SMAD5;USF2;EGR3
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.562608320968464,-1.3012890733726679,0.16590909090909092,0.5627726856987175,1.0,7/13,22.93%,GLRB;GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,GDP binding (GO:0019003),0.4640786473553799,1.3003103466445205,0.11357340720221606,0.8156992616313224,1.0,20/63,16.87%,RAB27A;RAP1B;RALB;KRAS;NRAS;GNAT1;RAP1A;RAB2A;DYNC1LI1;ARL8B;RAB12;RAB11B;RAB31;RAB5A;RAB7A;RAB5B;RAB18;GNAI3;RHEB;RAB8B
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.38441362853258,1.2956688973236699,0.020512820512820513,0.8234334178199673,1.0,78/597,10.34%,ERG;LEF1;ELK3;FLI1;LHX6;PBX1;TBX1;ESR1;SMARCA2;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;SOX13;ELF2;HHEX;TAL1;STAT3;NR3C1;SOX17;TGIF1;PKNOX2;PITX1;SOX18;TCF12;HMBOX1;MAFF;SOX9;KLF2;FOXQ1;ELK4;MBNL2;FOXL2;XBP1;TCF7L1;HOXA10;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;ATMIN;KLF10;NR1I3;FOXA3;ELF5;FOSL1;ETS2;JUNB;KLF13;MCM10;SPDEF;FOXN2;HOXD8;HOXD1;GMEB2;NFKB1;NEUROD1;POLA1;BACH2;NRL;CREM;CREB1;FOXK1;SOX4;NFIB;CREB3L4;SP2;KLF12;SMAD5;USF2;EGR3
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.6115575086410041,1.292050888693621,0.20106761565836298,0.8268698236439244,1.0,3/13,7.41%,PIP5K1B;PIK3C2A;PIK3CG
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6453155135660452,1.2907070817912558,0.20616570327552985,0.8222000906614013,1.0,1/10,0.09%,SHANK3
prerank,nuclear receptor binding (GO:0016922),0.4306607897508927,1.2898102930361368,0.11096938775510204,0.8160340898466873,1.0,22/111,12.24%,LEF1;TACC1;ESR1;FOXP1;HIF1A;KDM3A;ACTN4;DDX54;PKN1;NCOA1;TRIM68;TCF7L2;JMJD1C;ARID1A;KDM4C;NRIP1;CNOT1;SMARCE1;MMS19;DCAF1;OASL;ASXL1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4695921522538565,1.2818234219624207,0.13929618768328444,0.8360316817850391,1.0,14/54,15.26%,HDAC9;ACER2;TGM2;GLS2;GLS;ASAH2;SIRT5;PM20D2;HINT1;MIER1;SIRT6;ACR;ASAH1;FAAH
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.6281276792770403,1.2816743769134056,0.21296296296296297,0.8270503579794815,1.0,7/11,15.69%,DAB2IP;SASH1;TCF3;MAP3K11;STK38;TRAF6;MAP4K2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3768147631342338,1.281115792302346,0.015120967741935484,0.8197212217866713,1.0,100/732,10.72%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;AHR;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;SOX17;TGIF1;PKNOX2;PITX1;SOX18;TCF12;FOSL2;MAFF;SOX9;KDM6A;KLF2;FOXF1;FOXQ1;ELK4;SP6;FOXL2;XBP1;ZFP92;TCF7L1;FOXF2;HOXA10;H3-3A;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;JUNB;KLF13;LYL1;FOXN2;HOXD1;GMEB2;TCF3;NFKB1;NEUROD1;BACH2;NRL;ZNF2;CREM;CREB1;FOXK1;CHD2;SOX4;RELB;MAFB;BACH1;NFIB;CREB3L4;NRIP1;SP2;SKIL;KLF12;SMAD5;USF2;EGR3;FOXN3;TFAP4;POU2F1
prerank,LRR domain binding (GO:0030275),-0.5251266435204056,-1.2806636935659397,0.16312056737588654,0.611373823470268,1.0,5/14,12.75%,ROBO1;PAWR;LRRFIP2;PMF1;ZXDC
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3770414425143701,1.2801991991680164,0.014141414141414142,0.8137685472093913,1.0,98/731,10.34%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;AHR;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;SOX17;TGIF1;PKNOX2;PITX1;SOX18;TCF12;FOSL2;MAFF;SOX9;KDM6A;KLF2;FOXF1;FOXQ1;ELK4;SP6;FOXL2;XBP1;ZFP92;TCF7L1;FOXF2;HOXA10;H3-3A;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;JUNB;KLF13;LYL1;HOXD1;GMEB2;TCF3;NFKB1;NEUROD1;BACH2;NRL;ZNF2;CREM;CREB1;TRIM24;FOXK1;CHD2;TCF15;SOX4;RELB;MAFB;BACH1;NFIB;CREB3L4;NRIP1;SP2;SKIL;KLF12;SMAD5;USF2;EGR3
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5252190209234641,-1.2800948420491771,0.1681614349775785,0.6041216650125518,1.0,3/14,2.94%,ENPP1;FHIT;NUDT4
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.584183393690942,-1.2791605756358355,0.210989010989011,0.5980500904898126,1.0,3/10,9.73%,DSE;RENBP;DSEL
prerank,frizzled binding (GO:0005109),-0.4351821362525451,-1.2786356943016568,0.15512465373961218,0.5909225899631187,1.0,13/34,17.67%,WNT4;RNF43;WNT6;WNT9A;RYK;LRP6;SFRP1;FZD1;WNT16;FZD7;WNT11;DVL1;MYOC
prerank,retinoid X receptor binding (GO:0046965),0.6174559001099198,1.2777928065293143,0.21973929236499068,0.813587902657512,1.0,2/11,9.90%,TACC1;NRIP1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.49489071746972424,1.275373845221229,0.16494845360824742,0.8128931301112486,1.0,11/42,11.12%,SHE;YES1;FBXW7;PLCG2;BCAR3;LCK;RASA1;NEDD4;SAMSN1;CRK;ABL2
prerank,phosphatase activator activity (GO:0019211),0.6028692969153192,1.272343095679331,0.20113851992409867,0.815512418300168,1.0,9/14,27.10%,PPP2R5A;PPP2R5E;PPP2R5B;CALM1;FRS2;PHACTR4;B3GAT3;CALM3;PPP2R5C
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5245468727093966,1.2701542916700788,0.18739903069466882,0.8148330809362555,1.0,10/30,16.68%,RPS6KA3;RPS6KA1;SERPINB9;XIAP;GAS6;CARD16;TNFAIP8;BIRC3;CAST;BIRC2
prerank,ligand-gated cation channel activity (GO:0099094),-0.363488121075508,-1.26847161155141,0.0916030534351145,0.6112629931416784,1.0,22/75,18.63%,GRIN3A;GRIA2;P2RX4;GRIA3;GRIA1;KCNJ2;KCNJ13;GRIK4;GRIA4;GRIN2A;GRIK2;GRIK5;GRIK1;KCNJ10;GRIN2D;KCNN2;CCDC51;KCNJ8;KCNJ15;KCNJ6;CHRNA7;KCNN3
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3823006573425617,1.267871055169026,0.05016008537886873,0.8145861249255053,1.0,97/431,15.69%,RPS6KA5;RAB27A;TGM2;SNRK;ERN1;ACVRL1;GCH1;CDK6;INSR;DAPK1;MYH9;PEAK1;GBP5;PRAG1;MFHAS1;GBP4;MAP4K3;SIK1;RAP1B;STK3;RHOJ;STK4;LMTK2;RALB;GBP7;SYN3;CDC42BPB;MAST2;ATP1A3;ATP1A1;TAP2;MTHFD1L;SIK3;ACVR1;TSSK6;KRAS;NRAS;RAC1;ARL4A;STK26;GNAT1;MTREX;MLKL;RAP1A;RHOBTB1;TRIP13;RAB2A;DYNC1LI1;RAB38;SMARCA5;HASPIN;AKT2;NEK6;PXK;ABCD4;TUBE1;ARL5A;NUDT16;ARL8B;NMUR2;TWF2;ATP7B;PSMA6;DRG2;AKT3;SIK2;STK38;RNF112;LONP1;PIM1;ABCD1;RAB26;MKNK2;RAB11B;RHOB;HSP90AB1;TOP1;UHMK1;PFKL;TRIB1;RAB31;RAB5A;MTPAP;RAB7A;ABCG1;EIF2B2;ATL1;GBP3;MAP3K20;RAB32;PMVK;PNPLA8;RAB6A;PANK3;IRAK3;RPS6KA4;MAP4K2
prerank,guanyl ribonucleotide binding (GO:0032561),0.40257527575923546,1.2674591912952526,0.08695652173913043,0.8077557508668057,1.0,52/196,17.63%,RAB27A;TGM2;GCH1;INSR;PDE2A;GBP5;MFHAS1;GBP4;CNGB1;RAP1B;RHOJ;RALB;GBP7;RAPGEF2;KRAS;NRAS;RAC1;ARL4A;GNAT1;RAP1A;RHOBTB1;RAB2A;DYNC1LI1;RAB38;TUBE1;ARL5A;NUDT16;ARL8B;RAB12;NMUR2;DRG2;RNF112;RAB26;RAB11B;RHOB;RAB31;RAB5A;RAB7A;EIF2B2;ATL1;GBP3;RAB5B;RAB18;RAB32;GNAI3;RAB6A;RHEB;RHOA;RAB8B;RHOT1;ADSS2;RND1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.6151478677679854,1.2668398487023935,0.20218579234972678,0.8016599252736745,1.0,4/11,14.63%,SGMS1;DPAGT1;GNPTAB;PIGF
prerank,E-box binding (GO:0070888),0.49795784305154484,1.2633736880252668,0.1804733727810651,0.8062258144823133,1.0,8/34,12.41%,AHR;TAL1;TCF4;TCF3;NEUROD1;TCF15;TFAP4;MAX
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.4368735175889084,-1.2612306570773075,0.15424164524421594,0.6234338328020158,1.0,11/27,19.96%,SLC8A3;SLC41A1;SLC9A9;SLC8A1;SLC9A1;SLC9B2;CNNM4;SLC8A2;SLC4A8;SLC8B1;SLC9A8
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5546002728697403,-1.2599126881304288,0.18201284796573874,0.6189773461943465,1.0,2/11,5.79%,SLC22A4;SLC25A47
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.5658308331697199,-1.2570614134911766,0.210412147505423,0.6183163963168554,1.0,1/10,0.52%,DPYSL3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6022867245519808,1.2568850908071645,0.24773960216998192,0.8211203065406928,1.0,2/10,1.65%,SLCO2B1;SLCO2A1
prerank,ribonuclease activity (GO:0004540),0.46177941174987974,1.2510603622349463,0.17146974063400577,0.8339891951666225,1.0,14/56,14.46%,ERN1;SAMHD1;CNOT6;N4BP1;RNASE1;RNASEH2A;ANG;RNASE4;KHNYN;DICER1;INTS11;EXOSC1;CNOT7;ZC3H12C
prerank,inward rectifier potassium channel activity (GO:0005242),-0.4638519582195262,-1.2494540605727558,0.18059299191374664,0.6308830869517424,1.0,9/24,18.63%,ABCC9;KCNJ2;KCNJ13;KCNJ10;KCNN2;KCNJ8;KCNJ15;KCNJ6;KCNN3
prerank,nucleoside-triphosphatase activity (GO:0017111),0.38312018065879083,1.246966287284202,0.09192825112107623,0.8409700468048256,1.0,59/248,17.63%,DNM3;RAB27A;GNAQ;GCH1;MYH9;RAB11A;GBP5;GBP4;RASD2;GNB1;RAP1B;KIF26A;GPN3;RHOJ;RALB;SMCHD1;GBP7;GNAI2;ABCA3;KRAS;NRAS;RAC1;GNAT1;RAP1A;RHOBTB1;RAB2A;GNA12;RAB38;MYO1E;ARL8B;DRG2;RNF112;MYL6B;ABCD1;RAB43;RAB11B;RHOB;HBS1L;GNA13;RAB31;RAB5A;TOR3A;RAB7A;ATL1;GBP3;RAB5B;NKIRAS1;RAB18;RAB32;GNAI3;RAB6A;IRGM;RHEB;MFN1;RHOA;RAB8B;RHOT1;EEF2;RND1
prerank,lysine N-methyltransferase activity (GO:0016278),-0.479317565951603,-1.2454414694216227,0.19315403422982885,0.634047781215742,1.0,10/20,28.16%,KMT5A;EHMT2;SETD4;VCPKMT;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;SETD7;EEF1AKMT3
prerank,protein phosphatase 1 binding (GO:0008157),0.545292452283197,1.245082545789691,0.19289340101522842,0.8393253653390215,1.0,4/21,8.49%,PPP1R16B;KCNQ1;PPP1R9B;SHOC2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4347937852496011,1.242381378942314,0.15214384508990317,0.8409710012783868,1.0,10/71,6.08%,PTPRB;PTPRG;PTPN14;PTPRM;PTPN12;PTPRJ;PTP4A2;PTPRK;MTMR6;DUSP22
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5043511649014663,-1.239272278613027,0.2069767441860465,0.6427081188873286,1.0,7/16,18.10%,SLC26A7;SLC26A2;SLC26A6;SLC1A1;CLCN7;CFTR;SLC4A8
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3633973747163389,1.2392228733379722,0.02710843373493976,0.8441030411078101,1.0,107/831,10.72%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;LHX6;EPAS1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;ETV6;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;SOX17;TGIF1;PKNOX2;PITX1;ACTN4;ZFP57;SOX18;TCF12;FOSL2;MAFF;SOX9;KDM6A;ZBTB46;KLF2;FOXF1;FOXQ1;ELK4;SP6;FOXL2;XBP1;ZFP92;TCF7L1;FOXF2;HOXA10;H3-3A;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;JUNB;ASCL4;KLF13;LYL1;HOXD8;HOXD1;GMEB2;TCF3;NFKB1;NEUROD1;BACH2;NRL;ZNF2;CREM;CREB1;FOXK1;CHD2;TCF15;SOX4;RELB;MAFB;BACH1;NFIB;CREB3L4;NRIP1;SP2;SKIL;KLF12;SMAD5;USF2;EGR3;ZBTB10;TFAP4;POU2F1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.47291698997524295,1.2385563813512657,0.2043343653250774,0.8382862562278087,1.0,1/44,0.03%,MECOM
prerank,transcription coactivator binding (GO:0001223),0.5485346176414195,1.2381418435721958,0.2384737678855326,0.8316705892887531,1.0,6/20,9.12%,ESR1;PPARD;AHR;VGLL4;TEAD2;RPL23
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.40875731612741445,-1.2375596730713274,0.17073170731707318,0.638829518507258,1.0,8/38,10.33%,SERPING1;TFPI;SERPINH1;SERPINE2;SERPIND1;ANXA2;SERPINF1;SERPINE1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.6018992011096599,1.2290387328026389,0.24007561436672967,0.8552544189137442,1.0,3/10,10.68%,ANKRD13A;USP15;FAN1
prerank,acid-thiol ligase activity (GO:0016878),-0.5306631278135902,-1.2259320999898413,0.2463157894736842,0.6629303131142118,1.0,4/13,14.95%,ACSL1;AASDH;AACS;ACSS2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.5596485691277506,1.223687545882934,0.25573192239858905,0.8654749182043482,1.0,2/16,3.22%,CD38;BST1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.44076558873607335,1.2162191206437547,0.20028818443804033,0.8838704345742832,1.0,10/60,5.60%,NRP2;TEK;FLT1;KDR;TIE1;EPHB4;INSR;FLT4;LMTK2;RET
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.48697892156416756,1.2132455444621753,0.21263482280431434,0.8865770417710794,1.0,12/35,17.70%,FOXP1;NR3C1;H3-3A;KLF10;TAF1B;RRN3;POU2F1;SNAPC3;RELA;NPM1;PIH1D1;STAT1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4240594045810073,1.2093215885354964,0.19225449515905949,0.8924641688674726,1.0,19/85,15.84%,PLA2G4A;ABHD2;PGAP1;LIPE;BCHE;ENPP2;PLA2G2D;CA1;PON2;LPL;PLAAT3;PTRH1;GDPD1;PNPLA2;PNPLA6;FAAH;NDST3;CA2;ESD
prerank,DNA-binding transcription factor binding (GO:0140297),0.383301485003562,1.2075347702316124,0.15563298490127758,0.8914906383342851,1.0,36/189,14.16%,HDAC9;LDB2;PPARD;MEF2C;LMO2;CRTC1;NFATC1;HHEX;TAL1;STAT3;HDAC7;TLE4;SIK1;PITX1;TCF12;GTF2I;EIF4E;TCF7L2;FBP1;TCF3;NEUROD1;CTBP1;CREM;CREB1;NEK6;ZFPM1;MAD2L2;USF2;SPEN;RB1;MIER1;RELA;PTMA;MEF2A;NPM1;MEF2D
prerank,manganese ion binding (GO:0030145),-0.3799161174012481,-1.2061190299329239,0.1831831831831832,0.7136790002298272,1.0,8/48,8.76%,MPPED2;ADCY2;LARGE1;ME1;FAM20C;NEK4;PPM1M;TDP2
prerank,chemorepellent activity (GO:0045499),0.4958334168195781,1.2048605720121306,0.2442622950819672,0.8931440980506468,1.0,3/25,1.68%,SEMA6A;SEMA5B;SEMA7A
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.47415424298383785,1.202540775019591,0.21684867394695787,0.8934272112613095,1.0,15/34,22.17%,CNOT6;PAN3;CNOT6L;ISG20;ANGEL2;CNOT1;REXO2;CNOT2;CNOT7;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,metalloaminopeptidase activity (GO:0070006),-0.48364590456873235,-1.2025012335071656,0.23261390887290168,0.7151302858699671,1.0,4/16,7.33%,MMP14;MMP16;NPEPPS;ENPEP
prerank,kinase binding (GO:0019900),0.35824033475751627,1.2003015377554176,0.1003167898627244,0.8932564197207491,1.0,94/434,14.30%,FRMD5;CAV1;ESR1;UTRN;SLC12A7;PDE8A;ACVRL1;SMAD1;PLCG1;PPP2R5A;IQGAP1;DAB2IP;ADAM10;FAS;STAT3;NR3C1;HDAC7;TRIM14;HIF1A;MSN;PTPRJ;SIK1;CCNK;TTC28;PLCG2;CAV2;PPP1R12A;PAK2;RPS19;PIK3IP1;IKBKB;CEACAM1;GHR;PTPRK;TRIM68;TCF7L2;ATP1A4;LRBA;AURKA;RPS7;SKAP1;IFNAR2;RAC1;SASH1;CDKN1B;TRIB3;BCAR3;GNAT1;HNRNPA0;LCK;PTK2;AP2A1;GRB7;STX1A;TRPV4;RHOBTB1;CASP1;POLA1;WWC2;RPTOR;NEK6;ARHGEF7;LLGL1;CRK;RELB;PTPN1;RICTOR;MAP2K3;BCL2L1;RAD23A;PRKAB1;BTG1;RB1;MAP3K13;IRAK4;PEBP1;CARD16;RHOB;RELA;ADIPOR1;CEP68;ZFP36;MYH6;WARS1;HSP90AB1;PFKL;CDC25C;LRRC14;GSKIP;RPS6;NPM1;TRAF6;BCL2L14;APC
prerank,ion channel inhibitor activity (GO:0008200),0.4661248546865447,1.2000840344949362,0.24444444444444444,0.8862492785722145,1.0,10/35,12.71%,NEDD4L;FKBP1A;STX7;RASA1;STX1A;NEDD4;MCUB;VAMP8;STX8;RACK1
prerank,potassium channel regulator activity (GO:0015459),-0.3765653324346634,-1.1988468532645529,0.1935483870967742,0.7173952580118861,1.0,11/49,9.95%,KCNIP3;KCNIP4;WNK4;ABCC9;DLG1;SLC5A3;KCNMB2;KCNS3;KCNAB1;DPP6;WNK1
prerank,cytokine activity (GO:0005125),-0.31923000665336654,-1.197744755464419,0.0979381443298969,0.7119414751856668,1.0,23/131,14.75%,BMP6;IL34;WNT4;BMP5;BMP7;IL18;WNT6;BMP4;FGF2;CXCL16;WNT9A;IL16;TNFRSF11B;VEGFA;CXCL12;INHBA;TGFB3;TGFB2;WNT16;GDF11;GDF1;IL17D;WNT11
prerank,alpha-actinin binding (GO:0051393),-0.4445497831322231,-1.1969368866680576,0.21782178217821782,0.7056315635593926,1.0,5/24,4.17%,CACNA1C;CACNA1D;DAG1;PALLD;PDLIM7
prerank,GABA-A receptor activity (GO:0004890),-0.4744373587210037,-1.1942488958792041,0.19815668202764977,0.7047604220819236,1.0,8/18,22.93%,GABRG2;GABRA2;GABRB1;GABRB3;GABRG3;GABRA1;GABRA5;GABRA3
prerank,acylglycerol lipase activity (GO:0047372),0.5791504984072786,1.192440679164145,0.3026086956521739,0.9052122742261316,1.0,2/11,3.88%,ABHD2;LIPE
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5639876926926801,1.1886666516050324,0.2765567765567766,0.9112822476208846,1.0,7/14,17.97%,MINDY1;MINDY2;USP15;ATXN3;YOD1;DESI2;USP7
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5315524166230499,-1.1849709761850185,0.286697247706422,0.7240888345530284,1.0,4/10,13.11%,B3GALT1;B4GALT6;B3GALT5;B4GALT7
prerank,G protein-coupled receptor activity (GO:0004930),0.3685725497413683,1.183583158321955,0.16777777777777778,0.9215223448991637,1.0,15/239,6.51%,ADGRG6;ADGRL4;CALCRL;CYSLTR1;ADGRL2;NPR1;S1PR1;ADGRG3;ADGRE5;ADGRG1;ADRB1;CX3CR1;HCRTR1;MCHR1;OPN4
prerank,voltage-gated cation channel activity (GO:0022843),-0.32642008632441566,-1.1815274204908015,0.1206896551724138,0.7257531879613024,1.0,18/97,10.70%,CACNA1C;CACNA2D3;CACNA2D1;KCNB2;CACNA1D;GRIN3A;KCNMA1;KCNQ3;KCND2;KCND3;CACNB2;ITGAV;KCNC2;KCNS3;KCNQ4;CACNB1;KCNQ5;GRIN2A
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5127479843451148,-1.180964756963411,0.27956989247311825,0.7193652672564218,1.0,3/11,4.91%,KCNK2;KCND2;KCND3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.44433661213939935,1.179724583229948,0.24415204678362573,0.9269746082575958,1.0,12/49,10.38%,MINDY1;BABAM2;RNF169;MINDY2;UBL7;BRCC3;ZRANB1;IKBKG;ZFAND2B;RAD18;RAD23A;TNIP1
prerank,ATP binding (GO:0005524),0.3648470413774592,1.1782945947599257,0.15185601799775028,0.9241880881419575,1.0,59/266,15.69%,RPS6KA5;SNRK;ERN1;ACVRL1;CDK6;INSR;DAPK1;MYH9;PEAK1;PRAG1;MAP4K3;SIK1;STK3;STK4;LMTK2;SYN3;CDC42BPB;MAST2;ATP1A3;ATP1A1;TAP2;MTHFD1L;SIK3;ACVR1;TSSK6;STK26;MTREX;MLKL;TRIP13;SMARCA5;HASPIN;AKT2;NEK6;PXK;ABCD4;TWF2;ATP7B;AKT3;SIK2;STK38;LONP1;PIM1;ABCD1;MKNK2;HSP90AB1;TOP1;UHMK1;PFKL;TRIB1;MTPAP;ABCG1;EIF2B2;MAP3K20;PMVK;PNPLA8;PANK3;IRAK3;RPS6KA4;MAP4K2
prerank,hexosyltransferase activity (GO:0016758),0.3972774372729946,1.1770049199357022,0.2178343949044586,0.9215449147999101,1.0,13/101,8.79%,CSGALNACT1;TMTC2;LFNG;MGAT4A;GBE1;MFNG;B3GNT3;B4GALT4;MTAP;B3GNT4;B4GALT5;B4GAT1;B3GNT6
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.521266227887905,-1.1768668583933422,0.2838427947598253,0.7230463311378718,1.0,2/11,2.65%,EGFR;MAP3K5
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5369228078574979,1.1759403595791331,0.2862190812720848,0.9181374525320709,1.0,6/18,14.80%,SOCS2;PIK3R6;CISH;SLA2;SOCS6;SOCS4
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.39584611939706643,1.1726322575043024,0.2147477360931436,0.9223521042448303,1.0,22/100,15.31%,CERT1;PLA2G4A;ARAP3;PARD3;HIP1;HIP1R;IQGAP1;DAB2IP;DENND1B;TECPR1;PLEKHA5;SNX3;PLEKHA8;SNX24;ARAP2;ANKFY1;SNX11;KIF16B;CYTH3;SNX13;ATG2A;ATG2B
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3741716030119998,1.1720520269942962,0.1969519343493552,0.9171339223388202,1.0,18/188,6.46%,FLI1;PBX1;SMARCA2;MEF2C;SOX7;NR5A2;AHR;SOX13;HHEX;TAL1;STAT3;SOX17;SOX18;TCF12;LIN54;TCF7L2;ATMIN;FOXA3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.45320484064256605,1.1708763367181092,0.2642089093701997,0.9138425980016526,1.0,11/38,15.31%,PLA2G4A;PARD3;HIP1;DAB2IP;TECPR1;PLEKHA5;SNX3;KIF16B;SNX13;ATG2A;ATG2B
prerank,DNA binding (GO:0003677),0.34332456525342725,1.1676118256996904,0.08748728382502544,0.9176318616238307,1.0,101/694,13.44%,MECOM;ERG;LEF1;FLI1;FOXO1;EPAS1;PBX1;TBX1;SMARCA2;APP;PPARD;TSHZ2;ZBTB16;NR5A2;AHR;ZIC3;LRRFIP1;IRF2;SOX13;HHEX;STAT3;AIM2;SAMHD1;HIF1A;ARID3B;TSHZ1;RPS15;HMBOX1;MAFF;SOX9;KLF2;ZNF292;FOXF1;ELK4;FOXL2;XBP1;TCF7L1;FOXF2;MTF2;TCF7L2;TCF4;LIN9;CNBP;ETS2;JUNB;LYL1;MCM10;SPDEF;RPA1;TCF3;ARID1A;NEUROD1;POLA1;NRL;CDT1;CREM;SMARCA5;EZH1;TAF4B;ANG;MYBBP1A;SUB1;APLP2;CHD2;RAD51D;CGAS;MAFB;BRIP1;RNF4;NFIB;MEIOB;RAD18;RAD23A;KLF12;USF2;GLYR1;TFAP4;FAN1;POU2F1;CSRNP1;RPS27;ZMYND11;ATF6;UNG;CBFB;SNAPC3;LONP1;MCM9;PRDM2;OASL;RELA;MAX;WDR76;RPL6;SLTM;ERCC4;TOP1;IMPDH1;ZBTB6;ACR;ESRRB
prerank,protein homodimerization activity (GO:0042803),0.3456437150156803,1.1660725723708671,0.09484536082474226,0.9157611223261493,1.0,88/589,10.77%,ABCG2;PECAM1;ZHX3;NOD1;ST6GAL1;TBX1;CADM1;RBPMS;ZBTB16;ERN1;F11R;GCH1;B2M;AHR;RASIP1;LRRFIP1;PDGFB;HIP1;HIP1R;MYH9;IL6R;DAB2IP;FZD4;HHEX;PDE2A;ADAM10;STAT3;GBP5;TPST2;GBP4;SRGAP2;STK10;TRIM14;TPD52;KLHL7;TPD52L1;ACTN4;TBC1D22A;FLT4;CAV2;CAT;ABCB7;ACTN1;SPPL2A;STK4;SMCHD1;MAP3K9;IKBKB;CEACAM1;GHR;GREM1;TRIM68;MTHFD1L;BOK;CCDC88A;DROSHA;MID2;TOX3;ACVR1;EEA1;SH3GLB1;STK26;SYNE1;PDGFC;TCF3;PKD2;LPL;CITED1;GSTA4;ANG;MAP3K11;SLK;DEFA6;CHMP4A;CHMP4B;NUDT16;CEP57;IKBKG;CSF1;IZUMO1;BCL2L1;INPP5F;USF2;CYP2R1;TFAP4;GGCT;SCARB2;BNIP3
prerank,phosphotyrosine residue binding (GO:0001784),0.4594420215360488,1.1649284077857895,0.28101644245142005,0.9124723130721053,1.0,9/37,11.12%,SHE;YES1;PLCG2;BCAR3;LCK;RASA1;SAMSN1;CRK;ABL2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5685964320157092,1.1642308490133857,0.32007575757575757,0.907981470339873,1.0,1/11,3.14%,CNGB1
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4209399855920276,1.1631768693138596,0.2539912917271408,0.9043095789906586,1.0,12/60,6.28%,TEK;FLT1;KDR;TIE1;EPHB4;ACVRL1;INSR;FLT4;LMTK2;ACVR2A;RET;ACVR1
prerank,zinc ion binding (GO:0008270),0.35394285019950616,1.1630101109344932,0.16279069767441862,0.8980605299653139,1.0,59/293,17.13%,MYRIP;SHANK3;TNFSF10;RNF125;GCH1;MSRB3;ARHGEF2;PDE2A;GDA;SAMHD1;KLF7;TES;TET3;ENPP2;ASAH2;MYCBP2;PAM;EEA1;ADAMDEC1;SIRT5;ERAP1;KDM4C;PRIMPOL;ZNF2;TRIM24;PGGT1B;PTPN1;AFM;SIAH1;RC3H1;RPS27;ZMYND11;PITRM1;RNF112;PRDM2;ADH1A;SIRT6;TET2;SORD;TMEM163;AOC1;IFIH1;ACR;RPS29;S100A9;MSRB2;KAT6A;ARIH2;ACE;RNF5;CA2;ZFPL1;TAB3;CHORDC1;BIRC2;KDM5C;APIP;KDM4A;ZNF8
prerank,SUMO transferase activity (GO:0019789),-0.4740423146333989,-1.1593741575064425,0.27293577981651373,0.7673378677727042,1.0,6/16,19.12%,HDAC4;MDM2;PIAS1;PIAS3;TRIM28;CBX4
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.5486388144887588,1.1553459626037592,0.3094812164579606,0.9174157676568485,1.0,5/12,18.35%,PIK3C2A;PIK3R6;PIK3CG;IPMK;PIK3C2B
prerank,phosphate ion binding (GO:0042301),0.5734918287710016,1.1547031777471857,0.29136690647482016,0.9129553985569601,1.0,4/10,19.80%,PDE2A;RELA;ADSS2;PNP
prerank,cGMP binding (GO:0030553),0.5578534777393536,1.1534218737980857,0.3172043010752688,0.9105396315878618,1.0,3/11,6.12%,PDE2A;CNGB1;RAPGEF2
prerank,Tat protein binding (GO:0030957),0.5707183981338946,1.1533660116413873,0.33868092691622104,0.9040270127610326,1.0,5/10,16.05%,DLL1;DNAJA1;GABARAPL1;NPM1;CTDP1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.4390159248508456,-1.152795191545238,0.2805755395683453,0.7780947624020775,1.0,5/21,18.45%,GRM5;GRIA1;GRM1;CHRNA7;CHRFAM7A
prerank,transcription corepressor binding (GO:0001222),0.47567000236559076,1.1513213028149745,0.3005008347245409,0.9042991223437642,1.0,6/27,11.14%,ESR1;ZBTB16;MTF2;CTBP1;NEK6;CNOT2
prerank,sterol transfer activity (GO:0120015),0.5188725479785699,1.1512287529109964,0.31596638655462184,0.8980052576777972,1.0,2/17,3.09%,PLTP;STARD5
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.49284552636609713,1.1492021781979544,0.3,0.8981810485400399,1.0,3/21,8.31%,POLK;PRIMPOL;POLA1
prerank,cholesterol transfer activity (GO:0120020),0.52503066371748,1.1488967771991763,0.3151618398637138,0.8928647947723432,1.0,2/16,3.09%,PLTP;STARD5
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5492091061244984,1.1472803544958017,0.3411978221415608,0.8918069678259286,1.0,5/12,21.48%,SPPL2A;PSEN1;SPPL3;DDI2;NAPSA
prerank,serine-type peptidase activity (GO:0008236),-0.31718949011691977,-1.146902537151253,0.18695652173913044,0.7872808297818514,1.0,12/96,9.22%,F3;RHBDL3;DPP4;HTRA3;PCSK5;FAP;HTRA1;NAALAD2;KLK2;PLAT;RHBDF1;MMP2
prerank,endopeptidase activity (GO:0004175),-0.27971908105434673,-1.1465208534061522,0.07407407407407407,0.7797903546912981,1.0,40/257,12.49%,TRABD2B;ADAMTS12;ADAMTS2;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;ADAMTS10;ADAMTS5;F3;RHBDL3;DPP4;HTRA3;PCSK5;ADAMTSL1;FAP;MMP14;ADAMTS17;ADAMTSL4;MMP16;USP24;USP11;ADAM19;ADAMTS15;TASP1;ADAMTS1;ADAM33;KLK2;PLAT;USP13;RHBDF1;SFRP1;MMP2;USP49;USP33;ADAMTS14;USP10;ADAM9;MMP11;KDM8
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.351919068878389,-1.1455144297112325,0.22012578616352202,0.7745936328400702,1.0,12/55,9.52%,SLC24A3;CACNA1D;PKD1;MCU;CACNB2;TRPC3;ANXA2;ANXA6;TRPC1;ATP2A2;RYR2;SLC24A2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5412438797872094,1.1441872041969658,0.3471698113207547,0.8957636967138205,1.0,4/12,17.70%,TRAF1;BABAM2;TRAF6;STAT1
prerank,ubiquitin-specific protease binding (GO:1990381),-0.43367404652187247,-1.1432870931888826,0.2842377260981912,0.7729200489071455,1.0,3/19,7.20%,PRKN;SELENOS;AMFR
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.49775348984334444,-1.1414796857569867,0.3030927835051546,0.7701419466115227,1.0,5/11,13.03%,TRPC3;TRPC6;TRPC1;TRPC4;TRPC5
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3625509248628619,1.139635996836216,0.2275943396226415,0.904213163266531,1.0,34/181,12.89%,LDB2;TACC1;PPARD;LMO2;NFATC1;TAL1;STAT3;HIF1A;NFKBIA;PITX1;ACTN4;GTF2I;NCOA1;DLL1;DTX3L;TCF7L2;FBP1;DNAJA1;TCF3;ARID1A;NEUROD1;CREB1;TAF4B;ZFPM1;NRIP1;MAD2L2;PSMA6;SMARCE1;SPEN;RB1;GABARAPL1;MIER1;RELA;RNF25
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4642243530931761,-1.1390714043073074,0.30995475113122173,0.7690977289976064,1.0,8/15,10.63%,HS3ST3A1;HS3ST3B1;HS6ST3;HS2ST1;HS3ST4;HS6ST2;HS3ST5;HS6ST1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5093455192281674,1.138697577885807,0.30756302521008405,0.9006782778308933,1.0,5/18,6.28%,BMPR2;ENG;ACVRL1;ACVR2A;ACVR1
prerank,protein phosphatase regulator activity (GO:0019888),0.421944425813978,1.135670311428164,0.2936857562408223,0.9045262011847105,1.0,21/53,21.63%,PPP1R16B;PPP2R5A;PPP1R2;PPP1R9B;LMTK2;PPP2R2C;PPP2R5E;PPP2R5B;SHOC2;PPP2R3A;PPP2R2D;MGAT5;RCAN1;PPP1R7;CALM1;PPP2R2A;EIF2AK2;PPP2R1A;PPP2R1B;PPP4R1;PHACTR4
prerank,dynactin binding (GO:0034452),-0.4916640566397653,-1.1352032731107142,0.3225058004640371,0.7726965322169211,1.0,5/12,13.82%,BICD1;SNX6;SNX5;HTT;BICD2
prerank,store-operated calcium channel activity (GO:0015279),-0.51622686226985,-1.132333878186136,0.32231404958677684,0.7731241483691381,1.0,6/10,13.69%,TRPC3;TRPC6;TRPC1;TRPC4;TRPC5;ORAI2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.565735785524663,1.1320530605140233,0.3320610687022901,0.9101644709799003,1.0,2/10,10.68%,ANKRD13A;FAN1
prerank,solute:sodium symporter activity (GO:0015370),-0.40475812600888816,-1.130311176635254,0.27906976744186046,0.7713659450480047,1.0,6/27,18.10%,SLC4A10;SLC5A3;SLC20A1;SLC5A6;SLC5A11;SLC4A8
prerank,small GTPase binding (GO:0031267),0.36398755367464647,1.1295604374743726,0.2469733656174334,0.9123351772372409,1.0,35/170,13.06%,FGD5;UNC13B;CAV1;TBC1D30;EPS8;RIN3;SH3BP4;IQGAP1;FGD6;ARHGEF2;SRGAP2;DOCK4;SGSM1;PAK2;EXPH5;PKN1;BICDL1;NCKAP1;ULK1;MYCBP2;RUSC2;GCC2;EXOC5;YBX3;EXOC4;OCRL;CYRIB;MYO1C;ANKFY1;CYFIP1;PICALM;RILP;CCDC186;EXOC8;EVI5
prerank,signaling receptor complex adaptor activity (GO:0030159),0.4396217310749288,1.129371940118603,0.315625,0.9069020364056822,1.0,5/38,4.22%,SHANK3;NCK1;CARD10;SH2B2;SORBS1
prerank,glycine binding (GO:0016594),-0.4955766631307135,-1.1285669346454565,0.3230769230769231,0.7686916924513982,1.0,2/11,4.04%,GRIN3A;GLRB
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.48823030459352246,-1.1279848820167764,0.3125,0.7625737294962492,1.0,6/12,7.17%,IGF1;IRS1;GNAS;IGF2;YWHAG;SHC1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3939716592209964,1.127691710704189,0.28289473684210525,0.9060800206445436,1.0,13/73,13.38%,CALCRL;CYSLTR1;NPR1;NLRP6;CX3CR1;HCRTR1;MCHR1;INPP5K;APLNR;MC4R;MC1R;NPFFR1;LTB4R
prerank,myosin binding (GO:0017022),0.4182427008204814,1.126154451319242,0.29428172942817293,0.9050968556936557,1.0,9/55,9.05%,MYRIP;SHROOM4;RAB11A;SHROOM1;NKD2;LMTK2;SPATA6;LLGL1;USH2A
prerank,hormone receptor binding (GO:0051427),0.5283897781769713,1.125403254765282,0.3501628664495114,0.9014175021701131,1.0,2/14,7.27%,SOCS2;JAK1
prerank,solute:proton symporter activity (GO:0015295),0.5103239632222744,1.1243008461972739,0.3191126279863481,0.8988970849017884,1.0,4/16,9.81%,SLC39A8;SLC2A9;SLC15A2;SLC15A1
prerank,phospholipase binding (GO:0043274),-0.4668742870729385,-1.1205758546830438,0.314410480349345,0.7760007967224487,1.0,2/13,1.21%,ARHGAP6;PRKN
prerank,potassium channel activity (GO:0005267),-0.3178285868151441,-1.1200110903851048,0.22900763358778625,0.770078035300757,1.0,22/89,14.46%,KCNK2;KCNB2;KCNK5;KCNMA1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNMB2;KCNS3;KCNQ4;GRIK4;TMEM38A;KCNQ5;GRIK2;GRIK5;KCNA6;GRIK1;KCNT1;KCNN2;CCDC51
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5369296971238593,1.1198099725366761,0.33213644524236985,0.9069295741903056,1.0,3/12,9.15%,CDK6;CCNK;BRD4
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4880052133144206,-1.1186852563866125,0.34051724137931033,0.7662443808745402,1.0,3/12,7.17%,IRS1;GAB2;SHC1
prerank,receptor ligand activity (GO:0048018),-0.27362330304627075,-1.1179871137565323,0.10752688172043011,0.760835749638365,1.0,44/245,14.21%,BMP6;IGF1;IL34;EPHA7;SEMA3D;PTN;EDA;NBL1;WNT4;BMP5;FGF1;BMP7;IL18;DPP4;SEMA5A;WNT6;BMP4;GREM2;FGF2;WNT9A;IL16;TNFRSF11B;IGF2;NGF;JAG1;SEMA3B;NRG3;OSGIN2;SEMA3A;VEGFB;VEGFA;INHBA;TGFB3;TGFB2;WNT16;FGF7;TAFA2;SEMA6C;GDF11;GDF1;SEMA4B;HBEGF;SEMA3G;IL17D
prerank,ubiquitin protein ligase binding (GO:0031625),0.34757819044274635,1.1158410325540973,0.2595505617977528,0.9141356080938862,1.0,71/254,19.83%,FOXO1;FZD6;FZD4;MFHAS1;FBXW7;HIF1A;TNFRSF1B;NFKBIA;PRKAR2B;CASP8;TRAF1;NKD2;TMBIM6;RALB;SMAD7;HERC2;PRR5L;CD40;TRIB3;DNAJA1;ATXN3;SNCAIP;ARRB1;JAK1;UBE2G1;ARRDC1;WRAP53;NEK6;RPL23;IKBKG;SPOPL;RAD18;SMAD5;CXCR4;SUMO2;MC4R;MC1R;RB1;CUL1;RIPK1;GABARAPL1;RELA;PA2G4;HSP90AB1;ASB4;TRIB1;TXNIP;NDUFS2;UBE2K;TRAF6;APC;MID1;UBXN1;BAG4;CHEK2;RPL11;KDM4A;NEDD8;CUL3;YOD1;BAG1;USP7;RNF40;PRKACB;CUL2;USP25;BCL10;TSG101;SMAD2;NLK;GPI
prerank,calcium channel inhibitor activity (GO:0019855),0.5410807622169692,1.115658657886879,0.35428571428571426,0.908904188944498,1.0,3/11,16.26%,FKBP1A;MCUB;CALM1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.46475920145386423,-1.114950061302149,0.34467120181405897,0.7619826026037714,1.0,5/14,21.60%,NOX4;AIFM1;CYBB;NOX1;NCF2
prerank,poly-purine tract binding (GO:0070717),-0.39473915972213797,-1.1143280832038283,0.3106267029972752,0.7565068367958804,1.0,5/27,8.34%,RBMS3;ATXN1;DAZAP1;RBMS1;TIA1
prerank,adenyl ribonucleotide binding (GO:0032559),0.3428067214470572,1.113012862042589,0.24444444444444444,0.9111168656945211,1.0,63/291,15.69%,RPS6KA5;SNRK;ERN1;ACVRL1;CDK6;INSR;DAPK1;MYH9;PEAK1;PDE2A;PRAG1;PDE4D;MAP4K3;SIK1;STK3;STK4;LMTK2;SYN3;CDC42BPB;MAST2;ATP1A3;ATP1A1;TAP2;MTHFD1L;RAPGEF2;SIK3;ACVR1;FBP1;TSSK6;STK26;MTREX;MLKL;TRIP13;SMARCA5;HASPIN;AKT2;NEK6;PXK;ABCD4;TWF2;ATP7B;AKT3;SIK2;STK38;LONP1;PIM1;ABCD1;MKNK2;HSP90AB1;TOP1;UHMK1;PFKL;TRIB1;MTPAP;ABCG1;EIF2B2;MAP3K20;PMVK;PNPLA8;PANK3;IRAK3;RPS6KA4;MAP4K2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.343322319695669,1.1106600492250707,0.27353266888150607,0.9124412301101694,1.0,75/269,19.83%,FOXO1;FZD6;FZD4;MFHAS1;FBXW7;HIF1A;TNFRSF1B;NFKBIA;PRKAR2B;CASP8;TRAF1;NKD2;TMBIM6;RALB;DTX3L;SMAD7;HERC2;PRR5L;CD40;TRIB3;DNAJA1;ATXN3;SNCAIP;ARRB1;JAK1;UBE2G1;ARRDC1;WRAP53;NEK6;RPL23;IKBKG;SPOPL;RAD18;SMAD5;CXCR4;SUMO2;MC4R;MC1R;RB1;CUL1;RIPK1;GABARAPL1;RELA;PA2G4;HSP90AB1;ASB4;TRIB1;TXNIP;NDUFS2;UBE2K;TRAF6;APC;MID1;UBXN1;BAG4;CHEK2;RPL11;KDM4A;NEDD8;CUL3;YOD1;BAG1;STAT1;USP7;PARP9;RNF40;PRKACB;STAM;CUL2;USP25;BCL10;TSG101;SMAD2;NLK;GPI
prerank,DNA polymerase activity (GO:0034061),0.47271985106961933,1.109926269653127,0.3456998313659359,0.9091423483066395,1.0,3/22,8.31%,POLK;PRIMPOL;POLA1
prerank,phospholipase activator activity (GO:0016004),-0.507606953061339,-1.107088427246832,0.3599137931034483,0.7699843381630603,1.0,3/10,10.18%,ARHGAP6;SRC;STX4
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.41100323988081255,-1.1058317262374417,0.29797979797979796,0.7664945066069079,1.0,9/21,33.79%,P2RX4;GLRB;GRIK2;CHRNA7;CHRNB2;P2RX5;P2RX7;P2RX3;P2RX6
prerank,RNA polymerase binding (GO:0070063),0.49279427089897554,1.1058148624839128,0.35618729096989965,0.9161765544345407,1.0,6/18,16.51%,STOM;PKN2;NEDD4;ZFP36;PHRF1;ANP32B
prerank,glucuronosyltransferase activity (GO:0015020),0.4875358274505277,1.1057616934290881,0.3401709401709402,0.9105931859283748,1.0,1/19,0.47%,CSGALNACT1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.512656832911696,1.1028228036176353,0.3711340206185567,0.9083000028584215,1.0,4/16,10.58%,ANO2;TTYH2;NMUR2;ANO6
prerank,intracellular chloride channel activity (GO:0061778),0.512656832911696,1.1028228036176353,0.3711340206185567,0.9083000028584215,1.0,4/16,10.58%,ANO2;TTYH2;NMUR2;ANO6
prerank,histone deacetylase binding (GO:0042826),0.3838650285227539,1.1013615524367808,0.3252361673414305,0.9071135977415387,1.0,18/88,14.68%,LEF1;HDAC9;MEF2C;TAL1;PKN2;PKN1;MAPK8;HOXA10;PHF6;SP2;TFAP4;MIER1;RELA;HSP90AB1;MEF2A;MEF2D;TRAF6;KAT2B
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.4968496824960091,1.0985131683595553,0.36486486486486486,0.9101011060218305,1.0,8/16,20.08%,MTM1;MTMR6;SYNJ1;INPP5F;MTMR12;MTMR9;MTMR2;SACM1L
prerank,rRNA binding (GO:0019843),0.42069779139694663,1.0978748430812595,0.3297709923664122,0.9063184713642595,1.0,16/42,21.26%,RPS14;CAVIN1;RRS1;ANG;RPL23;MRPS18A;NOP53;FASTKD2;RPS13;EMG1;RPL11;PTCD3;MRPL11;RPS3;SBDS;RCC1L
prerank,vinculin binding (GO:0017166),0.5510324983200704,1.0957294844103633,0.3798165137614679,0.907163285050168,1.0,6/11,12.77%,UTRN;PXN;ACTN1;CTNNA1;SYNM;RTCB
prerank,triglyceride lipase activity (GO:0004806),0.4761436573772776,1.094611280537182,0.3464163822525597,0.9051678082099655,1.0,4/20,18.96%,LIPE;LPL;PNPLA2;CEL
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.4450407695211087,1.0932353940055695,0.3441033925686591,0.9039703429319617,1.0,12/28,23.28%,EDC3;DROSHA;RNASEH2A;NUDT16;DICER1;RPP30;RPP25;ENDOV;PRORP;MRPL44;RNASEH1;DBR1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4443000962384884,1.09310381497982,0.357487922705314,0.8990326824364442,1.0,9/28,19.21%,DAB2IP;TRAF1;BABAM2;RIPK1;BID;TRAF6;CASP8AP2;STAT1;MADD
prerank,phosphatidylglycerol binding (GO:1901611),0.5175006666824156,1.0923786018636512,0.38656987295825773,0.895922879536204,1.0,6/13,23.71%,PLTP;PITPNC1;PITPNA;OPA1;UQCC3;STOML2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.5317726679589607,1.0916862786234114,0.3817204301075269,0.8926055688832546,1.0,3/12,1.39%,BMPR2;ENG;ACVRL1
prerank,lipase activator activity (GO:0060229),-0.489750968202852,-1.0857695148894548,0.34375,0.8176019049741976,1.0,1/10,0.11%,ARHGAP6
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3475771241382451,1.0851838052462661,0.32167832167832167,0.9066166679033979,1.0,22/173,10.23%,ELK3;DACH1;PPARD;ZBTB16;ETV6;LRRFIP1;FOXP1;SOX13;HHEX;NR3C1;KLF8;TGIF1;ZFP57;ETS2;TCF3;NFKB1;CREM;FOXK1;BACH1;SP2;SKIL;KLF12
prerank,NADP binding (GO:0050661),0.4336472118809678,1.0843813593109364,0.3700159489633174,0.9036202657109837,1.0,3/32,4.11%,NOS3;LBR;CAT
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4177097573464487,1.0818623492042962,0.3397626112759644,0.9056172926058137,1.0,6/42,4.24%,ESAM;CD200;BSG;ROBO4;TMOD3;PDLIM1
prerank,double-stranded RNA binding (GO:0003725),0.38532900978966517,1.0816428182370768,0.34349030470914127,0.9009700127202805,1.0,16/70,13.89%,LRRFIP1;ADARB1;MSN;SLC3A2;ACTN1;MBNL1;DROSHA;DICER1;RFTN1;RC3H1;ADAR;OASL;HSP90AB1;IFIH1;FMR1;DHX15
prerank,phospholipase A2 activity (GO:0004623),0.45644325908120215,1.0815225753802946,0.36824877250409166,0.8962345003837925,1.0,3/26,8.50%,PLA2G4A;PLA2G2D;PLAAT3
prerank,nuclear receptor coactivator activity (GO:0030374),0.4044775866956135,1.0783253752130897,0.35714285714285715,0.9003487006717016,1.0,11/52,11.33%,TACC1;CNOT6;ACTN4;ACTN1;PKN1;NCOA1;SS18;RBM14;RNF4;ZMIZ1;ENY2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.48798678902127973,1.0745868918045258,0.3800738007380074,0.9064639130705453,1.0,1/16,1.45%,PIR
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.4038675818237003,-1.07456655386125,0.33773087071240104,0.843410986443271,1.0,12/21,17.12%,AKAP7;AKAP6;ARFGEF2;PRKACA;EZR;AKAP8L;RYR2;WASF3;WASF1;ACBD3;PJA2;PRRC1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.407159777916148,1.0741507386529103,0.35209235209235207,0.9027200892279411,1.0,10/51,10.90%,SLCO2B1;SLCO2A1;SLC25A16;SLC16A2;SLC35E4;CLCN3;ANKH;SLC25A30;SLC35D2;SLCO1B1
prerank,deubiquitinase activity (GO:0101005),0.37254521668699747,1.0734756725234536,0.3561290322580645,0.8996356920430504,1.0,11/88,10.53%,USP53;MINDY1;USP3;MINDY2;EIF3H;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4
prerank,voltage-gated sodium channel activity (GO:0005248),-0.399602407057205,-1.0714590739419727,0.35135135135135137,0.8452047349385197,1.0,11/22,29.17%,SCN7A;CACNA1G;SCN2B;SCN1A;SCN8A;SCN2A;SCN1B;SCN5A;SCN9A;CACNA1H;HCN4
prerank,myosin II binding (GO:0045159),0.5220315200595025,1.0699963028698405,0.4188191881918819,0.9048470666581049,1.0,3/10,8.82%,SHROOM4;SHROOM1;LLGL1
prerank,cAMP response element binding (GO:0035497),-0.486990127649653,-1.069811937080401,0.4057017543859649,0.8424802182157224,1.0,4/10,20.05%,CREB5;E4F1;CREB3L1;NR4A3
prerank,heme binding (GO:0020037),0.37990769002274105,1.0666677006206955,0.3672316384180791,0.9097720336866547,1.0,6/65,5.93%,NOS3;PTGS2;PXDN;CYP26A1;CAT;CYCS
prerank,phospholipase C activity (GO:0004629),-0.3876780095742659,-1.0631505560973011,0.36,0.8544942249370874,1.0,7/25,8.13%,PLCL1;PLCE1;EDNRA;PLCD3;PLCB3;PLCD1;BDKRB2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.37179543376103746,1.0621129380512961,0.3687002652519894,0.917985527462804,1.0,9/72,4.85%,FLII;PARD3;HIP1;HIP1R;KCNQ1;PLCB1;FCHO2;TIRAP;SDCBP
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.3312503483484862,-1.06133911649654,0.3516819571865443,0.8522818747086263,1.0,11/49,14.89%,ATP1A2;MPPED2;PXYLP1;DUSP11;EPHX2;LHPP;DUSP10;PTPN22;SBF1;PPP1CB;ACP6
prerank,steroid hydroxylase activity (GO:0008395),-0.4343579398077821,-1.06071359008539,0.4013452914798206,0.8470195400285729,1.0,3/16,4.73%,CYP7B1;CYP27A1;CYP1B1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3767137026150515,-1.0603658384687198,0.37659033078880405,0.8408438796669283,1.0,3/27,3.59%,LRP1;HSPG2;SYT1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.4844427833634631,-1.0599989112085386,0.42290748898678415,0.834772891514803,1.0,4/10,21.60%,NOX4;CYBB;NOX1;NCF2
prerank,cysteine-type endopeptidase activity (GO:0004197),0.3721120588507093,1.0596884881713027,0.36351706036745407,0.9198391194666798,1.0,13/78,12.86%,CTSC;CASP4;CASP8;USP15;TINAG;CASP7;CTSK;CTSO;MALT1;CASP1;PIGK;LGMN;CAPN5
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.48666746510897646,1.0578755286987447,0.42334494773519166,0.9205670218154524,1.0,5/13,18.06%,SH3BP4;CCDC88A;GDI2;EIF5;ARHGDIA
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.42133014845577604,1.0566995003875412,0.3854660347551343,0.9191036994731848,1.0,13/33,22.17%,CNOT6;CNOT6L;ISG20;ANGEL2;REXO2;DCP2;CNOT7;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,diacylglycerol kinase activity (GO:0004143),0.5068352459928673,1.0564510799174096,0.42286751361161523,0.9149639421040898,1.0,3/11,11.26%,DGKZ;DGKH;DGKE
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.45500187555237276,1.054588289751206,0.4161073825503356,0.9155529946858141,1.0,4/23,3.85%,PLCB4;PLCG1;PLCB1;PLCG2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5175626708707035,1.0543241260407865,0.4432234432234432,0.9114915920048792,1.0,1/12,1.09%,TENT4A
prerank,SUMO binding (GO:0032183),0.5030011351177964,1.0516962295108536,0.41237113402061853,0.9140315633057625,1.0,7/13,21.89%,HERC2;RNF4;SERBP1;CASP8AP2;USP25;SIMC1;RNF111
prerank,5'-3' exonuclease activity (GO:0008409),0.48281982777409355,1.0486226001934906,0.4092465753424658,0.9180993292256094,1.0,5/14,18.05%,FAN1;DCP2;TRIR;XRN2;DCLRE1C
prerank,tau-protein kinase activity (GO:0050321),0.469679176673784,1.0486125939944786,0.4396551724137931,0.9133589343377911,1.0,5/20,6.69%,FYN;TAOK2;MARK3;SIK3;DYRK1A
prerank,sulfotransferase activity (GO:0008146),-0.3641559856986338,-1.0470178310544689,0.3728813559322034,0.8663898742987183,1.0,7/33,10.63%,UST;HS3ST3A1;CHST15;TPST1;HS2ST1;CHST3;HS6ST1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.42278438653453077,1.0440361600873338,0.3990963855421687,0.9220234619000318,1.0,4/34,2.10%,ARAP3;PARD3;HIP1R;IQGAP1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.4134317524332808,-1.043450779993717,0.4004739336492891,0.8622973910338773,1.0,5/17,10.27%,EPHA3;EPHA7;EPHA8;EPHA6;EPHA10
prerank,ephrin receptor activity (GO:0005003),-0.4134317524332808,-1.043450779993717,0.4004739336492891,0.8622973910338773,1.0,5/17,10.27%,EPHA3;EPHA7;EPHA8;EPHA6;EPHA10
prerank,metalloexopeptidase activity (GO:0008235),-0.3233092481745465,-1.043102787070312,0.3724832214765101,0.8562496032197976,1.0,8/51,8.95%,AEBP1;CPQ;MMP14;MMP16;NPEPPS;ENPEP;CPXM2;CPXM1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.4049619080816148,-1.0429911267742877,0.40669856459330145,0.8495514904357987,1.0,6/20,16.77%,MOGAT3;LPGAT1;AGPAT4;LCLAT1;LPCAT1;AGPAT3
prerank,voltage-gated ion channel activity (GO:0005244),0.48574508507199354,1.0389451132680034,0.4425925925925926,0.9318475153550213,1.0,4/14,10.58%,CACNA1E;PKD2;VDAC3;ANO6
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5119536787987041,1.0386948225010741,0.4492753623188406,0.9277562293488479,1.0,1/11,2.28%,PPP1R2
prerank,mRNA 5'-UTR binding (GO:0048027),0.43771475224860346,1.034021382303658,0.40268456375838924,0.9354497128122211,1.0,10/24,26.35%,IGF2BP3;RPS14;RPS7;FMR1;RPS13;DHX36;RPL26;MRPS11;RPL41;SYNCRIP
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.44228058160621797,1.0327814777675126,0.4197324414715719,0.9341639223253717,1.0,8/22,21.31%,PPM1F;DUSP23;DUSP16;DUSP7;DUSP2;DUSP19;MTMR2;DUSP18
prerank,cysteine-type peptidase activity (GO:0008234),0.37003859833466446,1.0327395256518361,0.42276422764227645,0.9296013828399531,1.0,10/73,8.27%,CTSC;CASP4;CASP8;USP15;TINAG;CASP7;CTSK;CTSO;MALT1;CASP1
prerank,NF-kappaB binding (GO:0051059),0.44369610289232975,1.0322926091626006,0.42716857610474634,0.9261674504322147,1.0,6/24,14.04%,NFKBIA;TAF4B;PSMA6;RELA;RNF25;NPM1
prerank,transition metal ion binding (GO:0046914),0.3070301907297684,1.0318643262043732,0.4057507987220447,0.9227827514312373,1.0,59/397,13.80%,MYRIP;SHANK3;NOS3;TNFSF10;RNF125;GCH1;MSRB3;ARHGEF2;PDE2A;GDA;SAMHD1;KLF7;KDM3A;TES;LCN2;TET3;ENPP2;ASAH2;MYCBP2;PAM;ABO;EEA1;ADAMDEC1;RNF7;SIRT5;ERAP1;KDM4C;PRIMPOL;ZNF2;TRIM24;PGGT1B;ANG;NUDT16;PTPN1;AFM;SIAH1;ATP7B;CYP2R1;RC3H1;RPS27;ABL2;ZMYND11;PITRM1;RNF112;PIM1;PRDM2;ADH1A;MGAT5;ETHE1;SIRT6;TET2;SORD;TMEM163;AOC1;IFIH1;ACR;MTPAP;RPS29;SOD2
prerank,protein heterodimerization activity (GO:0046982),0.32313432345262066,1.0312515518138665,0.38987043580683156,0.9198368105563208,1.0,23/178,8.26%,EPAS1;ZHX3;RALGAPA2;MEF2C;AHR;PDGFB;HIP1;FZD4;HIF1A;RALGAPA1;KCNB1;ADRB1;IKBKB;SDCBP;XBP1;TCF4;ATP1A1;BOK;AURKA;ITGA3;TCF3;MICU2;NEUROD1
prerank,calcium-activated potassium channel activity (GO:0015269),-0.4525404203150732,-1.029185581597737,0.460352422907489,0.8811372526125285,1.0,5/11,20.12%,KCNMA1;KCNMB2;KCNN2;KCNN3;KCNU1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5091694160479435,1.0283575588712186,0.453382084095064,0.9231529406612345,1.0,4/10,17.35%,ATXN3;OTUD4;YOD1;DESI2
prerank,histone acetyltransferase binding (GO:0035035),0.44186166472433985,1.028216479408912,0.43257443082311736,0.9190602823951078,1.0,3/21,5.41%,EPAS1;HIF1A;TRIM68
prerank,gamma-tubulin binding (GO:0043015),0.4614739027926471,1.0274929980840284,0.4423728813559322,0.9166675136528527,1.0,8/21,21.35%,DIXDC1;RAB11FIP5;ARHGEF7;RAD51D;PAK1;CDK5RAP2;GIT1;RACGAP1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.40668119939542874,1.0256887828421144,0.4381679389312977,0.916908791619104,1.0,9/37,17.58%,GARS1;FARS2;IARS1;TARS3;LARS1;WARS1;RARS1;KARS1;WARS2
prerank,phosphatase inhibitor activity (GO:0019212),0.4452423942343421,1.0236334042636122,0.42735042735042733,0.91800570336486,1.0,5/20,15.04%,PPP1R2;PPP1R9B;LMTK2;MGAT5;STYX
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.4506910169882648,-1.023220149881127,0.44893617021276594,0.8909023683032673,1.0,8/11,36.71%,NDUFAF7;CARM1;PRMT9;PRMT8;PRMT2;PRMT7;PRMT6;PRMT1
prerank,calcium activated cation channel activity (GO:0005227),-0.407997542968282,-1.0230549413739507,0.44766146993318484,0.8842814608475184,1.0,5/17,14.25%,KCNMA1;ANO1;KCNMB2;TMEM63A;KCNN2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5026325164213554,1.020685109208007,0.46422018348623856,0.9211354562928336,1.0,2/11,7.06%,KCNQ1;KCNE2
prerank,pyrophosphatase activity (GO:0016462),0.3761641856239806,1.019207763192091,0.4295676429567643,0.9207693769720771,1.0,14/50,19.51%,ENTPD1;PLPP1;BNIP2;NUDT16;RNGTT;PRUNE1;DCP2;NUDT15;NUDT14;PLPP5;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,CoA-ligase activity (GO:0016405),-0.4360211068280954,-1.0173523219525114,0.4321266968325792,0.8940034927182937,1.0,4/14,20.86%,ACSL1;AACS;ACSS2;ACSBG1
prerank,Notch binding (GO:0005112),-0.38222164321662766,-1.017176901851893,0.4452380952380952,0.8875171492790005,1.0,5/22,7.80%,SNED1;AAK1;JAG1;CCN3;DTX1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3360204331010058,-1.0148558420883846,0.44846796657381616,0.8873598320571834,1.0,9/35,11.39%,PLCL1;MPPED2;PLCE1;ENPP1;PLCB3;ENPP3;TDP2;SMPD3;SMPD4
prerank,UDP-glycosyltransferase activity (GO:0008194),0.36356416365867794,1.0141433279795729,0.4410958904109589,0.9297898353481225,1.0,8/70,8.79%,CSGALNACT1;LFNG;MGAT4A;MFNG;B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,neurexin family protein binding (GO:0042043),-0.4581985537529819,-1.0139410918342593,0.4666666666666667,0.8833362523595462,1.0,5/10,10.58%,NLGN2;NLGN1;SYTL2;SYTL5;NLGN3
prerank,cation transmembrane transporter activity (GO:0008324),-0.32007168972528355,-1.0137692391668516,0.4155405405405405,0.8772652720406162,1.0,5/48,3.53%,SLC7A2;SLC41A1;SLC1A5;SLC6A9;SFXN2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3578183622142196,-1.0129164064678955,0.41798941798941797,0.8732258070222926,1.0,7/27,7.88%,SLC26A7;SLC22A8;SLC26A2;ANO1;SLC22A6;SLC39A14;SLC5A5
prerank,titin binding (GO:0031432),-0.42268471252185064,-1.0115296315616076,0.4539614561027837,0.870669873352305,1.0,2/13,10.96%,ACTN2;TRIM63
prerank,voltage-gated potassium channel activity (GO:0005249),-0.2879408347747114,-1.0102111302888905,0.4068441064638783,0.8678500195618325,1.0,23/80,18.87%,KCNK2;KCNB2;KCNMA1;KCNQ3;KCND2;KCND3;KCNC2;KCNS3;KCNJ2;KCNQ4;KCNJ13;KCNQ5;KCNA6;KCNJ10;KCNT1;KCNN2;KCNJ8;KCNJ15;LRRC38;KCNJ6;KCNE4;KCNN3;KCND1
prerank,iron ion binding (GO:0005506),-0.3167538804858318,-1.0092936682598104,0.46153846153846156,0.8640750038379788,1.0,13/48,20.30%,AGMO;AOX1;KDM7A;TET1;EGLN3;FDX1;SCD;FTO;SNCA;ACO2;NFU1;ABCE1;SCD5
prerank,DNA replication origin binding (GO:0003688),0.434553764520617,1.0075651985374499,0.4521452145214521,0.943140598319431,1.0,6/23,16.14%,MCM10;POLA1;MCM9;GRWD1;ORC5;ORC3
prerank,calcium ion binding (GO:0005509),-0.24372580221383608,-1.0071505452456022,0.4594594594594595,0.8635475440687104,1.0,52/323,11.30%,LRP1;FBN1;GSN;CDH11;FBLN1;ENPP1;ADGRV1;SPARC;CLEC3B;KCNIP4;ANXA5;SLC8A1;CDH13;THBS1;GJB2;SYT1;ASPH;SMOC2;C2CD5;CDH1;SCUBE1;S100A6;AMY1A;AMY1C;AMY1B;ANXA1;PCLO;NRXN1;RASGRP2;RCN3;THBS3;STIM1;SYT9;PLSCR2;SYT12;SYT11;ANXA2;ASPN;S100B;ANXA6;PITPNM3;ATP2A2;RCN1;ENPP3;ANXA3;RYR2;SLC25A12;TKT;S100A10;SLIT2;ANXA4;MICU1
prerank,kinase activity (GO:0016301),0.3368328943865799,1.007149078684776,0.45603015075376885,0.9397154410938191,1.0,26/109,18.35%,PRKD1;DGKZ;LYN;PRKD3;PIK3C2A;PKN2;DGKH;ITPKB;TRIB3;PIK3CG;CERKL;PANK2;NMRK1;EPHA4;GK5;DGKE;IDNK;CHKA;PMVK;RFK;PANK3;PAPSS1;DOLK;IPMK;CSNK2A1;PIK3C2B
prerank,I-SMAD binding (GO:0070411),0.4843899423517082,1.0031981955140876,0.4612736660929432,0.9464908524916601,1.0,4/13,10.28%,SMAD1;SMURF1;SMAD7;SMAD5
prerank,anion channel activity (GO:0005253),0.36727868685232185,1.0016039200648506,0.45414847161572053,0.9462007945522536,1.0,8/61,10.73%,LRRC8C;ANO2;LRRC8B;BEST1;CLCN3;VDAC3;ANO6;GABRD
prerank,protein phosphatase activator activity (GO:0072542),0.48242310976002045,1.0011417262374473,0.4678030303030303,0.9429903097117868,1.0,3/13,8.37%,PPP2R5A;PPP2R5E;PPP2R5B
prerank,amino acid binding (GO:0016597),0.4124213478229165,1.000230480246119,0.49597423510466987,0.941047399663377,1.0,2/31,4.82%,NOS3;PADI4
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3407223743405654,-0.9998059860358991,0.47564469914040114,0.8773203595047115,1.0,10/33,19.53%,AR;RECQL5;CTR9;PAF1;ERCC5;DRAP1;WDR43;HNRNPU;UVSSA;ELP4
prerank,serine-type endopeptidase activity (GO:0004252),-0.28583988493061413,-0.9985679695628841,0.4581673306772908,0.8743873922886378,1.0,9/80,9.22%,F3;RHBDL3;DPP4;PCSK5;FAP;KLK2;PLAT;RHBDF1;MMP2
prerank,lipid phosphatase activity (GO:0042577),0.4648145542173665,0.9984466004834363,0.46964285714285714,0.9414715154028391,1.0,3/14,6.61%,PLPP1;SGPP2;INPP5K
prerank,syntaxin-1 binding (GO:0017075),0.4291347986653027,0.9955154998588488,0.475,0.9449574781240954,1.0,3/22,4.38%,UNC13B;DAPK1;SYPL1
prerank,cell adhesion mediator activity (GO:0098631),0.4220972965861773,0.9955075278224496,0.48475120385232745,0.9406364750892908,1.0,5/24,9.25%,ESAM;BSG;ROBO4;BCAM;DSCAM
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.41488456514100375,0.9948858679810895,0.4720394736842105,0.9379554237373809,1.0,4/26,8.79%,CSGALNACT1;B3GNT3;B3GNT4;B3GNT6
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.42293708464385293,0.9945584346346537,0.46481178396072015,0.9345630681621834,1.0,4/23,7.56%,HIP1;HIP1R;PLEKHA5;SNX3
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.4473801889213401,-0.9926446852105438,0.4726477024070022,0.884375061688054,1.0,5/10,24.92%,NAA40;BRCA2;KAT8;NAA60;USP22
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.4766391755230688,0.9922542836076651,0.4691358024691358,0.9365704711010138,1.0,2/13,10.54%,ECI1;ECH1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.49156372094679185,0.9903057198995014,0.5009074410163339,0.9374326695580426,1.0,3/13,4.17%,KCNQ1;PRKAR2B;SOX9
prerank,chemokine binding (GO:0019956),-0.3427501749900477,-0.989573680916333,0.448,0.8865655293584537,1.0,4/30,5.58%,PDPN;CCR9;FGF2;ITGAV
prerank,thyroid hormone receptor binding (GO:0046966),0.41216751701730286,0.9889223267533198,0.4984025559105431,0.9367776901426028,1.0,8/28,22.80%,TACC1;JMJD1C;OASL;GTF2H1;TAF7;GAS2L1;MED12;MED17
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.440811463339998,-0.9880954575489805,0.4822222222222222,0.8843686077293883,1.0,4/11,18.55%,AMFR;UBE4B;UBE4A;UBR5
prerank,MHC class II protein complex binding (GO:0023026),-0.4404510479539388,-0.9874164834791348,0.4768211920529801,0.8800077402159862,1.0,3/11,11.17%,ATP1B1;HSP90AA1;CD81
prerank,PDZ domain binding (GO:0030165),0.35367541793515966,0.9860652968265848,0.47983310152990266,0.9397501258863469,1.0,11/61,6.54%,CADM1;F11R;USHBP1;FZD4;SNTG2;DOCK4;ADRB1;CLCN3;ATP2B4;RAPGEF2;TMEM88
prerank,thioesterase binding (GO:0031996),0.4840983223150944,0.9853000099534847,0.48598130841121495,0.9375460971667069,1.0,3/11,14.18%,TRAF1;RAC1;TRAF6
prerank,sodium channel activity (GO:0005272),-0.32314422415316185,-0.9826986494497933,0.4890710382513661,0.8859191482812243,1.0,15/37,29.17%,SCN7A;CACNA1G;GRIK4;GRIK2;GRIK5;GRIK1;SCN1A;SCN8A;SCN2A;SCN1B;SCN5A;SCN9A;CACNA1H;SCNN1A;HCN4
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4555017620745479,0.9818447622407435,0.47971781305114636,0.9422462420242309,1.0,6/14,19.93%,MTM1;MTMR6;SYNJ1;MTMR12;MTMR9;MTMR2
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4440406522468123,0.9813926459741105,0.4965753424657534,0.9392195417655784,1.0,5/18,7.33%,ENG;FKBP1A;SMAD7;USP15;TGFB1
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.30260882895954483,-0.9804933731860832,0.4923547400611621,0.8859931067736543,1.0,7/53,6.15%,MICAL3;MICAL2;DDO;AOX1;DPYD;NOX4;PRODH
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.41540431129065336,0.9791597998392677,0.4751203852327448,0.9406310013800584,1.0,3/25,2.00%,ARAP3;HIP1;HIP1R
prerank,hyaluronic acid binding (GO:0005540),0.47824203645750885,0.97904021126057,0.5029013539651838,0.9368529767114248,1.0,1/10,1.12%,LAYN
prerank,retinoic acid binding (GO:0001972),0.4810666896210029,0.9785291373380249,0.5017421602787456,0.9340273521447149,1.0,2/12,6.57%,CYP26A1;CYP26C1
prerank,copper ion binding (GO:0005507),-0.3132138919250453,-0.9723582099467977,0.47230320699708456,0.9020056729764606,1.0,10/42,18.34%,MOXD1;P2RX4;LOXL3;SOD3;LACC1;CCS;SNCA;GPC1;MT3;COX17
prerank,O-acyltransferase activity (GO:0008374),0.3914063316804318,0.9714646250111857,0.509375,0.947702099197843,1.0,7/30,15.79%,PLA2G4A;LPCAT3;SOAT2;MBOAT1;MOGAT1;DGAT1;MOGAT2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3436554033165584,0.9708715378563465,0.512396694214876,0.9451322640777224,1.0,16/69,15.79%,PLA2G4A;CERS4;LPCAT3;GLYAT;SOAT2;ZDHHC18;PLAAT3;KAT6B;ZDHHC9;HHAT;MOGAT1;KAT2B;DGAT1;KAT6A;NAA16;MOGAT2
prerank,hydro-lyase activity (GO:0016836),-0.3109690530966955,-0.970615194438086,0.49850746268656715,0.9002911295458502,1.0,13/41,16.40%,GMDS;HACD3;ECHDC1;ENO2;CA4;HACD1;ECHDC3;ECHDC2;L3HYPDH;CBS;NAXD;ENO3;ACO2
prerank,ubiquitin protein ligase activity (GO:0061630),0.2983609087359307,0.9685579977187249,0.5415244596131968,0.9467906277164537,1.0,51/228,16.73%,RNF125;SMURF1;RNF144B;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;HERC2;TRIM68;PELI1;XIAP;MYCBP2;RNF144A;UBE3B;CBLL1;IRF2BPL;RNF7;RNF167;NEDD4;TRIM25;RNF139;UBR1;TRIM24;NEURL3;NEURL1B;SIAH1;UBE2D3;RC3H1;CBL;UBE3A;RNF112;HECTD1;COP1;MYLIP;BIRC3;RNF25;RNF215;UBE2K;TRAF6;TOPORS;MSL2;ARIH2;RNF5;UBE3D;AREL1;BIRC2;NHLRC1
prerank,actinin binding (GO:0042805),-0.37164042736218345,-0.9682263940691131,0.49502487562189057,0.9004379068847849,1.0,3/21,3.02%,CACNA1C;CACNA1D;DAG1
prerank,gated channel activity (GO:0022836),0.4452077950121789,0.9679856676416748,0.5178571428571429,0.9441787589219426,1.0,1/14,1.04%,PIEZO1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.44975806157709974,-0.967670441219406,0.5076923076923077,0.8957760375823309,1.0,3/11,2.92%,AKAP13;SH3RF1;KSR1
prerank,nucleotidyltransferase activity (GO:0016779),0.42767094665035343,0.9673200756742203,0.5195246179966044,0.9417708054804029,1.0,6/19,19.06%,TENT4A;CGAS;MTPAP;PNPT1;PAPSS1;YRDC
prerank,kinesin binding (GO:0019894),-0.3488297714076789,-0.9662984154561983,0.535,0.8935673412817046,1.0,16/27,30.99%,ARHGEF10;IFT88;PLEKHM2;RAB29;KIF1B;TTBK2;KIFAP3;SNCA;PRC1;KLC2;KIF18B;TOR1B;TOR1A;CROCC;NEFH;FAM83D
prerank,mechanosensitive ion channel activity (GO:0008381),0.45681256996389413,0.9645803918919654,0.5171171171171172,0.9446971641949274,1.0,1/12,1.04%,PIEZO1
prerank,alpha-tubulin binding (GO:0043014),0.3865381641057124,0.9643432394459188,0.5320197044334976,0.9413144048260093,1.0,5/31,10.10%,FYN;DIP2B;TTLL7;TRPV4;ARL8B
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.38855012840251335,-0.9630785438916474,0.5116822429906542,0.8959755061267118,1.0,6/16,30.96%,SLC22A4;SLC25A42;SLC22A2;SLC22A3;SLC5A7;SLC29A4
prerank,fibroblast growth factor binding (GO:0017134),-0.37092445618195824,-0.9611985425527511,0.5330073349633252,0.8950345237676391,1.0,4/21,10.72%,FGFR2;THBS1;ITGAV;FGFR4
prerank,receptor tyrosine kinase binding (GO:0030971),0.3443739883336766,0.9607311413082139,0.5264705882352941,0.9462832358589365,1.0,12/56,15.29%,PTPN14;PITPNM2;DOCK4;NCK1;SH2B2;GRB14;PTPN1;GAS6;CBL;RACK1;LRP4;ALKAL2
prerank,active ion transmembrane transporter activity (GO:0022853),0.3723919056137994,0.9598451902544577,0.5265625,0.944563197373164,1.0,2/37,1.65%,SLCO2B1;SLCO2A1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.3880708763717947,0.9597145801164172,0.5109717868338558,0.9409460852637279,1.0,4/29,11.52%,ACER2;CTBS;PARG;OVGP1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.32575887993341507,0.9595412154372255,0.538961038961039,0.9374661127153021,1.0,11/91,7.56%,FLII;PARD3;HIP1;HIP1R;KCNQ1;PLCB1;FCHO2;TIRAP;SDCBP;PLEKHA5;SNX3
prerank,exoribonuclease activity (GO:0004532),0.45444459545551896,0.959183886022095,0.5193661971830986,0.9344375147379097,1.0,3/12,13.14%,CNOT6;EXOSC1;CNOT7
prerank,ATPase binding (GO:0051117),0.3429689234162101,0.9580865458147528,0.5212464589235127,0.9333461701583732,1.0,15/71,9.23%,CAV1;ESR1;PPP3CA;PDE4D;NKD2;RALB;ATXN3;ATP1B3;LCK;ATP6V0A1;PKD2;PSEN1;PEX26;CHMP4A;ANK1
prerank,adenylyltransferase activity (GO:0070566),0.41534287595646874,0.9577749998570161,0.5424292845257903,0.9303104487070663,1.0,5/21,15.50%,TENT4A;GPHN;OASL;MTPAP;KARS1
prerank,poly(A) binding (GO:0008143),-0.35607203606147564,-0.9568810679764397,0.5156626506024097,0.9000842932832694,1.0,5/21,15.51%,RBMS3;RBMS1;TIA1;HNRNPU;ELAVL4
prerank,ADP binding (GO:0043531),0.40406051731181214,0.956122477763177,0.5155482815057283,0.9304282792217944,1.0,5/25,13.77%,ERN1;MYH9;LONP1;ABCD1;ABCG1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.38336212138216813,-0.9559159309063714,0.5087719298245614,0.8968667973932524,1.0,8/17,24.60%,DPYD;TECR;BDH2;MECR;DECR1;DHCR24;DHCR7;PECR
prerank,MAP kinase activity (GO:0004707),-0.3960595618273114,-0.9555992922599864,0.5,0.8918446451285497,1.0,2/14,7.31%,MAPK4;MAPK10
prerank,U6 snRNA binding (GO:0017070),0.4516934630782924,0.9553908219426845,0.5213523131672598,0.9284381839706111,1.0,9/14,26.99%,LSM8;LSM3;LSM7;PRPF4;SART3;EIF5A;LSM2;TUT1;METTL16
prerank,Wnt-activated receptor activity (GO:0042813),0.43931977989683113,0.9552228388253944,0.5371024734982333,0.9251697643559886,1.0,4/15,4.59%,FZD6;FZD4;LRP5;TSPAN12
prerank,lysophospholipase activity (GO:0004622),0.42738996574087396,0.9539226697167985,0.5137457044673539,0.9246062355756887,1.0,4/20,14.60%,PLA2G4A;ENPP2;GDPD1;PNPLA6
prerank,cAMP binding (GO:0030552),0.48003830730892183,0.9534223301190645,0.5479204339963833,0.9220892693832938,1.0,3/11,6.12%,PDE2A;PDE4D;RAPGEF2
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.37837970148367367,0.9533034768972402,0.5246913580246914,0.9187385115132527,1.0,4/34,4.49%,IQGAP1;CCNK;STK3;STK4
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.4707040116003165,0.9529038528672729,0.5293040293040293,0.9160869612905662,1.0,2/10,7.41%,PIK3C2A;PIK3CG
prerank,endopeptidase regulator activity (GO:0061135),-0.31309637589450223,-0.9515611966158346,0.5438066465256798,0.895988128037906,1.0,7/40,11.32%,TFPI;ITIH2;RENBP;RECK;SERPIND1;APH1B;CST3
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2921079845701787,0.9506330068096166,0.562358276643991,0.9177946522163402,1.0,50/232,16.73%,RNF125;SMURF1;RNF144B;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;HERC2;TRIM68;PELI1;XIAP;MYCBP2;RNF144A;UBE3B;CBLL1;IRF2BPL;RNF7;RNF167;NEDD4;TRIM25;RNF139;UBR1;TRIM24;NEURL3;NEURL1B;SIAH1;UBE2D3;RC3H1;CBL;UBE3A;RNF112;HECTD1;COP1;MYLIP;BIRC3;RNF25;RNF215;TRAF6;TOPORS;MSL2;ARIH2;RNF5;UBE3D;AREL1;BIRC2;NHLRC1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3582596716277503,0.948632823143427,0.5299145299145299,0.9189786378781816,1.0,4/49,3.38%,MCTP1;PLA2G4A;CPNE8;ESYT2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4384544021280358,-0.947195799106778,0.5180180180180181,0.9014017812546623,1.0,3/10,12.49%,KDM7A;KDM2A;KDM8
prerank,RNA binding (GO:0003723),0.276485466199862,0.9465442751463902,0.7024048096192385,0.9200008417041934,1.0,471/1321,26.42%,NANOS3;SORBS2;NOVA2;PRPF38B;RBPMS;SPTBN1;FLNB;LRRFIP1;ADARB1;MYH9;FASN;STAT3;ANP32A;SAMHD1;MSN;DHX40;SNTB2;SLC3A2;LBR;ACTN4;DDX54;RPS15;TMSB4X;PKN2;TES;ACTN1;IGF2BP3;IMP3;RPS19;RPS14;RBM20;MBNL1;PTBP3;RPSA;MBNL2;RPS16;CAVIN1;RPL38;NANOS2;FARS2;EIF4E;N4BP1;CTNNA1;EDC3;EIF3H;UCHL5;RPL34;RPS20;RPL39;DROSHA;PPP1R10;HNRNPF;CNBP;SF3B4;RPS7;UBAP2;NXF2;MBNL3;SYNE1;RPS24;TASOR;ZNFX1;SEC63;HNRNPA0;MTREX;HNRNPK;FCF1;RBM14;NOSIP;RPL37A;GTF2E2;ZNF326;SRBD1;ASCC3;HNRNPD;WRAP53;RPF1;RPL36;TRIM25;EIF1AX;EIF1;RPS18;WDR33;SPATS2;SAMSN1;RSL24D1;DDX50;RPL15;NELFE;DYNC1LI1;RBM25;PHF6;RRS1;SUCLG1;GLRX3;ANG;PINX1;THOC2;NAP1L4;RPS8;KHNYN;NPM3;MYBBP1A;LSM8;RPL14;SUB1;YBX3;GDI2;RPL23;RPL17;DUT;NUDT16;CHD2;TBCA;NIFK;DNTTIP2;PTRH1;PTPN1;DICER1;G3BP1;PUM1;RFTN1;HELZ;HNRNPLL;SMG7;RPL9;SERBP1;RPL4;TWF2;RPL13A;RBM18;CNOT1;HELB;RPS11;RPL32;PSMA6;OTUD4;RBM3;SUMO2;FSCN1;YTHDC1;RC3H1;PPHLN1;RPL22;SPEN;RBM15;RPS27;DRG2;RPL31;RPS23;KCTD12;TFB2M;RO60;EXOSC1;CFAP65;ADAR;DDX51;DCP2;RNPS1;MRPL13;RPL13;LSM3;MRPS12;RPS12;PUM2;SRP9;LONP1;RPP30;NUP98;FAU;EIF5B;PEBP1;APEH;OASL;RPP25;NOP53;UTP4;RSRC2;HNRNPC;PA2G4;RPL6;ZFP36;RPL10;RACK1;FASTKD2;RTCB;EIF2AK4;RNMT;SLTM;HSP90AB1;TOP1;NOP16;FBLL1;BTF3;MRPL41;IFIH1;NOL10;GRWD1;FMR1;MTPAP;RPS6;POLR1G;CAST;SF3B6;DHX15;R3HDM1;NPM1;FBRSL1;QKI;SCAF11;MAP3K20;RPL29;ZC3H12C;RRP9;MRPL4;LARP4B;ADAT1;PELP1;RPS25;SRFBP1;YY1;NSRP1;RPL35A;RPS13;RPS21;SNW1;RPL27;RPL18;XRN2;AIMP1;ENDOV;MRPL23;RPL7L1;TPT1;EMG1;RPL27A;LSM14A;YBX1;YLPM1;NELFCD;MRPS5;RRP1B;KARS1;ZCCHC17;AQR;CEBPZ;RBM42;RPS10;RDX;DDX20;G3BP2;EIF5;BAG4;LUC7L2;UTP6;HNRNPUL1;MRPL37;CWC22;AGFG1;PNPT1;ZC3H4;ANXA11;VIRMA;ZFP36L1;PDCD11;TRMT6;MAK16;PRDX1;RPL11;ALYREF;XPOT;UBE2I;CDC40;CSDE1;HEATR1;LSM7;ESF1;PRPF40A;RPL8;PHF5A;EEF2;NOP14;PTCD3;ZCCHC7;MRPL11;HELZ2;PRKRIP1;METTL14;GRB2;RALY;HSPE1;DIAPH1;LARP4;TXN;RPL18A;HNRNPM;BST2;CISD2;HMGN5;MRPL54;KDM1A;PPP1CC;STRAP;NUDT1;MRPS9;DHX34;DHX36;YRDC;HNRNPAB;CPNE3;SRSF10;FUS;EIF2AK2;BCCIP;MEX3C;ZNF638;HDGF;NOM1;THOC5;ERH;RPL21;LSM1;MRPL43;MRPS26;SART1;RPL3;CCDC47;DAZL;GNL2;MRPL12;SART3;MRPL44;RPS3;DEK;UBE2L3;PURA;PPIB;SBDS;ELAVL1;PEF1;ZCCHC3;RPS28;DDX47;NOL4;SETX;RPN1;DENR;RCC1L;TAF15;PRKRA;KPNB1;URB1;RPL7;RNASEH1;SF3A2;CPSF6;JMJD6;TOE1;RIDA;CCDC9B;LUC7L;TCOF1;ZC3H14;RTF1;MRPS30;THUMPD1;GCN1;NOCT;CDK11B;TRNAU1AP;NOA1;PRPF3;RPL26;EIF4ENIF1;PURB;HMGB1;RTRAF;LACTB2;MRPL1;JUN;RBM7;NGDN;PIN4;NOL6;TRA2B;PPIA;DBR1;SRP19;RARS2;SNRPD3;EIF4E2;YWHAE;SND1;FUBP1;RPUSD2;NSUN6;MAP4;PUS7;FKBP4;SRSF4;ALKBH8;RRP12;DCP1B;SMG6;DNAJC2;RBM33;PPIG;PCDHGA9;NUP42;MRPL39;EIF5A;TENT4B;DDX28;PSPC1;MKRN2;LAS1L;LYAR;EIF3G;EIF4H;ZFR;CPSF2;SYF2;MRPL32;MRPL14;SECISBP2L;MRPS11;MRPL9;LSM2;HNRNPA3;PNO1;AARS2;MTIF2;PCF11;SNUPN;DIDO1;ISG20L2;RBMX;DDX6;SNRNP200;SUMO1;DAP3;NOLC1;ADK;PCID2;MRPL15;RCC2;LARP1B;CPSF3;PUF60;PABPC1L;RPS17;PABPC4L;MRPL42;GSPT2;PRPF40B;ISY1;GFM1;RPL28;WDR46;TRMT10C;UBE2N;DDX60;TCF20;RPL41;NCOA5;RP9;SYNCRIP;RPS2;EDF1;GTPBP4;ACAA2
prerank,syntaxin binding (GO:0019905),0.3399906652161038,0.9435005993818579,0.5487465181058496,0.9235226855650742,1.0,11/61,12.82%,UNC13B;DAPK1;RAB11A;SYPL1;STX6;STX7;CACNA1A;SNAP23;VAMP8;STX8;STXBP3
prerank,telomerase RNA binding (GO:0070034),0.4048032129415013,0.9433168885570896,0.5564924114671164,0.9203340711500582,1.0,9/22,24.34%,WRAP53;PINX1;SMG7;DCP2;HNRNPC;DHX36;SNRPD3;SMG6;TENT4B
prerank,galactosyltransferase activity (GO:0008378),0.46585045956856186,0.9431985850376217,0.52994555353902,0.9170080006934714,1.0,4/11,10.66%,B4GALT4;B4GALT5;B3GNT6;A4GALT
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.4319283256660662,0.9431306779150064,0.5238938053097345,0.9135884071233213,1.0,3/15,7.56%,PLA2G4A;PLEKHA5;SNX3
prerank,G protein-coupled receptor binding (GO:0001664),-0.24708790230972155,-0.9411228891681498,0.625,0.9115482998438601,1.0,28/132,15.84%,WNT4;PRKN;GRK3;RNF43;BICD1;WNT6;TULP3;GNAO1;WNT9A;GNAS;RYK;AGTR1;LRP6;GPRASP2;GNAI1;SFRP1;CXCL12;USP33;FZD1;GPRC5B;WNT16;FZD7;S1PR2;GNA14;ARHGEF11;WNT11;PTCH2;DVL1
prerank,androgen receptor binding (GO:0050681),0.3963419229532017,0.9399140808934799,0.5431893687707641,0.9173834835244994,1.0,5/25,8.10%,FOXP1;KDM3A;PKN1;TRIM68;KDM4C
prerank,transaminase activity (GO:0008483),-0.42130975170092266,-0.9395491202042983,0.5478260869565217,0.9098971739145965,1.0,3/11,12.73%,ABAT;GOT1;OAT
prerank,protein kinase regulator activity (GO:0019887),-0.2596638316563723,-0.9391383953963334,0.5874439461883408,0.9051801149325264,1.0,30/95,19.53%,PARVA;TAOK3;GPRC5C;CCND2;DNAJC3;PRKAG2;KIDINS220;SPDYA;CCNL2;STRADA;PRKAR1B;RGCC;WNK1;PRKAG3;CCNL1;GPRC5B;PRKAR1A;CDKN1A;CCNT2;CCNG2;SMCR8;WNT11;SNCA;CDKN1C;MT3;PRKAG1;DUS2;CSNK2B;CCNF;ELP4
prerank,histone deacetylase activity (GO:0004407),0.4084878161614227,0.9386803211553706,0.5515370705244123,0.9167193321808412,1.0,1/19,0.51%,HDAC9
prerank,nuclear export signal receptor activity (GO:0005049),0.4522602307501671,0.9383046264814725,0.5480943738656987,0.9140401531578446,1.0,5/11,24.27%,XPO1;NUP214;CSE1L;EIF4ENIF1;NUP42
prerank,chemoattractant activity (GO:0042056),0.39745065609793373,0.9382802944059657,0.560064935064935,0.9106045080841043,1.0,3/26,5.08%,PDGFB;VEGFC;VEGFD
prerank,kinase activator activity (GO:0019209),-0.3320666771525256,-0.9372863519418907,0.5457063711911357,0.9044622180707182,1.0,15/30,28.02%,GPRC5C;PRKAG2;SPDYA;STRADA;RGCC;WNK1;GPRC5B;WNT11;MT3;AGAP2;GPRC5A;TPX2;EPO;TREM2;FGF13
prerank,RNA cap binding (GO:0000339),-0.3762878003466632,-0.937197090268765,0.5632754342431762,0.8990644249028835,1.0,3/16,10.90%,CYFIP2;EIF4A1;EIF4E3
prerank,carboxy-lyase activity (GO:0016831),-0.3470102856043276,-0.9350099974971999,0.571072319201995,0.8986742335514075,1.0,6/23,20.25%,ECHDC1;GGCX;ODC1;AZIN1;PCK2;DDC
prerank,thiol-dependent deubiquitinase (GO:0004843),0.3269765221099841,0.9336065466481698,0.5656167979002624,0.917717121005558,1.0,16/83,19.18%,USP53;USP3;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4;USP12;OTULIN;YOD1;USP8;DESI2;USP7;USP25;USP21
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3087672592051566,0.9332016944392094,0.5738295318127251,0.9151435914674139,1.0,9/134,4.92%,ABCC4;SLCO2B1;ABCG2;SLC39A8;SLCO2A1;SLC38A5;SLC3A2;SLC6A6;SLC35B3
prerank,adrenergic receptor binding (GO:0031690),-0.3707889361675093,-0.9331909534677936,0.533678756476684,0.8977983856650861,1.0,4/16,8.32%,MAGI2;DLG4;GNAS;ADRA2A
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3906407653027984,-0.932510665276146,0.5727272727272728,0.8940887108678431,1.0,2/14,3.03%,SLC26A7;SLC26A2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.4449054003330373,0.9309906429332706,0.5659340659340659,0.9166024565054055,1.0,2/13,2.68%,SLC7A7;SLC38A5
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.3809688154436454,-0.9301206351979897,0.5669099756690997,0.894582110438261,1.0,2/15,7.48%,P2RX4;P2RY14
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.45563009063478893,0.9283887773976034,0.5592233009708738,0.9190731543013246,1.0,2/11,12.99%,PADI4;PADI1
prerank,C-C chemokine binding (GO:0019957),0.39911723794499315,0.9280760202124293,0.5570247933884298,0.916259422131284,1.0,6/22,20.78%,ACKR1;CX3CR1;CXCR4;ZFP36;CCR1;CXCR6
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.40083662380124213,0.9279035109614697,0.5728813559322034,0.9131665833114271,1.0,5/24,12.04%,DAPK1;PTK2B;MAPKAPK3;EEF2K;MKNK2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3882813996386091,0.9248847386484046,0.5630914826498423,0.916213095215512,1.0,3/26,4.54%,PPP1R2;PPP1R9B;LMTK2
prerank,cation:chloride symporter activity (GO:0015377),0.45670927316032317,0.9211919936455036,0.5580952380952381,0.9208956159919727,1.0,2/10,7.83%,SLC12A7;SLC12A9
prerank,ion gated channel activity (GO:0022839),0.39428360260690315,0.9184634213706359,0.571917808219178,0.9234917500707611,1.0,4/24,10.58%,ANO2;TTYH2;NMUR2;ANO6
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.39930461326187283,0.9169562809318278,0.5548387096774193,0.9233893202495426,1.0,4/21,2.87%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,cyclic nucleotide binding (GO:0030551),0.40099777917819757,0.916858601442224,0.5714285714285714,0.9201960729957689,1.0,4/21,6.12%,PDE2A;PDE4D;CNGB1;RAPGEF2
prerank,ankyrin binding (GO:0030506),-0.3556776222889356,-0.9142752950701855,0.5701149425287356,0.9278536294749904,1.0,5/19,8.78%,CACNA1D;SLC8A1;CDH1;FLNC;NRCAM
prerank,insulin-like growth factor I binding (GO:0031994),0.43168533975835277,0.9138687154989273,0.5424354243542435,0.9229511524098992,1.0,2/13,1.57%,ITGA6;INSR
prerank,ribosomal small subunit binding (GO:0043024),0.4129937048974781,0.9130550362245461,0.5892547660311959,0.9212811570952404,1.0,6/17,17.60%,EIF1;UNG;PIM1;NPM1;MTIF3;PTCD3
prerank,peptidase activator activity (GO:0016504),0.38894996949347316,0.9120223428528034,0.5764705882352941,0.9201125374096613,1.0,6/22,16.97%,CAV1;MAL;APH1A;PSME1;VSIR;CASP8AP2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4126888771203511,-0.9106267118834526,0.5918367346938775,0.9310535330762959,1.0,4/10,8.10%,DPP4;FAP;NAALAD2;DPP6
prerank,protein kinase inhibitor activity (GO:0004860),-0.2935551160213591,-0.9096014241909616,0.6055045871559633,0.9281618382266404,1.0,12/42,15.70%,SPRED1;PARVA;TAOK3;CIT;DNAJC3;CAMK2N1;SPRED2;CDKN1A;CEP43;SMCR8;SNCA;CDKN1C
prerank,magnesium ion binding (GO:0000287),0.2971073047907996,0.909591489558886,0.639549436795995,0.9219347565648076,1.0,37/135,20.94%,SNRK;ERN1;PDE2A;SIK1;STK3;STK4;CDC42BPB;MAST2;SIK3;TSSK6;STK26;NEK6;DUT;NUDT16;HPRT1;FAN1;NT5C3A;ABL2;SIK2;STK38;MTPAP;MAP3K20;PDXP;ENDOV;IRAK3;RHEB;YDJC;NIM1K;PLSCR1;PRKACB;DHX36;NLK;PDCD6;MSH2;PGM1;MAP2K7;PLK1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.321445042988869,0.9093896635071846,0.596537949400799,0.9189970470722361,1.0,11/75,13.15%,ABCC4;RDH16;HADHA;CBR1;GLYR1;SPR;LDHD;ADH1A;SORD;HADH;IMPDH1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.373288457834431,-0.9093693870178715,0.5849514563106796,0.9178792072611635,1.0,4/16,12.91%,ATP6V0A4;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.373288457834431,-0.9093693870178715,0.5849514563106796,0.9178792072611635,1.0,4/16,12.91%,ATP6V0A4;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,sterol binding (GO:0032934),-0.28378769808523663,-0.9084380541321803,0.6460481099656358,0.9146300341964205,1.0,17/56,15.63%,SIDT1;GRAMD1B;GRAMD1C;INSIG2;APOD;RORA;OSBPL8;OSBPL5;ANXA6;SOAT1;OSBPL3;CD81;OSBPL6;VDAC1;INSIG1;SCP2;SYP
prerank,neuropeptide binding (GO:0042923),0.4147245480234369,0.9074010587063729,0.568760611205433,0.9198137041315723,1.0,4/18,18.65%,MCHR1;NMUR2;MC4R;OPRL1
prerank,transforming growth factor beta binding (GO:0050431),0.3842016920187627,0.9064901811929573,0.5773026315789473,0.9183053064797734,1.0,3/23,2.12%,ENG;ACVRL1;NRROS
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.31210331750336917,-0.9061677524425915,0.6275071633237822,0.9146779952037457,1.0,9/32,16.60%,KDM7A;TET1;KDM2A;EGLN3;P4HTM;KDM8;BBOX1;FTO;PHYHD1
prerank,omega peptidase activity (GO:0008242),0.3149236620545926,0.9043752215121337,0.6223684210526316,0.9196769199948858,1.0,18/89,19.18%,USP53;USP3;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4;APEH;GGH;USP12;OTULIN;YOD1;USP8;DESI2;USP7;USP25;USP21
prerank,phosphatase binding (GO:0019902),0.3041311796769423,0.9040895325991346,0.6444444444444445,0.9170353608346888,1.0,20/105,10.57%,CTSC;IQGAP1;STAT3;PXN;FLT4;JAK3;CEACAM1;MAST2;SKAP1;CDKN1B;LCK;JAK1;PTK2;SNX3;SHOC2;ANAPC7;FBXL2;ANK1;AP3B1;SH3YL1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3439668040792775,0.9028614746967375,0.5982142857142857,0.9163246666538317,1.0,7/46,8.79%,LFNG;MGAT4A;MFNG;B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.3895444770893488,0.9017022255589324,0.5869218500797448,0.9156469474698976,1.0,4/23,2.87%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,aminopeptidase activity (GO:0004177),-0.32175388379078795,-0.9008108327501901,0.6105263157894737,0.9221306169179111,1.0,6/26,16.69%,MMP14;MMP16;NPEPPS;ENPEP;KDM8;BLMH
prerank,GABA receptor binding (GO:0050811),-0.39901667076984915,-0.9007573637155492,0.5995370370370371,0.9169415136750227,1.0,6/11,26.28%,ARFGEF2;TRAK1;SHISA7;PLCL2;GABARAP;JAKMIP1
prerank,hexosaminidase activity (GO:0015929),-0.3891572948011699,-0.8971502615117669,0.6061855670103092,0.9198377577430644,1.0,6/12,31.98%,CEMIP;HEXA;HYAL1;NAGA;HYAL3;HEXD
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.43098596497769526,0.8968009346687252,0.581981981981982,0.9222206957847084,1.0,4/12,8.79%,B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2688570442770567,0.896307281125769,0.7261904761904762,0.9199682558580421,1.0,58/346,14.50%,RNF125;SMURF1;RNF144B;RNF141;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;TRAF1;ZNRF3;UBA7;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;PELI1;XIAP;MYCBP2;RNF144A;UBE3B;CBLL1;IRF2BPL;RNF7;TRIM47;UBE2G1;RNF167;NEDD4;TRIM25;RNF139;MALT1;UBR1;TRIM24;UBE2H;NEURL3;NEURL1B;RNF146;FBXW2;RNF4;SIAH1;UBE2D3;RC3H1;CBL;UBE3A;CUL1;RNF112;HECTD1;COP1;MYLIP;BIRC3;RNF25;ASB4;RNF215;FBXL3;UBE2K;TRAF6;TOPORS
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.43397536207693105,0.8940174469892399,0.5962962962962963,0.9215441207664469,1.0,5/12,18.64%,KDM3A;JMJD1C;KDM4C;KDM4A;KDM1A
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.42244433186639085,0.8906314090929539,0.6064400715563506,0.9252742004845664,1.0,2/14,7.06%,KCNQ1;KCNE2
prerank,DNA secondary structure binding (GO:0000217),0.36390242667230377,0.8901198386614966,0.6041009463722398,0.9230929846944215,1.0,5/31,10.76%,MEF2C;LIN54;RAD51D;RAD18;XRCC2
prerank,SH2 domain binding (GO:0042169),0.3570756271815304,0.8900751076460803,0.5952380952380952,0.9200057753943574,1.0,8/31,8.99%,AFAP1L2;SH2B2;CCDC88A;SKAP1;LCK;PTK2;TRPV4;CRK
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.4474745969415711,0.8898801707787624,0.6186915887850467,0.9141294254111617,1.0,5/11,20.73%,GRPEL1;BAG4;BAG1;SIL1;BAG2
prerank,adenyl nucleotide binding (GO:0030554),0.4474745969415711,0.8898801707787624,0.6186915887850467,0.9141294254111617,1.0,5/11,20.73%,GRPEL1;BAG4;BAG1;SIL1;BAG2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.42899771460916614,0.8896172271996939,0.601063829787234,0.9115619155354479,1.0,4/12,17.70%,H3-3A;POU2F1;RELA;STAT1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.33731677939327154,-0.8893103314918612,0.6275510204081632,0.932170676347219,1.0,10/21,34.76%,FGF1;FGF2;FGF7;FGF10;NPTN;FGF18;KLB;FGF22;FGF9;FGF5
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.3932080629233957,-0.8889738174685066,0.6040723981900452,0.9277617423738928,1.0,2/11,14.85%,AKR1B1;RDH13
prerank,serotonin receptor activity (GO:0099589),0.38918298017712705,0.8887885397070463,0.611764705882353,0.9039098017764808,1.0,1/22,1.96%,HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.38918298017712705,0.8887885397070463,0.611764705882353,0.9039098017764808,1.0,1/22,1.96%,HTR2A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.38918298017712705,0.8887885397070463,0.611764705882353,0.9039098017764808,1.0,1/22,1.96%,HTR2A
prerank,sequence-specific mRNA binding (GO:1990825),-0.4024267993508922,-0.8877712795089933,0.6147186147186147,0.9252386003280242,1.0,5/10,28.90%,LARP6;SHFL;RBM24;SSB;DHX9
prerank,phosphatase activity (GO:0016791),-0.25554491375289107,-0.8864808765109565,0.7052238805970149,0.9227775692241358,1.0,15/73,15.24%,ATP1A2;PLPP3;ALPL;PXYLP1;DUSP11;LPIN1;EPHX2;LHPP;DUSP10;PTPN22;SBF1;PPP1CB;PLPPR5;ACP6;APTX
prerank,filamin binding (GO:0031005),-0.38644934043424317,-0.8854731605721101,0.6227272727272727,0.9197479691145405,1.0,1/11,0.52%,DPYSL3
prerank,insulin-like growth factor binding (GO:0005520),0.4083716164148461,0.8836591772230155,0.5921985815602837,0.9111735076993736,1.0,2/15,1.57%,ITGA6;INSR
prerank,metallocarboxypeptidase activity (GO:0004181),-0.31603337665303954,-0.8792624932816757,0.6475195822454308,0.9284980497356911,1.0,10/26,24.80%,AEBP1;CPXM2;CPXM1;AGBL4;CPM;AGBL1;ACE2;AGBL2;PEPD;CPZ
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3731949854926586,-0.8765167387217739,0.618510158013544,0.9296625883700437,1.0,2/12,10.90%,CYFIP2;EIF4E3
prerank,bHLH transcription factor binding (GO:0043425),0.3915144193302629,0.8755967187059422,0.6222596964586846,0.9242794568004962,1.0,4/19,10.33%,LMO2;TCF12;TCF3;USF2
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.38562862180336904,-0.874571083090848,0.6345291479820628,0.9290338469862409,1.0,4/11,19.30%,HNRNPA2B1;RAD50;HNRNPA1;TERF2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.38769310653480293,0.8731474868259377,0.6312292358803987,0.9257876201593808,1.0,6/18,16.85%,TMOD3;PDLIM1;CNN3;STXBP6;PAK4;PDLIM5
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3731155784699141,0.8728197276678671,0.6291390728476821,0.9233735500443482,1.0,4/26,4.80%,ABCG2;SLC16A9;SLC16A2;SLC6A6
prerank,endoribonuclease activity (GO:0004521),0.35209891768710444,0.8721773409884352,0.6389324960753532,0.9215297186877374,1.0,11/32,24.13%,ERN1;KHNYN;DICER1;INTS11;ZC3H12C;ENDOV;ENDOG;RIDA;LACTB2;SND1;SMG6
prerank,chloride channel regulator activity (GO:0017081),0.4044431761088299,0.8704069226090364,0.6288659793814433,0.9220028998922324,1.0,5/14,11.53%,STX7;STX1A;SGK3;VAMP8;STX8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4289564321810996,0.8668301980411944,0.6123188405797102,0.9256254566974673,1.0,2/10,8.38%,GDA;DCTD
prerank,growth factor activity (GO:0008083),-0.24934698389189364,-0.8622206607368896,0.7896678966789668,0.9506798792792289,1.0,19/74,19.90%,PTN;FGF1;FGF2;IGF2;NGF;JAG1;NRG3;OSGIN2;VEGFB;VEGFA;INHBA;FGF7;HBEGF;MDK;PDGFA;FGF10;ANGPTL3;CLCF1;NTF3
prerank,phosphatidic acid binding (GO:0070300),0.3894026304483865,0.8619252106421047,0.6502546689303905,0.932023353887697,1.0,8/19,23.07%,PLTP;RAPGEF2;PITPNC1;RAPGEF6;PACSIN2;OPA1;UQCC3;MAPKAP1
prerank,metal ion binding (GO:0046872),0.2569296960966154,0.8615127697469203,0.819327731092437,0.9297358463915184,1.0,58/477,11.67%,CSGALNACT1;MCTP1;TGM2;SNRK;LCP1;ERN1;PIR;PLA2G4A;IQGAP1;PDE2A;PPP3CA;PITPNM2;TPD52;SIK1;ESYT2;RASGRP3;STK3;SELP;CDH2;STK4;PADI4;CDC42BPB;ENPP2;SPARCL1;ASAH2;RET;MAST2;PAM;PPP3CB;CHP2;RAPGEF2;SIK3;PLA2G2D;FBP1;TSSK6;STK26;BNIP2;ITPR3;AGRN;CDH15;MICU2;PKD2;LPL;NEK6;IHH;DUT;NUDT16;CDH23;HPRT1;FAN1;CD320;NT5C3A;SYT15;ABL2;SIK2;STK38;GRIN1;CDHR5
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3898480848534311,-0.8614955257085853,0.6488888888888888,0.9470726374690411,1.0,2/10,4.64%,ANO1;CLCN2
prerank,mannosyltransferase activity (GO:0000030),0.37455776458618456,0.8601980956949287,0.6302931596091205,0.9292577186227567,1.0,1/21,0.82%,TMTC2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.36861275196466126,-0.8601408858587833,0.6759259259259259,0.9447663743246221,1.0,7/13,29.75%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC11A1;SLC9A4;SLC9A2
prerank,amyloid-beta binding (GO:0001540),0.3002989321774645,0.859575283365493,0.6903765690376569,0.9274533966846483,1.0,13/79,11.71%,APBB2;INSR;FZD6;FZD4;BCHE;ATP1A3;CACNA1A;ITM2A;CLSTN1;EPHA4;ITGA2;GRIN1;PICALM
prerank,symporter activity (GO:0015293),-0.384821351257045,-0.8587354134787011,0.6113636363636363,0.9427120552868767,1.0,3/10,14.19%,SLC5A5;SLC5A6;MFSD2A
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3667601792221201,-0.8579415573246861,0.6436781609195402,0.9394146793480759,1.0,4/13,16.77%,AGPAT4;LCLAT1;LPCAT1;AGPAT3
prerank,telomeric DNA binding (GO:0042162),0.34122756365320045,0.8525549707365144,0.6563944530046225,0.9380144977987466,1.0,12/32,24.13%,HMBOX1;RPA1;HNRNPD;SMG7;ACD;UPF2;TERF1;KDM1A;PURA;TEN1;TELO2;SMG6
prerank,methylation-dependent protein binding (GO:0140034),0.3111127962853635,0.8472823078071126,0.6961483594864479,0.9448600397156153,1.0,16/57,19.77%,KMT2E;SPIN1;MTF2;CHD1;CDYL;TRIM24;GLYR1;ZMYND11;FMR1;ATRX;KDM4A;CXXC1;PHF19;ZCWPW2;ING3;RBBP5
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.3025195735827653,-0.8460439778326112,0.7351351351351352,0.958907215431239,1.0,9/29,12.77%,SPRED1;YWHAG;PKIA;CIT;PRKAG2;PRKAR1B;SPRED2;PRKAR1A;CDKN1A
prerank,histone methyltransferase binding (GO:1990226),0.40007550482091975,0.8458259394189047,0.6405693950177936,0.9444770238439835,1.0,6/11,22.76%,LCORL;HSP90AB1;CTNNB1;LCOR;PRDM4;PHF1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.3376226116948333,0.8455643552328123,0.6594427244582043,0.9418743314296839,1.0,2/30,3.36%,SLC39A8;SLC31A1
prerank,3'-5' exonuclease activity (GO:0008408),0.31080982931638174,0.8443456959997991,0.6824712643678161,0.9410323309134548,1.0,13/45,22.17%,CNOT6;CNOT6L;ISG20;ANGEL2;REXO2;CNOT7;TRIR;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,carboxylic acid binding (GO:0031406),0.3282747303719,0.843636983152519,0.6802413273001509,0.9394311794044186,1.0,3/38,8.53%,NOS3;PADI4;UBR1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3645312493722336,0.8433276459718689,0.6513605442176871,0.9369263431076431,1.0,1/20,0.92%,SLC39A8
prerank,sodium:proton antiporter activity (GO:0015385),-0.3747456489043841,-0.8409465660491826,0.6756756756756757,0.9637080031504999,1.0,6/11,29.75%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC9A4;SLC9A2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.36380920790709503,0.838980977984958,0.6672268907563025,0.9390184955966023,1.0,3/21,9.31%,CDK6;CCNK;CDK2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.36380920790709503,0.838980977984958,0.6672268907563025,0.9390184955966023,1.0,3/21,9.31%,CDK6;CCNK;CDK2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3444830755685016,0.8377380077342497,0.6873111782477341,0.9383679289481169,1.0,8/32,15.20%,SLC38A5;SLC3A2;SLC6A6;SLC43A2;SLC38A1;SLC25A38;SLC36A4;SLC7A5
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3410275930310598,-0.837683463522494,0.6704035874439462,0.9649988889360959,1.0,12/15,53.52%,COX6B1;NDUFA4L2;COX4I2;COX7A1;NDUFA4;COX6A2;COX10;COX5B;COX15;COX8A;CYB5A;COX7A2L
prerank,ribosomal large subunit binding (GO:0043023),0.4038599777294617,0.8353022990242109,0.6764705882352942,0.9398821887600955,1.0,4/11,14.04%,RBM3;EIF6;MRRF;NPM1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.3459617636782727,-0.8348521581235301,0.6797235023041475,0.9654067014355121,1.0,5/12,18.15%,SLC25A42;SLC19A1;SLC25A25;SLC25A23;SLC17A9
prerank,tau protein binding (GO:0048156),-0.2677135905668623,-0.8342364885615526,0.7674418604651163,0.9616157631852009,1.0,7/40,9.84%,ROCK2;MAP2;BRSK1;HSP90AA1;S100B;BIN1;APOE
prerank,chloride channel activity (GO:0005254),-0.2512698133028727,-0.8341150123600594,0.7845117845117845,0.9568415454267686,1.0,13/59,15.49%,SLC26A7;GLRB;ANO1;CLCN2;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRB3;GABRG3;FXYD1;CLCN7
prerank,disordered domain specific binding (GO:0097718),0.35435395265639485,0.8331771999292398,0.6710963455149501,0.9408360137906047,1.0,8/23,22.19%,FYN;TEAD2;RB1;HSP90AB1;CALM1;NUMA1;SMAD2;FN1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.24200197959991904,-0.8322003904799592,0.8,0.9558889732163128,1.0,16/74,16.55%,NADK2;PI4KA;GK;FAM20C;FAM20A;GALK2;PAPSS2;DGKD;DGKI;HK2;DCAKD;SPHK1;PIK3CD;MVK;GALK1;DGKQ
prerank,CXCR chemokine receptor binding (GO:0045236),-0.35840959557613833,-0.8308930639805232,0.6651480637813212,0.9534953452453432,1.0,3/11,13.60%,CXCL12;ITCH;YARS1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.4242717027545984,0.8280348961879632,0.6734317343173432,0.9467516745763884,1.0,2/10,9.54%,CD200;IZUMO1
prerank,water transmembrane transporter activity (GO:0005372),-0.37730980929094426,-0.827564256563763,0.702355460385439,0.9549271730125112,1.0,1/11,1.60%,PDPN
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.36053675903016486,-0.8255311164911631,0.6933333333333334,0.9539373732262986,1.0,2/12,12.14%,AOX1;FDX1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.34191631512962845,0.8247076559191667,0.6898839137645107,0.9499393349970231,1.0,12/28,22.93%,MAP3K9;RPS6KA1;AURKA;AURKC;MAP2K3;MAPKAPK3;PRKCG;MAP2K5;MAP2K4;MAP2K7;MAP2K6;MAPK14
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.38744478824207773,0.8215923281848225,0.6958855098389982,0.9527001530311494,1.0,2/15,6.70%,SLC39A8;SLC26A1
prerank,cardiolipin binding (GO:1901612),-0.37110308155834615,-0.8200771953329471,0.6913319238900634,0.959074861336476,1.0,1/10,4.03%,GSDME
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.384137303690665,0.8193690137878841,0.670863309352518,0.953863781583268,1.0,3/14,21.25%,AK4;CMPK1;DTYMK
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.34954552380945403,-0.8187657692528649,0.6830357142857143,0.9565968046393056,1.0,5/11,18.15%,SLC25A42;SLC19A1;SLC25A25;SLC25A23;SLC17A9
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.36142374679444833,0.8179214325562149,0.6995073891625616,0.9534542033230785,1.0,4/22,9.43%,RNF169;MINDY2;ZRANB1;IKBKG
prerank,sodium channel regulator activity (GO:0017080),0.32182831450272015,0.8176273759608644,0.7287878787878788,0.9510857094249443,1.0,5/37,8.62%,NEDD4L;FXYD6;ATP2B4;NEDD4;SGK3
prerank,acetylation-dependent protein binding (GO:0140033),-0.3134320640975321,-0.8162020368199316,0.7096774193548387,0.9515690199412842,1.0,9/20,16.76%,PSME4;TAF1;SMARCA4;THAP7;BRD9;ZMYND8;BAZ2A;BRDT;CARM1
prerank,lysine-acetylated histone binding (GO:0070577),-0.3134320640975321,-0.8162020368199316,0.7096774193548387,0.9515690199412842,1.0,9/20,16.76%,PSME4;TAF1;SMARCA4;THAP7;BRD9;ZMYND8;BAZ2A;BRDT;CARM1
prerank,P-type ion transporter activity (GO:0015662),0.3836983061258575,0.8120327753404022,0.6821705426356589,0.9578874951512379,1.0,3/12,10.25%,ATP2B4;ATP2C1;ATP7B
prerank,chloride channel inhibitor activity (GO:0019869),0.39865196507298833,0.8102808551138375,0.6773049645390071,0.9579187730695077,1.0,4/10,11.53%,STX7;STX1A;VAMP8;STX8
prerank,nucleosomal DNA binding (GO:0031492),-0.2954796835163385,-0.809226778422302,0.7619047619047619,0.9594284115292046,1.0,8/21,23.60%,CHD4;SMARCA4;SMARCB1;MTA2;ACTL6A;RBBP4;SMARCD2;RCC1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.3452329857873553,0.8084086647827863,0.7086743044189853,0.9582283675059344,1.0,4/24,14.73%,ITPKB;AK4;CMPK1;PMVK
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.3930626242863058,0.8037156571747941,0.6931608133086876,0.963799561206166,1.0,3/10,14.68%,CDKN1B;INCA1;KAT2B
prerank,miRNA binding (GO:0035198),-0.27480018390421945,-0.8001384385211996,0.7994652406417112,0.9705590450319891,1.0,10/30,21.32%,HNRNPA2B1;AGO3;RBM4;ZC3H7B;HNRNPA1;DDX21;TUT4;ZNF346;SOX2;MATR3
prerank,nuclease activity (GO:0004518),0.3058033377149923,0.799946132026854,0.7714701601164483,0.9671103999575542,1.0,7/52,8.78%,SAMHD1;ISG20;N4BP1;RNASE1;RNASEH2A;ANG;RNASE4
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3214265471790169,0.7984962514174292,0.7187017001545595,0.9666424651409812,1.0,15/34,26.18%,UBE2G1;UBE2H;UBE2D3;UBE2K;UBE2I;CDC34;UBE2Q1;UBE2L3;UBE2F;UBE2J2;UBE2D1;UBE2R2;UBE2E1;AKTIP;UBE2N
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.346282144615191,-0.7971467748150506,0.7246049661399548,0.9712446015814004,1.0,6/12,29.75%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC9A4;SLC9A2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.3994156375078701,0.7964150318413538,0.6708860759493671,0.9643404177333428,1.0,3/10,14.85%,DUSP16;DUSP7;DUSP2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.3994156375078701,0.7964150318413538,0.6708860759493671,0.9643404177333428,1.0,3/10,14.85%,DUSP16;DUSP7;DUSP2
prerank,carboxypeptidase activity (GO:0004180),-0.26351156870223974,-0.7936903764807433,0.7833333333333333,0.9723852562914462,1.0,11/35,19.06%,AEBP1;NAALAD2;CPXM2;CPXM1;AGBL4;SCPEP1;CTSZ;BLMH;CPM;AGBL1;ACE2
prerank,endopeptidase activator activity (GO:0061133),0.38872080445671364,0.7908526848466507,0.6814814814814815,0.9709455474224279,1.0,4/10,23.19%,APH1A;PSME1;VSIR;ADRM1
prerank,MHC class I protein binding (GO:0042288),0.37722885414896473,0.7905964126956926,0.7015706806282722,0.968438450049867,1.0,5/13,28.92%,TAP2;TAP1;TAPBP;ATP5F1B;ABCB9
prerank,peptide hormone receptor binding (GO:0051428),-0.349271732714804,-0.789255196975298,0.7399103139013453,0.9749765655311045,1.0,8/11,50.82%,CCK;PSMC5;ADCYAP1;PTHLH;VIP;UCN2;GPHB5;GHRH
prerank,ATPase regulator activity (GO:0060590),0.31083437871731,0.7875840388448274,0.760061919504644,0.9705711249631803,1.0,11/38,20.73%,FNIP2;DNAJA1;ATP1B3;GRPEL1;BAG4;BAG1;SIL1;DNAJB1;DNAJC10;DNAJB6;BAG2
prerank,ligand-gated calcium channel activity (GO:0099604),-0.30671666953689086,-0.7870688093527141,0.7553444180522565,0.9738552552201919,1.0,4/19,13.75%,P2RX4;RYR2;GRIN2A;GRIN2D
prerank,pentosyltransferase activity (GO:0016763),-0.2651783134444047,-0.787045855248467,0.8086253369272237,0.9692295530593769,1.0,8/36,17.31%,LARGE1;SIRT2;PARP3;PARP11;LACC1;QPRT;PARP8;ART3
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.29836348846282335,-0.7837030047448371,0.7786458333333334,0.970030404206363,1.0,5/22,12.91%,ATP6V0A4;ATP2A2;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,histone acetyltransferase activity (GO:0004402),0.31460776020627274,0.7810888578020991,0.7537764350453172,0.9779946739779466,1.0,8/30,16.90%,EPC1;ARRB1;KAT6B;HAT1;SRCAP;KAT2B;KAT6A;BAZ1A
prerank,methyl-CpG binding (GO:0008327),-0.29257016600360186,-0.7795490912295555,0.8077858880778589,0.971993857225217,1.0,4/22,12.33%,TET1;CXXC4;ZBTB38;CXXC5
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.3506982939432065,-0.7788242407432421,0.7146017699115044,0.9686118396437541,1.0,3/10,9.20%,ECHDC1;ECHDC3;ECHDC2
prerank,NAD+ binding (GO:0070403),-0.3397713699421828,-0.77764639006895,0.75,0.9658649348755659,1.0,2/12,4.18%,CRYL1;SIRT2
prerank,mRNA binding (GO:0003729),0.24166771990434066,0.7773856934147312,0.8924122310305775,0.980961887951093,1.0,49/249,16.02%,NANOS3;NOVA2;RBPMS;ADARB1;IGF2BP3;RPS14;RBM20;PTBP3;NANOS2;N4BP1;EDC3;CNBP;RPS7;HNRNPA0;HNRNPK;RBM14;SRBD1;MARF1;RBM25;THOC2;KHNYN;YBX3;NUDT16;G3BP1;PUM1;HNRNPLL;SERBP1;ANGEL2;RPL13A;YTHDC1;RC3H1;RBM15;RNPS1;MRPL13;PUM2;NUP98;HNRNPC;ZFP36;FMR1;SF3B6;QKI;ZC3H12C;LARP4B;NSRP1;RPS13;LSM14A;AQR;G3BP2;LUC7L2
prerank,WW domain binding (GO:0050699),0.32036278860658246,0.7769852977664857,0.7305295950155763,0.9787125801577984,1.0,7/26,20.24%,RAPGEF2;DAZAP2;CDC25C;PMEPA1;NDFIP2;LITAF;TCEAL9
prerank,MAP kinase kinase activity (GO:0004708),0.36729324548864734,0.7768330170531775,0.7352415026833632,0.9760851688653298,1.0,8/15,22.93%,MAP3K9;MAP2K3;MAPKAPK3;MAP2K5;MAP2K4;MAP2K7;MAP2K6;MAPK14
prerank,signal sequence binding (GO:0005048),0.30796106090354985,0.774979987951017,0.7825396825396825,0.9762015655519788,1.0,4/35,4.99%,NFKBIA;BABAM2;CAT;AP2B1
prerank,receptor antagonist activity (GO:0048019),-0.308903498973088,-0.7736818400300034,0.7697516930022573,0.9672387048689903,1.0,2/17,11.08%,DKK3;DKK2
prerank,protein kinase activator activity (GO:0030295),0.2794530104761107,0.7735503461084378,0.775,0.9755798357469705,1.0,9/60,10.66%,IQGAP1;AFAP1L2;STK3;PAK2;STK4;RPLP1;RPTOR;RICTOR;GAS6
prerank,microtubule plus-end binding (GO:0051010),-0.29678195696516485,-0.7732035071400819,0.7682926829268293,0.9635777033463807,1.0,3/20,6.34%,CLIP4;CLIP3;STIM1
prerank,MAP kinase phosphatase activity (GO:0033549),0.369699074450357,0.7723817382572096,0.7036395147313691,0.9745969781433294,1.0,3/12,14.85%,DUSP16;DUSP7;DUSP2
prerank,RNA stem-loop binding (GO:0035613),-0.3336822880474818,-0.7722279353043399,0.7633262260127932,0.9607142316582447,1.0,3/12,15.36%,CPEB3;LARP6;RC3H2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3509819073673163,0.7691477862711283,0.7368421052631579,0.9767227687204709,1.0,3/17,21.25%,AK4;CMPK1;DTYMK
prerank,R-SMAD binding (GO:0070412),-0.29468756115446076,-0.7687477906766721,0.8140703517587939,0.9613512858377726,1.0,4/18,9.53%,DDX5;SMAD6;SMAD3;RGCC
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3598417744082641,0.7684961325633213,0.7444852941176471,0.9748673585753286,1.0,5/14,19.56%,RPP30;RPP25;TSEN34;TSEN2;PRORP
prerank,motor activity (GO:0003774),0.275425998719099,0.7682732833500224,0.8221906116642959,0.9724028040072046,1.0,12/60,12.55%,MYH9;STARD9;KIF26A;DNAH3;KIF22;MYO1E;DYNLRB1;KIF23;KIF19;DNAH17;MYL6B;KIF16B
prerank,DNA polymerase binding (GO:0070182),-0.3129867662402486,-0.7661937326397288,0.8037383177570093,0.9607477563221912,1.0,4/18,12.56%,HSP90AA1;RTEL1;SMARCA4;FANCI
prerank,histone demethylase activity (GO:0032452),0.32629157877497156,0.7652490592908647,0.7857142857142857,0.9741445448796814,1.0,10/27,22.77%,KDM3A;KDM6A;JMJD1C;KDM4C;JARID2;KDM5C;KDM4A;KDM1A;JMJD6;PHF2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.31777384858644786,-0.7648663314991896,0.7719714964370546,0.9583430523133039,1.0,4/15,16.77%,AGPAT4;LCLAT1;LPCAT1;AGPAT3
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.33706414596909495,0.7642784255025833,0.7598684210526315,0.9728318339419211,1.0,4/20,13.77%,TJP2;AK4;MAGI3;CMPK1
prerank,phosphatidate phosphatase activity (GO:0008195),0.36483723693038195,0.7629840849822036,0.7378815080789947,0.9720074670923442,1.0,2/13,5.65%,PLPP1;LPIN3
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.3149704219063136,-0.7613133813755056,0.7873303167420814,0.9591109884530399,1.0,4/13,29.29%,TARBP1;THUMPD3;METTL1;TRMT10B
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.31492977678568046,-0.7607386485973746,0.7915690866510539,0.9555815787696361,1.0,1/15,2.77%,CCR9
prerank,methylated histone binding (GO:0035064),0.27587827091408995,0.7607007438884842,0.8125874125874126,0.9728474372666371,1.0,19/62,22.77%,KMT2E;SPIN1;MTF2;CHD1;CDYL;TRIM24;GLYR1;ZMYND11;FMR1;ATRX;KDM4A;CXXC1;PHF19;ZCWPW2;ING3;RBBP5;TAF7;PHF1;PHF2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3406079678330534,-0.7582158229756523,0.7734553775743707,0.9548280255268405,1.0,3/11,14.01%,SLC5A3;SLC2A10;SLC5A11
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.33436355574812776,-0.7571414154251278,0.782312925170068,0.9520800614278305,1.0,2/11,10.03%,NUDT4;NUDT7
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.35852088140995636,0.7570995037145077,0.7219152854511971,0.9756543545492206,1.0,2/12,12.21%,OPN4;OPN5
prerank,mRNA methyltransferase activity (GO:0008174),0.36129539914048736,0.7547158966614689,0.7559633027522936,0.9764735499919891,1.0,6/12,27.21%,RNMT;METTL14;TRMT10C;TRMT61B;METTL16;NSUN2
prerank,myosin V binding (GO:0031489),0.3569924642373453,0.7532877700826643,0.7680412371134021,0.9757382193871892,1.0,5/15,22.84%,RAB11A;RAB11B;RAB6A;RAB25;RAB3A
prerank,epidermal growth factor receptor binding (GO:0005154),0.31476290373342214,0.7514177100847315,0.7956081081081081,0.975775589078701,1.0,9/25,19.31%,HIP1;CCDC88A;TGFA;SNX4;SNX1;GRB2;PLSCR1;LINGO1;BTC
prerank,transferrin receptor binding (GO:1990459),-0.33879647644233535,-0.7508761270525252,0.778705636743215,0.9564311012512892,1.0,3/10,11.17%,RGMA;CHUK;CD81
prerank,CoA hydrolase activity (GO:0016289),-0.303814071804303,-0.7508590166063999,0.7699530516431925,0.9522027836698862,1.0,8/16,38.22%,ACOT11;NUDT7;ACOT9;ACOT8;ACOT1;ACOT7;HIBCH;ACOT12
prerank,potassium:proton antiporter activity (GO:0015386),-0.3409925495559604,-0.745522924190516,0.7752808988764045,0.9550327025653503,1.0,5/10,29.75%,SLC9A9;SLC9A1;SLC9A8;SLC9A4;SLC9A2
prerank,muscle alpha-actinin binding (GO:0051371),-0.30923553476141963,-0.7443119306512171,0.8137931034482758,0.9524615363645085,1.0,5/15,16.90%,PALLD;PDLIM7;PDLIM4;LDB3;PDLIM2
prerank,tubulin binding (GO:0015631),0.22491307628507787,0.7434200998787269,0.9472502805836139,0.9844722937743958,1.0,37/295,14.39%,DNM3;MTUS1;DIXDC1;RAB11A;ARHGEF2;REEP1;DST;STARD9;FYN;KIF26A;DIP2B;RAB11FIP5;MAST2;TTLL7;CCDC88A;MID2;TRPV4;KIF22;PHF6;ARHGEF7;TBCA;RAD51D;CEP57;PRUNE1;ARL8B;KIF23;KIF19;EML6;GABARAPL1;KIF16B;FMR1;PEX14;NDEL1;TTLL5;APC;S100A9;MID1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3013452278113768,0.7425009609803079,0.8210180623973727,0.9830847642685938,1.0,5/32,11.36%,KCNQ1;KCNB1;KCNE2;KCNG4;KCNA4
prerank,snRNA binding (GO:0017069),-0.23676346785755234,-0.7404543693935544,0.869942196531792,0.9535745097657643,1.0,11/42,25.24%,SNRNP70;DDX39B;CCNT2;CDK9;HNRNPU;DDX21;RNPC3;SNRPA1;RBM41;HEXIM2;SNRNP35
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3740772151456649,0.7392001948373395,0.7732342007434945,0.9849146759022687,1.0,2/10,4.20%,PRKAR2B;PKIG
prerank,endonuclease activity (GO:0004519),0.27418106500728456,0.7349010655323266,0.8528571428571429,0.9880795470801652,1.0,7/49,14.46%,ERN1;ANG;KHNYN;DICER1;INTS11;ERCC4;ZC3H12C
prerank,leucine zipper domain binding (GO:0043522),-0.3253329536765936,-0.7244360555738583,0.8161434977578476,0.9690303640760756,1.0,1/10,0.74%,PAWR
prerank,voltage-gated anion channel activity (GO:0008308),-0.29653985961871715,-0.7183220233420464,0.8393285371702638,0.9721030780073796,1.0,5/15,20.96%,ANO1;CLCN2;VDAC1;CLCN1;VDAC2
prerank,translation elongation factor activity (GO:0003746),0.33436539290300343,0.7176569508091971,0.7825311942959001,1.0,1.0,5/14,25.98%,EEFSEC;EEF2;EIF5A;EIF5AL1;GFM1
prerank,GTPase inhibitor activity (GO:0005095),0.3415774498598287,0.7161182785390259,0.8039568345323741,1.0,1.0,1/13,2.10%,IQGAP1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.24403170554632686,-0.7127804985644788,0.8781869688385269,0.9740584076505613,1.0,13/34,28.16%,KMT5A;EHMT2;SETDB1;DOT1L;SETD4;VCPKMT;MEN1;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;SETD7;EEF1AKMT3
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2910965112050793,0.7105767464529298,0.8450704225352113,1.0,1.0,13/31,26.18%,UBE2G1;UBE2H;UBE2D3;UBE2K;CDC34;UBE2Q1;UBE2L3;UBE2J2;UBE2D1;UBE2R2;UBE2E1;AKTIP;UBE2N
prerank,cholesterol binding (GO:0015485),0.26722411076584773,0.708641018512762,0.8624641833810889,1.0,1.0,5/47,8.02%,CAV1;STARD5;PROM1;OSBPL10;SOAT2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3116030824070722,0.7084276318029882,0.8240131578947368,1.0,1.0,6/19,17.12%,AFAP1L2;PAK2;GREM1;GAS6;ALKAL2;ABI1
prerank,exonuclease activity (GO:0004527),0.2665004557128713,0.7067356663069967,0.8964497041420119,1.0,1.0,9/46,15.02%,CNOT6;ISG20;ENPP2;FAN1;REXO2;EXOSC1;CNOT7;TRIR;XRN2
prerank,methyltransferase activity (GO:0008168),-0.22351485672661228,-0.7050157973924079,0.9265175718849841,0.9788363889162897,1.0,23/46,38.54%,FTSJ3;METTL27;COQ5;LCMT1;NDUFAF7;ASMT;BUD23;EEF1AKMT1;NNMT;PRMT8;RRP8;BCDIN3D;EEF1AKMT3;AS3MT;NTMT1;PRMT7;MEPCE;COMTD1;EEF1AKMT4;AMT;PRMT1;EEF1AKMT2;METTL4
prerank,monocarboxylic acid binding (GO:0033293),0.31797023961501764,0.7042634522966902,0.8226837060702875,1.0,1.0,2/18,6.57%,CYP26A1;CYP26C1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.25307351172249126,0.7029737169726388,0.8911174785100286,1.0,1.0,8/60,7.19%,PPP3CA;PPM1F;PPM1L;PPP3CB;MTMR6;PGAM5;PPM1D;LCK
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.28011349747643205,0.6994423048137165,0.8589743589743589,1.0,1.0,3/31,8.09%,SLC12A7;SLC12A9;PKD2
prerank,mannose binding (GO:0005537),0.3316573100551039,0.6933848336933792,0.8327402135231317,1.0,1.0,3/12,26.58%,ACR;CLN5;LMAN2L
prerank,regulatory RNA binding (GO:0061980),-0.22482137517327866,-0.693090210775053,0.9452449567723343,0.9870781934042367,1.0,11/38,22.43%,HNRNPA2B1;AGO3;RBM4;ZC3H7B;HNRNPA1;DDX21;TUT4;ZNF346;SOX2;MATR3;PIWIL2
prerank,tRNA methyltransferase activity (GO:0008175),-0.28542454240263415,-0.6923081793310422,0.8660508083140878,0.9837248071821018,1.0,10/16,44.89%,TARBP1;THUMPD3;BCDIN3D;METTL2A;METTL2B;THUMPD2;TRMT13;TRMT9B;TRMT44;FTSJ1
prerank,microtubule binding (GO:0008017),0.21371992882615498,0.6909996061376737,0.9793103448275862,1.0,1.0,31/222,16.82%,DNM3;MTUS1;RAB11A;ARHGEF2;REEP1;DST;STARD9;KIF26A;MAST2;CCDC88A;MID2;TRPV4;CAMSAP2;KIF22;CEP57;KIF23;KIF19;EML6;KIF16B;FMR1;PEX14;NDEL1;APC;S100A9;MID1;CEP290;CHP1;TERF1;CEP295;FNTA;ABRAXAS2
prerank,nuclear localization sequence binding (GO:0008139),0.30661364989174916,0.6840264852888004,0.8598290598290599,1.0,1.0,5/18,21.53%,NFKBIA;NUP214;NUP153;KPNB1;KPNA4
prerank,phospholipase activity (GO:0004620),0.24881806591942848,0.6839188878865399,0.915041782729805,1.0,1.0,7/67,9.99%,PLCB4;PLA2G4A;ENPP2;PLA2G2D;LPL;PLAAT3;GDPD1
prerank,translation initiation factor activity (GO:0003743),0.26735566187059645,0.6824863986858097,0.8929110105580694,1.0,1.0,8/36,16.00%,EIF4E;EIF3H;EIF1;EIF2B5;EIF5B;EIF2B2;MTIF3;EIF5
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2759009484654113,0.6810805386894979,0.865533230293663,1.0,1.0,10/34,24.70%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2759009484654113,0.6810805386894979,0.865533230293663,1.0,1.0,10/34,24.70%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7
prerank,death domain binding (GO:0070513),0.32733613474824236,0.680500860902683,0.8299445471349353,1.0,1.0,5/11,16.24%,CRADD;BCL2L1;RIPK1;RACK1;IRGM
prerank,death receptor binding (GO:0005123),0.31572322790068386,0.6774829590566669,0.8434163701067615,1.0,1.0,5/15,19.21%,DAB2IP;RIPK1;BID;CASP8AP2;MADD
prerank,snoRNA binding (GO:0030515),0.2731271297677603,0.6718489283632785,0.8694267515923567,1.0,1.0,8/30,18.90%,IMP3;ISG20;NUDT16;RRP9;UTP6;HEATR1;NOP14;NUDT1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.31011338823682094,-0.6716489830723036,0.857451403887689,0.9992821265747732,1.0,7/10,40.35%,POLD1;EXO1;DCLRE1B;EXD2;FEN1;MGME1;TATDN1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.3089888660188165,0.6644116485640112,0.84375,1.0,1.0,2/15,7.41%,PIK3C2A;PIK3CG
prerank,aspartic-type peptidase activity (GO:0070001),0.32322452813040337,0.6632708936074244,0.8408239700374532,1.0,1.0,4/10,26.86%,PSEN1;DDI2;NAPSA;CTSE
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2522781159489765,0.661141273165152,0.9167927382753404,1.0,1.0,8/42,17.36%,CCNK;CDKN1B;CCNYL1;CCNY;INCA1;KAT2B;CCNJ;CCNC
prerank,3'-5' DNA helicase activity (GO:0043138),-0.26751255847575,-0.6580713260120458,0.8891509433962265,1.0,1.0,2/16,6.00%,NAV2;RECQL5
prerank,RNA methyltransferase activity (GO:0008173),0.28905858659668426,0.6576211328200974,0.8784246575342466,1.0,1.0,3/19,13.10%,TGS1;FBLL1;HENMT1
prerank,RNA polymerase II complex binding (GO:0000993),-0.22856195833059517,-0.6559515131085766,0.9243697478991597,1.0,1.0,8/32,19.53%,RECQL5;CTR9;PAF1;ERCC5;WDR43;HNRNPU;UVSSA;ELP4
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3312821815870839,0.6536411806663655,0.8305709023941068,1.0,1.0,3/10,18.34%,NAA11;NAA16;NAA30
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.28905056964379444,-0.652496399249275,0.8844444444444445,1.0,1.0,4/11,27.59%,APEX2;NEIL3;NTHL1;NEIL1
prerank,ubiquitin binding (GO:0043130),0.2283048201994674,0.6453182400386969,0.9491978609625669,1.0,1.0,22/73,23.19%,MVB12B;FBXW7;N4BP1;NEDD4;IKBKG;VPS28;RAD23A;CXCR4;BUB3;ILRUN;UBXN1;DDI2;BIRC2;WDR48;GGA3;USP25;TSG101;VPS36;UBXN2A;FBXO7;UCHL3;ADRM1
prerank,kinase inhibitor activity (GO:0019210),0.26062126099194793,0.6444724026674772,0.9234303215926493,1.0,1.0,11/33,19.79%,NCK1;CDKN1B;GMFG;WARS1;TRIB1;GSKIP;NPM1;MBIP;SH3BP5L;PRKRIP1;DUSP19
prerank,neuropeptide receptor activity (GO:0008188),-0.22252975186804458,-0.6415688022591368,0.9461756373937678,1.0,1.0,3/29,7.45%,SORCS2;SORCS1;SORCS3
prerank,ribosome binding (GO:0043022),-0.2023754283464967,-0.6376863699468152,0.9819277108433735,1.0,1.0,8/46,16.54%,CPEB1;CPEB2;CPEB3;CPEB4;EIF3C;SHFL;SEC61A2;IGHMBP2
prerank,lipase activity (GO:0016298),0.2442515309384774,0.63082551064946,0.9423076923076923,1.0,1.0,8/43,18.96%,ABHD2;LIPE;LPL;PNPLA2;PNPLA8;FAAH;LIPA;CEL
prerank,exopeptidase activity (GO:0008238),0.23071624431727367,0.6272881274172256,0.9579100145137881,1.0,1.0,9/50,15.61%,PRCP;CPE;PM20D2;ERAP1;NUDT16;LAP3;GGH;ACE;ZMPSTE24
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.2932677147260764,0.6263145142818192,0.8795620437956204,1.0,1.0,3/13,15.10%,DICER1;FAN1;ENDOV
prerank,microtubule minus-end binding (GO:0051011),0.29590639948176256,0.6257287999154624,0.8896797153024911,1.0,1.0,7/13,29.48%,CAMSAP2;CEP290;NUMA1;TUBGCP2;CAMSAP1;HAUS4;TUBGCP3
prerank,channel activity (GO:0015267),0.23945592441821312,0.6233178452066981,0.9421875,1.0,1.0,6/41,14.87%,AQP11;TRPV6;TRPV4;MCUB;PANX1;CHRNB1
prerank,NADPH binding (GO:0070402),0.29297366592101864,0.6220899753028492,0.896797153024911,1.0,1.0,1/13,3.41%,LBR
prerank,microtubule motor activity (GO:0003777),0.22935604959964082,0.6217212924527598,0.9617083946980854,1.0,1.0,9/51,12.55%,STARD9;KIF26A;DNAH3;KIF22;DYNLRB1;KIF23;KIF19;DNAH17;KIF16B
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.2967208843090102,0.6191131132359377,0.872822299651568,1.0,1.0,3/12,18.17%,CBR1;CBR4;NQO2
prerank,hormone activity (GO:0005179),-0.19191928276110876,-0.6139719642814596,0.9826989619377162,1.0,1.0,1/54,0.34%,IGF1
prerank,Hsp70 protein binding (GO:0030544),0.24245098277989788,0.6109522702868342,0.9373040752351097,1.0,1.0,2/31,6.78%,ERN1;DNAJA1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2788317604924747,0.6082812272316039,0.9119170984455959,1.0,1.0,2/18,13.32%,RDH16;SRD5A2
prerank,N-acetyltransferase activity (GO:0008080),0.2704016242970045,0.6079808998640173,0.9192439862542955,1.0,1.0,3/19,14.68%,NAT2;SMARCE1;KAT2B
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.23788002134193106,-0.596729047580046,0.9616306954436451,1.0,1.0,7/17,33.81%,ACOT11;PPT1;PLA2G6;ACOT9;ACOT8;ACOT1;ACOT7
prerank,O-methyltransferase activity (GO:0008171),-0.2694601673791326,-0.5956476090903385,0.9327548806941431,1.0,1.0,4/10,31.10%,FTSJ3;ASMT;BCDIN3D;MEPCE
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.23697054960337746,0.592428096403362,0.9592476489028213,1.0,1.0,13/35,33.08%,PTRH1;NT5C3A;DTWD2;QRSL1;MTFMT;AARS2;LCMT2;TRMT12;TRIT1;GATC;ALKBH1;TYW3;PUS10
prerank,5'-nucleotidase activity (GO:0008253),0.2837990331794839,0.5908344455971355,0.9280575539568345,1.0,1.0,2/13,10.88%,NT5C2;NT5C3A
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.21814810672094764,-0.5905680535461902,0.9523809523809523,1.0,1.0,3/25,7.77%,SIRT2;PARP3;PARP11
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.2549302082376845,0.5885650177470515,0.9362068965517242,1.0,1.0,4/22,11.71%,MESD;DNAJA1;AP2A1;PICALM
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.20821606670621884,-0.5868939692298033,0.9769820971867008,1.0,1.0,11/27,31.45%,POLR2B;POLR3H;MED20;POLRMT;POLR2I;TERT;MED21;POLR3K;POLR2D;CRCP;POLR2G
prerank,histone methyltransferase activity (GO:0042054),-0.19980528339977097,-0.5819941165532845,0.9867021276595744,1.0,1.0,12/32,30.37%,KMT5A;EHMT2;SETDB1;DOT1L;CARM1;MEN1;PRMT8;FBL;PRMT2;SETD7;NTMT1;PRMT7
prerank,CCR chemokine receptor binding (GO:0048020),-0.2081644766995106,-0.581677593644517,0.9717514124293786,1.0,1.0,17/28,47.43%,NES;CCL19;CCR2;CCL2;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2555487879805108,0.5781852183345405,0.9395973154362416,1.0,1.0,7/20,19.18%,EIF3H;COPS2;YOD1;DESI2;USP7;USP25;USP21
prerank,four-way junction DNA binding (GO:0000400),-0.2257816246967614,-0.5735227574715507,0.9670588235294117,1.0,1.0,7/17,24.99%,RAD51B;MSH6;HMGB2;MEN1;RAD51C;GEN1;XRCC3
prerank,acetyltransferase activity (GO:0016407),-0.19994391145255164,-0.5725491644719696,0.9836065573770492,1.0,1.0,6/31,15.56%,PAFAH2;ACAT1;SPHK1;SAT1;KAT8;PAFAH1B2
prerank,ATPase activator activity (GO:0001671),0.24894320695223704,0.5680785628715012,0.9408783783783784,1.0,1.0,5/20,20.04%,DNAJA1;ATP1B3;DNAJB1;DNAJC10;DNAJB6
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.2639411645390439,0.5650190066684488,0.9392265193370166,1.0,1.0,2/14,11.89%,RDH16;ADH1A
prerank,acetylcholine receptor activity (GO:0015464),-0.21061725760738859,-0.5647112967829914,0.975,1.0,1.0,14/22,47.85%,CHRNA7;CHRFAM7A;CHRM3;CHRM2;CHRM1;CHRNB2;CHRM5;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;HRH4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.22153931393484133,0.555452260085528,0.9784283513097073,1.0,1.0,8/33,18.93%,ZNF326;RRN3;RPRD1B;ESRRB;RPRD2;ERBB2;CDC73;RPRD1A
prerank,glutathione transferase activity (GO:0004364),0.2362283908205861,0.5523517218479782,0.9648,1.0,1.0,4/23,12.62%,ALOX5AP;GSTA4;LTC4S;GSTP1
prerank,single-stranded DNA binding (GO:0003697),0.18618978727746097,0.5458780985977438,0.9936788874841972,1.0,1.0,12/93,13.02%,SAMHD1;MCM10;RPA1;POLA1;SUB1;RAD51D;MEIOB;RAD23A;LONP1;MCM9;ERCC4;TOP1
prerank,neuropeptide receptor binding (GO:0071855),-0.22893016933644023,-0.5452636485646679,0.9571106094808126,1.0,1.0,4/14,30.81%,SHANK1;NPY;NTS;APLN
prerank,nucleotidase activity (GO:0008252),0.25153210793654546,0.5408212284451233,0.9525483304042179,1.0,1.0,2/15,10.88%,NT5C2;NT5C3A
prerank,C-C chemokine receptor activity (GO:0016493),0.2336506477417401,0.5391644554767963,0.9457627118644067,1.0,1.0,4/21,20.78%,CX3CR1;CXCR4;CCR1;CXCR6
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.2210850416307072,-0.5378305673313121,0.9665071770334929,1.0,1.0,3/14,22.40%,ACO2;NFU1;RSAD2
prerank,ribonuclease P RNA binding (GO:0033204),0.2674613370273988,0.5350305255143044,0.9402697495183044,1.0,1.0,2/10,12.20%,RPP30;RPP25
prerank,ribonuclease P activity (GO:0004526),0.26437772405930565,0.5330031708102624,0.9320388349514563,1.0,1.0,5/11,27.99%,RPP30;RPP25;PRORP;RPP38;RPP14
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.17597399436692546,-0.5325784238429153,0.9916897506925207,1.0,1.0,19/40,34.86%,DNMT3A;HNMT;TARBP1;LCMT1;TPMT;ASMT;NNMT;PRMT8;FBL;THUMPD3;RRP8;AS3MT;METTL18;PRMT7;GNMT;MEPCE;COMTD1;METTL2A;METTL2B
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.2657030493469714,0.530828575458408,0.9486238532110092,1.0,1.0,4/10,28.46%,SETD5;PRDM9;NSD2;SMYD2
prerank,calcium-release channel activity (GO:0015278),0.24114048869435714,0.5262230196020677,0.9413854351687388,1.0,1.0,2/17,8.09%,ITPR3;PKD2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.22117236817043207,0.5258987247418679,0.972176759410802,1.0,1.0,9/27,26.09%,POLR1A;PRIMPOL;POLR1B;POLR3B;POLR3A;POLR2L;POLR2J;POLR3F;PRIM1
prerank,ATP hydrolysis activity (GO:0140603),0.20262704288725092,0.5228017050217921,0.9872,1.0,1.0,6/41,13.50%,KIF26A;SMCHD1;ABCA3;MYO1E;ABCD1;TOR3A
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.18908892003772235,-0.5193457356731565,0.9821428571428571,1.0,1.0,2/24,8.44%,GLUL;ZDHHC20
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.21021521482823569,-0.5172682838203994,0.9812646370023419,1.0,1.0,6/15,31.83%,KMT2D;SETMAR;SETD4;SETD1A;WDR5;WDR82
prerank,tRNA binding (GO:0000049),0.20175591238103666,0.5144822054079287,0.9837037037037037,1.0,1.0,19/43,32.41%,FARS2;EIF2AK4;AIMP1;KARS1;XPOT;YRDC;TRNAU1AP;NSUN6;ALKBH8;AARS2;TRMT10C;NSUN2;CARS1;RPUSD4;TRMT10A;NEMF;ALKBH1;TYW5;EIF2A
prerank,vitamin D receptor binding (GO:0042809),0.2392210600454806,0.5128703094302971,0.9443478260869566,1.0,1.0,4/14,22.80%,SNW1;TAF7;MED12;MED17
prerank,palmitoyltransferase activity (GO:0016409),0.20972040955880084,0.5126555019447349,0.9686520376175548,1.0,1.0,9/28,23.64%,ZDHHC18;ZDHHC9;HHAT;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC17;ZDHHC2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.18934017670966563,0.5110786253692358,0.9971509971509972,1.0,1.0,13/57,24.80%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;UQCRQ;NDUFS4;NDUFS6;UQCRC1;NDUFB9;NDUFC1;NDUFS8;NDUFB7;COX6A1
prerank,damaged DNA binding (GO:0003684),-0.16250222224077743,-0.5020867968334325,0.9967741935483871,1.0,1.0,17/44,32.51%,CRY2;DDB2;ERCC5;APTX;DDB1;XPC;HMGB2;NEIL3;SMC6;TDG;NTHL1;POLD1;RAD1;DCLRE1B;RPA2;ERCC1;FEN1
prerank,chemokine receptor binding (GO:0042379),0.20229018600436752,0.5014507981572105,0.989329268292683,1.0,1.0,3/35,10.41%,CX3CR1;PPBP;CCL14
prerank,neuropeptide hormone activity (GO:0005184),0.22204773869346706,0.49374008288436366,0.9752475247524752,1.0,1.0,22/22,77.83%,UCN;AGRP;PPY;NPFF;SPX;GAL;PNOC;OXT;CORT;NMB;QRFP;HCRT;GHRH;NPPA;CALCB;CRH;PENK;VIP;GRP;ADCYAP1;NPY;CCK
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.2190220339204188,-0.4933838332206805,0.9612068965517241,0.9990063195592399,1.0,3/11,21.58%,NAA40;NAA80;NAA60
prerank,chemokine activity (GO:0008009),-0.1646604548290003,-0.48027079739342815,0.9915254237288136,0.9976875579939607,1.0,12/31,39.20%,CXCL16;CXCL12;CCL19;CCL2;CCL28;CCL5;CXCL5;CCL11;CCL4;PF4;CCL7;CCL8
prerank,single-stranded DNA helicase activity (GO:0017116),0.20530050869810987,0.47078812761855426,0.9825783972125436,1.0,1.0,19/19,79.49%,HELB;RFC3;RFC5;MCM6;RFC2;MCM7;MCM2;RAD51;RFC4;MCM5;WRNIP1;POLQ;PIF1;CHTF8;CHTF18;DHX9;DSCC1;HELQ;DNA2
prerank,deoxyribonuclease activity (GO:0004536),-0.19628697191741132,-0.47004751598282807,0.9847826086956522,0.9954139355738982,1.0,6/14,37.00%,ERCC5;MAP1S;DNASE1L2;DNASE1L1;ZRANB3;APLF
prerank,pseudouridine synthase activity (GO:0009982),0.21752181577308838,0.46718764010260894,0.9724137931034482,1.0,1.0,7/13,30.36%,PUS7L;TRUB1;RPUSD2;PUS7;PUSL1;RPUSD4;RPUSD1
prerank,N-methyltransferase activity (GO:0008170),0.20245788800677084,0.46182303028884486,0.9795221843003413,1.0,1.0,3/20,12.87%,TFB2M;PEMT;RNMT
prerank,chemokine receptor activity (GO:0004950),0.19555740913159322,0.4532400841308692,0.9882154882154882,1.0,1.0,4/24,20.78%,CX3CR1;CXCR4;CCR1;CXCR6
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.2262740040496546,0.4499062064110826,0.9795539033457249,1.0,1.0,1/11,7.75%,ITPR3
prerank,beta-tubulin binding (GO:0048487),0.17961294174389536,0.44438936092951564,1.0,1.0,1.0,9/31,22.69%,TTLL7;TRPV4;ARL8B;GABARAPL1;PEX14;RACGAP1;UXT;TAOK1;APPL1
prerank,proton transmembrane transporter activity (GO:0015078),0.17234927280091542,0.44284955757700584,0.995334370139969,1.0,1.0,2/39,6.36%,CLCN3;OTOP2
prerank,single-stranded RNA binding (GO:0003727),0.17033830306755837,0.43717403388242976,0.9985315712187959,1.0,1.0,7/43,15.60%,HNRNPF;CNBP;LONP1;IFIH1;FMR1;ENDOV;AQR
prerank,endodeoxyribonuclease activity (GO:0004520),0.18876208033333708,0.4354009926454367,0.989983305509182,1.0,1.0,9/20,28.27%,ERCC4;ENDOV;DCLRE1C;ENDOG;RPS3;MBD4;APEX1;RBBP8;EXOG
prerank,MHC protein binding (GO:0042287),0.18107782047661414,0.4149027117259027,0.9949748743718593,1.0,1.0,1/20,5.78%,TAP2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.1928051230537419,0.41337429110892204,0.9932998324958124,1.0,1.0,14/14,80.74%,CAPN5;CAPN12;CAPN3;CAPN10;CAPN13;CAPN9;CAPNS2;CAPN11;CAPN8;CAPN15;CAPNS1;CAPN1;CAPN6;CAPN2
prerank,nuclear import signal receptor activity (GO:0061608),-0.16537219725870722,-0.39200133779476837,0.9976525821596244,0.9986961682915912,1.0,8/15,41.62%,TNPO2;KPNA2;IPO5;KPNA3;IPO9;IPO4;KPNA6;KPNA7
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.1844830832967172,0.3810973666962882,0.9909747292418772,1.0,1.0,11/11,81.56%,CHRNB1;CHRNA9;CHRNA4;CHRNA10;CHRNA2;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNB2;CHRNA7
prerank,ferrous iron binding (GO:0008198),0.15384131244588206,0.35276429140535787,1.0,0.9992512642115812,1.0,5/21,23.67%,EGLN1;TET2;ACP5;EGLN2;FXN
